Seed	Sign	Gene_target	Ensembl	Repeated	N_repeated	Repeated2	N_repeated2	P-value	Ortholist2	Orthologs	TRRUST(+)	Phenotype	GO	GOterm	Keyword	Reactome	Reactome_terms
COQ8A	positive	CBX7	ENSG00000100307	COQ8A	1	COQ8A	1	0.000528067313456226		WBGene00007615(0);WBGene00001995(0)	CDH1		GO:0005634;GO:0005829;GO:0005654;GO:0006325;GO:0000790;GO:0005515;GO:0000122;GO:0031519;GO:0035102	PRC1 complex;nucleus;nucleoplasm;cytosol;chromatin organization;nuclear chromatin;protein binding;negative regulation of transcription by RNA polymerase II;PcG protein complex	3D-structure;Chromatin regulator;Nucleus;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ8A	positive	FRAT2	ENSG00000181274	COQ8A	1	COQ8A	1	0.000718888856063416					GO:0007275;GO:0016055;GO:0005737;GO:0005829;GO:0003674;GO:0005575;GO:0008283;GO:1904886	Wnt signaling pathway;cytoplasm;cytosol;molecular_function;cellular_component;beta-catenin destruction complex disassembly	Reference proteome;Wnt signaling pathway	R-HSA-162582;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-4641262;R-HSA-196299	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Beta-catenin phosphorylation cascade
COQ8A	positive	FAM117A	ENSG00000121104	COQ8A	1	COQ8A	1	0.00107246346036505							Alternative splicing;Coiled coil;Phosphoprotein;Reference proteome		
COQ8A	positive	PCMTD2	ENSG00000203880	COQ8A	1	COQ8A	1	0.00209388268615052	WBGene00020090	WBGene00020090(0)			GO:0005737;GO:0006464;GO:0032259;GO:0004719;GO:0006479	cellular protein modification process;protein-L-isoaspartate (D-aspartate) O-methyltransferase activity;cytoplasm;protein methylation	Alternative splicing;Cytoplasm;Lipoprotein;Myristate;Reference proteome		
COQ8A	positive	GAA	ENSG00000171298	COQ8A	1	COQ8A	1	0.00251677179266452	WBGene00017071;WBGene00019895	WBGene00019895(0);WBGene00018682(0)		Glycogen storage disease due to acid maltase deficiency infantile onset;Glycogen storage disease due to acid maltase deficiency late-onset;GLYCOGEN STORAGE DISEASE TYPE II;GLYCOGEN STORAGE DISEASE II	GO:0016020;GO:0016021;GO:0030246;GO:0003824;GO:0005975;GO:0016787;GO:0005765;GO:0008152;GO:0004553;GO:0016798;GO:0005764;GO:0005886;GO:0070062;GO:0043312;GO:0070821;GO:0035577;GO:0043202;GO:0060048;GO:0101003;GO:0004558;GO:0032450;GO:0090599;GO:0007040;GO:0005980;GO:0000023;GO:0002086;GO:0005985;GO:0006006;GO:0043181;GO:0002026;GO:0003007;GO:0005977;GO:0006941;GO:0007626;GO:0009888;GO:0046716;GO:0050884;GO:0050885	carbohydrate metabolic process;catalytic activity;carbohydrate binding;membrane;integral component of membrane;hydrolase activity, hydrolyzing O-glycosyl compounds;cell;hydrolase activity;lysosomal membrane;metabolic process;hydrolase activity, acting on glycosyl bonds;lysosome;plasma membrane;extracellular exosome;neutrophil degranulation;tertiary granule membrane;azurophil granule membrane;lysosomal lumen;cardiac muscle contraction;ficolin-1-rich granule membrane;alpha-1,4-glucosidase activity;maltose alpha-glucosidase activity;alpha-glucosidase activity;lysosome organization;glycogen catabolic process;maltose metabolic process;diaphragm contraction;sucrose metabolic process;glucose metabolic process;vacuolar sequestering;regulation of the force of heart contraction;heart morphogenesis;glycogen metabolic process;striated muscle contraction;locomotory behavior;tissue development;muscle cell cellular homeostasis;neuromuscular process controlling posture;neuromuscular process controlling balance	3D-structure;Direct protein sequencing;Disease mutation;Disulfide bond;Glycogen storage disease;Glycoprotein;Glycosidase;Hydrolase;Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Signal	R-HSA-168249;R-HSA-168256;R-HSA-1430728;R-HSA-1643685;R-HSA-71387;R-HSA-6798695;R-HSA-5668914;R-HSA-3229121;R-HSA-5663084;R-HSA-70221;R-HSA-8982491;R-HSA-5357609	Innate Immune System;Immune System;Metabolism;Disease;Metabolism of carbohydrates;Neutrophil degranulation;Diseases of metabolism;Glycogen storage diseases;Diseases of carbohydrate metabolism;Glycogen breakdown (glycogenolysis);Glycogen metabolism;Glycogen storage disease type II (GAA)
COQ8A	positive	PEX6	ENSG00000124587	COQ8A	1	COQ8A	1	0.00275594180130545	WBGene00004195	WBGene00004195(0)		Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome;Deafness-enamel hypoplasia-nail defects syndrome;Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER COMPLEMENTATION GROUP 4;Zellweger Syndrome;HEIMLER SYNDROME 2;PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 4B	GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0005829;GO:0042995;GO:0005515;GO:0007031;GO:0005778;GO:0097733;GO:0005777;GO:0016887;GO:0050821;GO:0001750;GO:0006625;GO:0008022;GO:0016558;GO:0044877;GO:0042623;GO:0016561	ATP binding;cytoplasm;membrane;nucleotide binding;cytosol;cell projection;protein binding;ATPase activity;peroxisome organization;peroxisomal membrane;photoreceptor cell cilium;peroxisome;protein stabilization;photoreceptor outer segment;protein targeting to peroxisome;protein C-terminus binding;protein import into peroxisome matrix;protein-containing complex binding;ATPase activity, coupled;protein import into peroxisome matrix, translocation	ATP-binding;Alternative splicing;Amelogenesis imperfecta;Cell projection;Cytoplasm;Deafness;Disease mutation;Membrane;Methylation;Nucleotide-binding;Peroxisome;Peroxisome biogenesis;Peroxisome biogenesis disorder;Polymorphism;Reference proteome;Repeat;Zellweger syndrome	R-HSA-9033241;R-HSA-9609507	Peroxisomal protein import;Protein localization
COQ8A	positive	METTL7A	ENSG00000185432	COQ8A	1	COQ8A	1	0.00275594180130545		WBGene00019968(0);WBGene00019675(0);WBGene00019963(0);WBGene00019961(0)			GO:0016020;GO:0016021;GO:0016740;GO:0008168;GO:0032259;GO:0005783;GO:0005811;GO:0005576;GO:0043312;GO:1904724	methyltransferase activity;membrane;integral component of membrane;transferase activity;methylation;endoplasmic reticulum;lipid droplet;extracellular region;neutrophil degranulation;tertiary granule lumen	Endoplasmic reticulum;Lipid droplet;Membrane;Methyltransferase;Polymorphism;Reference proteome;Signal;Transferase	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ8A	positive	SCAP	ENSG00000114650	COQ8A	1	COQ8A	1	0.00329674486739551	WBGene00004744				GO:0016020;GO:0016021;GO:0005789;GO:0000139;GO:0032934;GO:0032933;GO:0005783;GO:0005794;GO:0006629;GO:0008202;GO:0031410;GO:0008203;GO:0005515;GO:0012507;GO:0051082;GO:0045541;GO:0044877;GO:0001666;GO:0006955;GO:0007568;GO:0019217;GO:0032868;GO:0042304;GO:0044255;GO:0045540;GO:0045716;GO:0032991;GO:0043231	membrane;integral component of membrane;endoplasmic reticulum membrane;Golgi membrane;sterol binding;SREBP signaling pathway;protein binding;endoplasmic reticulum;Golgi apparatus;lipid metabolic process;steroid metabolic process;cytoplasmic vesicle;cholesterol metabolic process;ER to Golgi transport vesicle membrane;unfolded protein binding;negative regulation of cholesterol biosynthetic process;protein-containing complex binding;response to hypoxia;immune response;aging;regulation of fatty acid metabolic process;response to insulin;regulation of fatty acid biosynthetic process;cellular lipid metabolic process;regulation of cholesterol biosynthetic process;positive regulation of low-density lipoprotein particle receptor biosynthetic process;protein-containing complex;intracellular membrane-bounded organelle	Alternative splicing;Cholesterol metabolism;Cytoplasmic vesicle;Endoplasmic reticulum;Glycoprotein;Golgi apparatus;Isopeptide bond;Lipid metabolism;Membrane;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Steroid metabolism;Sterol metabolism;Transmembrane;Transmembrane helix;Ubl conjugation;WD repeat	R-HSA-1430728;R-HSA-556833;R-HSA-8957322;R-HSA-1655829	Metabolism;Metabolism of lipids;Metabolism of steroids;Regulation of cholesterol biosynthesis by SREBP (SREBF)
COQ8A	positive	C2orf68	ENSG00000168887	COQ8A	1	COQ8A	1	0.00329674486739551							Alternative splicing;Reference proteome		
COQ8A	positive	ZBTB44	ENSG00000196323	COQ8A	1	COQ8A	1	0.00329674486739551					GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding	Alternative splicing;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger		
COQ8A	positive	LETMD1	ENSG00000050426	COQ8A	1	COQ8A	1	0.00360143218529851		WBGene00009276(0)			GO:0016020;GO:0016021;GO:0005654;GO:0005739;GO:0043022;GO:0005515;GO:0005741	ribosome binding;membrane;integral component of membrane;nucleoplasm;nucleolus;mitochondrion;protein binding;mitochondrial outer membrane	Alternative splicing;Membrane;Mitochondrion;Mitochondrion outer membrane;Polymorphism;Proto-oncogene;Reference proteome;Transmembrane;Transmembrane helix		
COQ8A	positive	CCDC28A	ENSG00000024862	COQ8A	1	COQ8A	1	0.00393115830743329					GO:0005515	protein binding	Chromosomal rearrangement;Coiled coil;Polymorphism;Reference proteome		
COQ8A	positive	RNASET2	ENSG00000026297	COQ8A	1	COQ8A	1	0.00393115830743329	WBGene00019624	WBGene00019624(0)		Cystic leukoencephalopathy without megalencephaly;LEUKOENCEPHALOPATHY CYSTIC WITHOUT MEGALENCEPHALY;LEUKOENCEPHALOPATHY CYSTIC WITHOUT MEGALENCEPHALY	GO:0003723;GO:0090502;GO:0033897;GO:0005783;GO:0016787;GO:0005615;GO:0090305;GO:0005576;GO:0004519;GO:0090501;GO:0004518;GO:0005764;GO:0005788;GO:0070062;GO:0043312;GO:0004521;GO:0006401;GO:0035578;GO:0004540;GO:0043202	RNA binding;ribonuclease T2 activity;RNA phosphodiester bond hydrolysis, endonucleolytic;endoplasmic reticulum;hydrolase activity;lyase activity;extracellular space;nucleic acid phosphodiester bond hydrolysis;extracellular region;nuclease activity;endonuclease activity;RNA phosphodiester bond hydrolysis;lysosome;endoplasmic reticulum lumen;extracellular exosome;neutrophil degranulation;endoribonuclease activity;RNA catabolic process;azurophil granule lumen;ribonuclease activity;lysosomal lumen	3D-structure;Alternative splicing;Disease mutation;Disulfide bond;Endonuclease;Endoplasmic reticulum;Glycoprotein;Hydrolase;Immunity;Innate immunity;Lyase;Lysosome;Mitochondrion;Nuclease;Polymorphism;Reference proteome;Secreted;Signal	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ8A	positive	RNF44	ENSG00000146083	COQ8A	1	COQ8A	1	0.00428767281799236	WBGene00012194				GO:0046872	metal ion binding	Alternative splicing;Metal-binding;Reference proteome;Zinc;Zinc-finger		
COQ8A	positive	CAMK2G	ENSG00000148660	COQ8A	1	COQ8A	1	0.00428767281799236	WBGene00006779;WBGene00000553				GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005515;GO:0007275;GO:0006470;GO:0030154;GO:0004683;GO:0005516;GO:0042802;GO:0005737;GO:0007399;GO:0043005;GO:0005654;GO:0005829;GO:0016529;GO:1900034;GO:0042803;GO:0030666;GO:0051924;GO:0033017;GO:0060333;GO:0030073;GO:0004723;GO:0014733;GO:0005954;GO:0000082;GO:0006816;GO:0046777;GO:1901897;GO:0014069	ATP binding;protein phosphorylation;protein kinase activity;calmodulin binding;calmodulin-dependent protein kinase activity;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein binding;multicellular organism development;protein dephosphorylation;cell differentiation;identical protein binding;cytoplasm;nervous system development;neuron projection;nucleoplasm;cytosol;sarcoplasmic reticulum;regulation of cellular response to heat;protein homodimerization activity;endocytic vesicle membrane;regulation of calcium ion transport;sarcoplasmic reticulum membrane;interferon-gamma-mediated signaling pathway;insulin secretion;regulation of neuron projection development;calcium-dependent protein serine/threonine phosphatase activity;regulation of skeletal muscle adaptation;calcium- and calmodulin-dependent protein kinase complex;G1/S transition of mitotic cell cycle;calcium ion transport;protein autophosphorylation;regulation of relaxation of cardiac muscle;postsynaptic density	3D-structure;ATP-binding;Alternative splicing;Calmodulin-binding;Developmental protein;Differentiation;Kinase;Membrane;Mental retardation;Neurogenesis;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Sarcoplasmic reticulum;Serine/threonine-protein kinase;Transferase	R-HSA-168256;R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-382551;R-HSA-162582;R-HSA-983712;R-HSA-372790;R-HSA-388396;R-HSA-1643685;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-449836;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-8953897;R-HSA-9006925;R-HSA-9607240;R-HSA-418594;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-438064;R-HSA-442755;R-HSA-9609736;R-HSA-3371556;R-HSA-913531;R-HSA-111885;R-HSA-112040;R-HSA-112043;R-HSA-8986944;R-HSA-397014;R-HSA-5576891;R-HSA-5578775;R-HSA-936837;R-HSA-6802952;R-HSA-6802957;R-HSA-5576892;R-HSA-877300;R-HSA-442742;R-HSA-442982;R-HSA-9022692;R-HSA-438066;R-HSA-9617324;R-HSA-9620244;R-HSA-111933;R-HSA-111996;R-HSA-111997;R-HSA-1489509;R-HSA-6802949;R-HSA-399719;R-HSA-399721;R-HSA-5673000;R-HSA-6802946;R-HSA-6802955;R-HSA-3371571;R-HSA-111932;R-HSA-442729	Immune System;Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Transport of small molecules;Signal Transduction;Ion channel transport;Signaling by GPCR;GPCR downstream signalling;Disease;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Other interleukin signaling;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;Cellular responses to external stimuli;Intracellular signaling by second messengers;FLT3 Signaling;G alpha (i) signalling events;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;Assembly and cell surface presentation of NMDA receptors;Cellular response to heat stress;Interferon Signaling;Opioid Signalling;G-protein mediated events;PLC beta mediated events;Transcriptional Regulation by MECP2;Muscle contraction;Cardiac conduction;Ion homeostasis;Ion transport by P-type ATPases;Signaling by BRAF and RAF fusions;Oncogenic MAPK signaling;Phase 0 - rapid depolarisation;Interferon gamma signaling;CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling;Ras activation upon Ca2+ influx through NMDA receptor;Regulation of MECP2 expression and activity;Unblocking of NMDA receptors, glutamate binding and activation;Negative regulation of NMDA receptor-mediated neuronal transmission;Long-term potentiation;Calmodulin induced events;Ca-dependent events;CaM pathway;DAG and IP3 signaling;Signaling by RAS mutants;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;RAF activation;Signaling by moderate kinase activity BRAF mutants;Paradoxical activation of RAF signaling by kinase inactive BRAF;HSF1-dependent transactivation;CaMK IV-mediated phosphorylation of CREB;CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
COQ8A	positive	PLCL2	ENSG00000154822	COQ8A	1	COQ8A	1	0.00428767281799236	WBGene00004045	WBGene00004039(0);WBGene00004045(0)			GO:0005737;GO:0035556;GO:0007165;GO:0006629;GO:0008081;GO:0004435;GO:0050811;GO:0070679;GO:0032228;GO:0120163;GO:0048015;GO:0032959;GO:0051209;GO:0002322;GO:0002337;GO:0007214;GO:0033135;GO:0050859;GO:1900122;GO:0016787;GO:0016042	signal transduction;inositol 1,4,5 trisphosphate binding;intracellular signal transduction;lipid metabolic process;phosphatidylinositol phospholipase C activity;phosphoric diester hydrolase activity;GABA receptor binding;regulation of synaptic transmission, GABAergic;cell;cytoplasm;negative regulation of cold-induced thermogenesis;phosphatidylinositol-mediated signaling;inositol trisphosphate biosynthetic process;release of sequestered calcium ion into cytosol;B cell proliferation involved in immune response;B-1a B cell differentiation;gamma-aminobutyric acid signaling pathway;regulation of peptidyl-serine phosphorylation;negative regulation of B cell receptor signaling pathway;positive regulation of receptor binding;hydrolase activity;lipid catabolic process	Acetylation;Alternative splicing;Cytoplasm;Phosphoprotein;Polymorphism;Reference proteome;Transducer		
COQ8A	positive	MAST3	ENSG00000099308	COQ8A	1	COQ8A	1	0.0046728193090837	WBGene00002192;WBGene00000186	WBGene00010838(0);WBGene00002192(0);WBGene00007047(0);WBGene00011992(0)			GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0000287;GO:0005515;GO:0035556;GO:0007010;GO:0018105	ATP binding;protein binding;magnesium ion binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;nucleotide binding;kinase activity;transferase activity;phosphorylation;intracellular signal transduction;cytoskeleton organization;peptidyl-serine phosphorylation	3D-structure;ATP-binding;Kinase;Magnesium;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ8A	positive	BICRAL	ENSG00000112624	COQ8A	1	COQ8A	1	0.0046728193090837					GO:0016514	transcription coactivator activity;positive regulation of transcription, DNA-templated;SWI/SNF complex	Phosphoprotein;Reference proteome		
COQ8A	positive	CNNM3	ENSG00000168763	COQ8A	1	COQ8A	1	0.0046728193090837	WBGene00016879;WBGene00007255;WBGene00016343;WBGene00019869	WBGene00016879(0);WBGene00016343(0);WBGene00011260(0)			GO:0016020;GO:0016021;GO:0006811;GO:0005886;GO:0005515;GO:0055085;GO:0022857	membrane;integral component of membrane;ion transport;plasma membrane;protein binding;transmembrane transport;transmembrane transporter activity	3D-structure;Alternative splicing;CBS domain;Cell membrane;Glycoprotein;Ion transport;Membrane;Phosphoprotein;Reference proteome;Repeat;Transmembrane;Transmembrane helix;Transport		
COQ8A	positive	SESN1	ENSG00000080546	COQ8A	1	COQ8A	1	0.00508853800764797	WBGene00022279	WBGene00022279(0)			GO:0005634;GO:0005737;GO:0016491;GO:0055114;GO:0001650;GO:0005515;GO:1901031;GO:1904262;GO:0005829;GO:0061700;GO:0031932;GO:0042149;GO:0072593;GO:0071230;GO:0034198;GO:0051920;GO:0016684;GO:0070728;GO:0016239;GO:0071233;GO:0098869;GO:1990253	nucleus;regulation of response to reactive oxygen species;cytoplasm;nucleoplasm;oxidoreductase activity;oxidation-reduction process;fibrillar center;protein binding;negative regulation of TORC1 signaling;cytosol;GATOR2 complex;TORC2 complex;cellular response to glucose starvation;reactive oxygen species metabolic process;cellular response to amino acid stimulus;cellular response to amino acid starvation;peroxiredoxin activity;oxidoreductase activity, acting on peroxide as acceptor;leucine binding;positive regulation of macroautophagy;cellular response to leucine;cellular oxidant detoxification;cellular response to leucine starvation	Alternative splicing;Cytoplasm;Nucleus;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome		
COQ8A	positive	FRAT1	ENSG00000165879	COQ8A	1	COQ8A	1	0.00508853800764797					GO:0005737;GO:0043231;GO:0005829;GO:0005515;GO:0016055;GO:0060070;GO:1904886;GO:0090263	cytoplasm;intracellular membrane-bounded organelle;cytosol;protein binding;Wnt signaling pathway;canonical Wnt signaling pathway;beta-catenin destruction complex disassembly;positive regulation of canonical Wnt signaling pathway	3D-structure;Cytoplasm;Phosphoprotein;Proto-oncogene;Reference proteome;Wnt signaling pathway	R-HSA-162582;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-4641262;R-HSA-196299	Signal Transduction;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Beta-catenin phosphorylation cascade
COQ8A	positive	TCFL5	ENSG00000101190	COQ8A	1	COQ8A	1	0.00553686826640465					GO:0005634;GO:0046983;GO:0006355;GO:0003677;GO:0003700;GO:0007275;GO:0030154;GO:0007283;GO:0000981;GO:0000790;GO:0000978;GO:0001227;GO:0000122;GO:0042127;GO:0006366;GO:0045595;GO:0001673	regulation of transcription, DNA-templated;spermatogenesis;DNA-binding transcription factor activity;protein dimerization activity;nucleus;DNA binding;multicellular organism development;cell differentiation;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;regulation of cell population proliferation;transcription by RNA polymerase II;regulation of cell differentiation;male germ cell nucleus	Alternative splicing;DNA-binding;Developmental protein;Differentiation;Nucleus;Polymorphism;Reference proteome;Spermatogenesis;Transcription;Transcription regulation		
COQ8A	positive	MXI1	ENSG00000119950	COQ8A	1	COQ8A	1	0.00553686826640465	WBGene00003163	WBGene00003163(0)		Prostate Cancer	GO:0005634;GO:0005730;GO:0005829;GO:0046983;GO:0003677;GO:0005515;GO:0000981;GO:0000790;GO:0001227;GO:0000122;GO:0042994;GO:0003714;GO:0000977;GO:0090575;GO:0008285	protein dimerization activity;nucleus;nucleoplasm;nucleolus;cytosol;DNA binding;protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II;cytoplasmic sequestering of transcription factor;transcription corepressor activity;RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II transcription factor complex;negative regulation of cell population proliferation	Alternative splicing;DNA-binding;Disease mutation;Nucleus;Proto-oncogene;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ8A	positive	PAN2	ENSG00000135473	COQ8A	1	COQ8A	1	0.00553686826640465	WBGene00017951	WBGene00017951(0)			GO:0003676;GO:0006397;GO:0005634;GO:0005737;GO:0046872;GO:0016787;GO:0090305;GO:0005515;GO:0004527;GO:0004518;GO:0000175;GO:0090503;GO:0000932;GO:0000288;GO:0000289;GO:0010606;GO:0031251;GO:0004535;GO:0005829	protein binding;nucleic acid binding;mRNA processing;poly(A)-specific ribonuclease activity;nuclear-transcribed mRNA poly(A) tail shortening;PAN complex;nucleus;cytoplasm;metal ion binding;hydrolase activity;nucleic acid phosphodiester bond hydrolysis;exonuclease activity;nuclease activity;3'-5'-exoribonuclease activity;RNA phosphodiester bond hydrolysis, exonucleolytic;P-body;nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;positive regulation of cytoplasmic mRNA processing body assembly;cytosol	Alternative splicing;Cytoplasm;Exonuclease;Hydrolase;Metal-binding;Nuclease;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;WD repeat;mRNA processing	R-HSA-8953854;R-HSA-429914;R-HSA-429947	Metabolism of RNA;Deadenylation-dependent mRNA decay;Deadenylation of mRNA
COQ8A	positive	OGT	ENSG00000147162	COQ8A	1	COQ8A	1	0.00553686826640465	WBGene00003858	WBGene00003858(1)		MENTAL RETARDATION X-LINKED 106	GO:0005634;GO:0005737;GO:0016020;GO:0016740;GO:0005829;GO:0005654;GO:0016757;GO:0005739;GO:0005886;GO:0006325;GO:0042995;GO:0005515;GO:0048511;GO:0006915;GO:0006486;GO:0032922;GO:0048015;GO:0008289;GO:0031966;GO:0006493;GO:0045944;GO:0016579;GO:0032991;GO:0006357;GO:0016032;GO:0005547;GO:0032435;GO:0007165;GO:0120162;GO:0031397;GO:0046626;GO:0032868;GO:0043995;GO:0043996;GO:0046972;GO:0008375;GO:0016262;GO:0097363;GO:0006110;GO:0006111;GO:0007584;GO:0016485;GO:0035020;GO:0043981;GO:0043982;GO:0043984;GO:0045862;GO:0061087;GO:0080182;GO:0000123;GO:0017122	protein binding;transferase activity, transferring glycosyl groups;protein O-linked glycosylation;nucleus;cytoplasm;membrane;transferase activity;nucleoplasm;cytosol;plasma membrane;mitochondrion;chromatin organization;cell projection;rhythmic process;apoptotic process;protein glycosylation;lipid binding;circadian regulation of gene expression;phosphatidylinositol-mediated signaling;mitochondrial membrane;positive regulation of transcription by RNA polymerase II;protein deubiquitination;protein-containing complex;regulation of transcription by RNA polymerase II;viral process;phosphatidylinositol-3,4,5-trisphosphate binding;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;signal transduction;positive regulation of cold-induced thermogenesis;negative regulation of protein ubiquitination;regulation of insulin receptor signaling pathway;response to insulin;histone acetyltransferase activity (H4-K5 specific);histone acetyltransferase activity (H4-K8 specific);histone acetyltransferase activity (H4-K16 specific);acetylglucosaminyltransferase activity;protein N-acetylglucosaminyltransferase activity;protein O-GlcNAc transferase activity;regulation of glycolytic process;regulation of gluconeogenesis;response to nutrient;protein processing;regulation of Rac protein signal transduction;histone H4-K5 acetylation;histone H4-K8 acetylation;histone H4-K16 acetylation;positive regulation of proteolysis;positive regulation of histone H3-K27 methylation;histone H3-K4 trimethylation;histone acetyltransferase complex;protein N-acetylglucosaminyltransferase complex	3D-structure;Acetylation;Alternative splicing;Apoptosis;Biological rhythms;Cell membrane;Cell projection;Chromatin regulator;Cytoplasm;Direct protein sequencing;Disease mutation;Glycoprotein;Glycosyltransferase;Host-virus interaction;Lipid-binding;Membrane;Mental retardation;Mitochondrion;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;TPR repeat;Transferase;Ubl conjugation;Ubl conjugation pathway	R-HSA-392499;R-HSA-597592;R-HSA-5688426;R-HSA-5689603;R-HSA-3247509;R-HSA-4839726;R-HSA-3214847	Metabolism of proteins;Post-translational protein modification;Deubiquitination;UCH proteinases;Chromatin modifying enzymes;Chromatin organization;HATs acetylate histones
COQ8A	positive	CSAD	ENSG00000139631	COQ8A	1	COQ8A	1	0.00601995089680074	WBGene00006762				GO:0005737;GO:0003824;GO:0016829;GO:0016831;GO:0030170;GO:0019752;GO:0042412;GO:0004068;GO:0004782;GO:0019449;GO:0019452	catalytic activity;pyridoxal phosphate binding;carboxylic acid metabolic process;carboxy-lyase activity;cytoplasm;lyase activity;taurine biosynthetic process;aspartate 1-decarboxylase activity;sulfinoalanine decarboxylase activity;L-cysteine catabolic process to hypotaurine;L-cysteine catabolic process to taurine	3D-structure;Alternative splicing;Decarboxylase;Lyase;Pyridoxal phosphate;Reference proteome	R-HSA-1430728;R-HSA-71291;R-HSA-1614558;R-HSA-1614635	Metabolism;Metabolism of amino acids and derivatives;Degradation of cysteine and homocysteine;Sulfur amino acid metabolism
COQ8A	positive	BRD3	ENSG00000169925	COQ8A	1	COQ8A	1	0.00601995089680074	WBGene00022473;WBGene00010199;WBGene00010345				GO:0005634;GO:0006325;GO:0005515;GO:0003682;GO:0006357;GO:0070577	protein binding;nucleus;chromatin organization;chromatin binding;regulation of transcription by RNA polymerase II;lysine-acetylated histone binding	3D-structure;Acetylation;Alternative splicing;Bromodomain;Chromatin regulator;Chromosomal rearrangement;Coiled coil;Isopeptide bond;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation		
COQ8A	positive	CEP68	ENSG00000011523	COQ8A	1	COQ8A	1	0.00654003032104111					GO:0005737;GO:0005634;GO:0005829;GO:0030054;GO:0005856;GO:0005515;GO:0005815;GO:0005813;GO:0019901;GO:0007098;GO:0019904;GO:0033365;GO:0010457	cytoplasm;nucleoplasm;cytosol;cytoskeleton;cell junction;protein binding;centriolar satellite;centrosome;microtubule organizing center;protein kinase binding;centrosome cycle;protein domain specific binding;protein localization to organelle;centriole-centriole cohesion	Alternative splicing;Cytoplasm;Cytoskeleton;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation		
COQ8A	positive	TNRC6B	ENSG00000100354	COQ8A	1	COQ8A	1	0.00654003032104111					GO:0003676;GO:0003723;GO:0005737;GO:0005515;GO:0035278;GO:0031047;GO:0000932;GO:0005829;GO:0006417;GO:0060213;GO:1900153;GO:0005654;GO:0045652;GO:0007223;GO:0010629;GO:0010628;GO:0035194;GO:0035195	nucleic acid binding;miRNA mediated inhibition of translation;RNA binding;cytoplasm;protein binding;gene silencing by RNA;P-body;nucleoplasm;cytosol;regulation of translation;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;regulation of megakaryocyte differentiation;Wnt signaling pathway, calcium modulating pathway;negative regulation of gene expression;positive regulation of gene expression;posttranscriptional gene silencing by RNA;gene silencing by miRNA	Alternative splicing;Coiled coil;Cytoplasm;Disease mutation;Phosphoprotein;Polymorphism;RNA-binding;RNA-mediated gene silencing;Reference proteome;Translation regulation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-195721;R-HSA-2262752;R-HSA-3858494;R-HSA-5683057;R-HSA-5687128;R-HSA-6807070;R-HSA-8878171;R-HSA-8953897;R-HSA-9006925;R-HSA-211000;R-HSA-157118;R-HSA-8939211;R-HSA-9006931;R-HSA-8986944;R-HSA-2559580;R-HSA-2559583;R-HSA-9018519;R-HSA-5628897;R-HSA-1912422;R-HSA-1912408;R-HSA-2559585;R-HSA-4086398;R-HSA-8936459;R-HSA-9022692;R-HSA-8934593;R-HSA-8943723;R-HSA-426496;R-HSA-8948700	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;Signaling by WNT;Cellular responses to stress;Beta-catenin independent WNT signaling;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;Transcriptional regulation by RUNX1;Cellular responses to external stimuli;Intracellular signaling by second messengers;Gene Silencing by RNA;Signaling by NOTCH;ESR-mediated signaling;Signaling by Nuclear Receptors;Transcriptional Regulation by MECP2;Oxidative Stress Induced Senescence;Cellular Senescence;Estrogen-dependent gene expression;TP53 Regulates Metabolic Genes;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Oncogene Induced Senescence;Ca2+ pathway;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Regulation of MECP2 expression and activity;Regulation of RUNX1 Expression and Activity;Regulation of PTEN mRNA translation;Post-transcriptional silencing by small RNAs;Competing endogenous RNAs (ceRNAs) regulate PTEN translation
COQ8A	positive	HDAC5	ENSG00000108840	COQ8A	1	COQ8A	1	0.00654003032104111	WBGene00001837;WBGene00001838;WBGene00018319	WBGene00001837(0);WBGene00009663(0);WBGene00219378(0);WBGene00009657(0)	SLC2A1;YY1		GO:0090051;GO:0051091;GO:0010832;GO:0045944;GO:0005737;GO:0005634;GO:0044212;GO:0032869;GO:0016607;GO:0005794;GO:0046872;GO:0005829;GO:0016787;GO:0006325;GO:0006476;GO:0005515;GO:0006954;GO:0000122;GO:0004407;GO:0016575;GO:0032041;GO:0070932;GO:0005654;GO:0042113;GO:0000118;GO:0040029;GO:0045892;GO:0000978;GO:0008134;GO:0033558;GO:0042826;GO:0005080;GO:0006338;GO:0030183;GO:0043393;GO:0001085;GO:0070491;GO:0010830;GO:0003682;GO:0006342;GO:0014823;GO:0030182;GO:0042220;GO:0042493;GO:0071222;GO:0032991	nucleus;cytoplasm;histone deacetylase activity;histone deacetylation;chromatin organization;histone deacetylase complex;regulation of gene expression, epigenetic;negative regulation of cell migration involved in sprouting angiogenesis;positive regulation of DNA-binding transcription factor activity;negative regulation of myotube differentiation;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;cellular response to insulin stimulus;nuclear speck;Golgi apparatus;metal ion binding;cytosol;hydrolase activity;protein deacetylation;protein binding;inflammatory response;negative regulation of transcription by RNA polymerase II;NAD-dependent histone deacetylase activity (H3-K14 specific);histone H3 deacetylation;nucleoplasm;B cell activation;negative regulation of transcription, DNA-templated;RNA polymerase II cis-regulatory region sequence-specific DNA binding;transcription factor binding;protein deacetylase activity;histone deacetylase binding;protein kinase C binding;chromatin remodeling;B cell differentiation;regulation of protein binding;RNA polymerase II transcription factor binding;repressing transcription factor binding;regulation of myotube differentiation;chromatin binding;chromatin silencing;response to activity;neuron differentiation;response to cocaine;response to drug;cellular response to lipopolysaccharide;protein-containing complex	3D-structure;Acetylation;Alternative splicing;Chromatin regulator;Cytoplasm;Hydrolase;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-1257604;R-HSA-5663202;R-HSA-6807070;R-HSA-9006925;R-HSA-157118;R-HSA-1980143;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2894858;R-HSA-2894862;R-HSA-8943724;R-HSA-2122947;R-HSA-350054	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;PIP3 activates AKT signaling;Diseases of signal transduction;PTEN Regulation;Intracellular signaling by second messengers;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;Regulation of PTEN gene transcription;NOTCH1 Intracellular Domain Regulates Transcription;Notch-HLH transcription pathway
COQ8A	positive	CTSF	ENSG00000174080	COQ8A	1	COQ8A	1	0.00654003032104111	WBGene00007055;WBGene00000776;WBGene00019986	WBGene00000784(0);WBGene00000785(0);WBGene00013076(0);WBGene00013072(0);WBGene00013764(0);WBGene00009158(0);WBGene00019314(0);WBGene00016306(0);WBGene00016300(0);WBGene00044760(0);WBGene00022189(0);WBGene00019986(0);WBGene00007055(0);WBGene00000782(0);WBGene00000781(0)		CLN13 disease;CEROID LIPOFUSCINOSIS NEURONAL 13	GO:0016787;GO:0008233;GO:0008234;GO:0006508;GO:0005764;GO:0005615;GO:0070062;GO:0004197;GO:0062023;GO:0019886;GO:0043202;GO:1903561;GO:0051603	proteolysis;cysteine-type peptidase activity;hydrolase activity;peptidase activity;lysosome;extracellular space;extracellular exosome;cysteine-type endopeptidase activity;collagen-containing extracellular matrix;antigen processing and presentation of exogenous peptide antigen via MHC class II;lysosomal lumen;extracellular vesicle;proteolysis involved in cellular protein catabolic process	3D-structure;Disease mutation;Disulfide bond;Glycoprotein;Hydrolase;Lysosome;Neurodegeneration;Neuronal ceroid lipofuscinosis;Polymorphism;Protease;Reference proteome;Signal;Thiol protease;Zymogen	R-HSA-1280218;R-HSA-168256;R-HSA-2132295	Adaptive Immune System;Immune System;MHC class II antigen presentation
COQ8A	positive	ACADSB	ENSG00000196177	COQ8A	1	COQ8A	1	0.00654003032104111	WBGene00019433;WBGene00016943;WBGene00020419;WBGene00015894	WBGene00016943(0);WBGene00015894(0);WBGene00020366(0);WBGene00019406(0);WBGene00008566(0);WBGene00008567(0);WBGene00008565(0);WBGene00008564(0)		2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY;2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY	GO:0016491;GO:0050660;GO:0055114;GO:0016627;GO:0005739;GO:0005759;GO:0006629;GO:0006631;GO:0003995;GO:0009083	flavin adenine dinucleotide binding;oxidation-reduction process;oxidoreductase activity, acting on the CH-CH group of donors;acyl-CoA dehydrogenase activity;oxidoreductase activity;mitochondrion;mitochondrial matrix;lipid metabolic process;fatty acid metabolic process;branched-chain amino acid catabolic process	3D-structure;Acetylation;Alternative splicing;Disease mutation;FAD;Fatty acid metabolism;Flavoprotein;Lipid metabolism;Mitochondrion;Oxidoreductase;Phosphoprotein;Polymorphism;Reference proteome;Transit peptide	R-HSA-1430728;R-HSA-71291;R-HSA-70895	Metabolism;Metabolism of amino acids and derivatives;Branched-chain amino acid catabolism
COQ8A	positive	AGO1	ENSG00000092847	COQ8A	1	COQ8A	1	0.00709945651945099	WBGene00000105;WBGene00000106	WBGene00004093(0);WBGene00018921(0);WBGene00006449(0);WBGene00011910(0);WBGene00020707(0);WBGene00021711(0);WBGene00007624(0);WBGene00010263(0);WBGene00004094(0);WBGene00011061(0);WBGene00022877(0)			GO:0003676;GO:0031047;GO:0005515;GO:0000993;GO:0016525;GO:0045944;GO:0005737;GO:0005634;GO:0003723;GO:0090502;GO:0000932;GO:0000956;GO:0016442;GO:0005654;GO:0005829;GO:0006417;GO:0060964;GO:1990904;GO:0045652;GO:0007223;GO:0003725;GO:0031054;GO:0035196;GO:0070578;GO:0005844;GO:0035278;GO:0010629;GO:0010501;GO:0035280;GO:0010628;GO:0035194;GO:0003727;GO:0035198;GO:0001047;GO:0000978;GO:0044212;GO:0010586;GO:1901224	protein binding;nucleic acid binding;gene silencing by RNA;RNA polymerase II complex binding;negative regulation of angiogenesis;positive regulation of transcription by RNA polymerase II;cytoplasm;nucleus;RNA binding;RNA phosphodiester bond hydrolysis, endonucleolytic;P-body;nuclear-transcribed mRNA catabolic process;RISC complex;nucleoplasm;cytosol;regulation of translation;regulation of gene silencing by miRNA;ribonucleoprotein complex;regulation of megakaryocyte differentiation;Wnt signaling pathway, calcium modulating pathway;double-stranded RNA binding;pre-miRNA processing;production of miRNAs involved in gene silencing by miRNA;RISC-loading complex;polysome;miRNA mediated inhibition of translation;negative regulation of gene expression;RNA secondary structure unwinding;miRNA loading onto RISC involved in gene silencing by miRNA;positive regulation of gene expression;posttranscriptional gene silencing by RNA;single-stranded RNA binding;miRNA binding;core promoter binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;transcription regulatory region DNA binding;miRNA metabolic process;positive regulation of NIK/NF-kappaB signaling	3D-structure;Cytoplasm;Disease mutation;RNA-binding;RNA-mediated gene silencing;Reference proteome;Repressor;Ribonucleoprotein;Transcription;Transcription regulation;Translation regulation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-195721;R-HSA-2262752;R-HSA-3858494;R-HSA-5683057;R-HSA-5687128;R-HSA-6807070;R-HSA-8878171;R-HSA-8953897;R-HSA-9006925;R-HSA-211000;R-HSA-5578749;R-HSA-157118;R-HSA-8939211;R-HSA-9006931;R-HSA-8986944;R-HSA-2559580;R-HSA-2559583;R-HSA-9018519;R-HSA-5628897;R-HSA-1912422;R-HSA-1912408;R-HSA-2559585;R-HSA-4086398;R-HSA-8936459;R-HSA-9022692;R-HSA-203927;R-HSA-426486;R-HSA-8934593;R-HSA-8943723;R-HSA-426496;R-HSA-8948700	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;Signaling by WNT;Cellular responses to stress;Beta-catenin independent WNT signaling;MAPK family signaling cascades;MAPK6/MAPK4 signaling;PTEN Regulation;Transcriptional regulation by RUNX1;Cellular responses to external stimuli;Intracellular signaling by second messengers;Gene Silencing by RNA;Transcriptional regulation by small RNAs;Signaling by NOTCH;ESR-mediated signaling;Signaling by Nuclear Receptors;Transcriptional Regulation by MECP2;Oxidative Stress Induced Senescence;Cellular Senescence;Estrogen-dependent gene expression;TP53 Regulates Metabolic Genes;Pre-NOTCH Expression and Processing;Pre-NOTCH Transcription and Translation;Oncogene Induced Senescence;Ca2+ pathway;RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function;Regulation of MECP2 expression and activity;MicroRNA (miRNA) biogenesis;Small interfering RNA (siRNA) biogenesis;Regulation of RUNX1 Expression and Activity;Regulation of PTEN mRNA translation;Post-transcriptional silencing by small RNAs;Competing endogenous RNAs (ceRNAs) regulate PTEN translation
COQ8A	positive	ZNF692	ENSG00000171163	COQ8A	1	COQ8A	1	0.00709945651945099					GO:0003676;GO:0005634;GO:0046872;GO:0005730;GO:0003677;GO:0000978;GO:0001227;GO:0000122	nucleic acid binding;nucleus;metal ion binding;nucleoplasm;nucleolus;DNA binding;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;negative regulation of transcription by RNA polymerase II	3D-structure;Alternative splicing;DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger	R-HSA-212436;R-HSA-73857;R-HSA-74160	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription)
COQ8A	positive	ZNF581	ENSG00000171425	COQ8A	1	COQ8A	1	0.00709945651945099	WBGene00003015				GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding	DNA-binding;Metal-binding;Nucleus;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ8A	positive	SYF2	ENSG00000117614	COQ8A	1	COQ8A	1	0.00770068674868685	WBGene00019402	WBGene00019402(1)			GO:0003723;GO:0006397;GO:0008380;GO:0005634;GO:0016607;GO:0005515;GO:0005681;GO:0000398;GO:0071013;GO:0005654;GO:0000974;GO:0071007;GO:0071014;GO:0001701;GO:0007095;GO:0007369;GO:0008284;GO:0048568	RNA binding;mRNA processing;RNA splicing;nucleus;nuclear speck;protein binding;spliceosomal complex;mRNA splicing, via spliceosome;catalytic step 2 spliceosome;nucleoplasm;Prp19 complex;U2-type catalytic step 2 spliceosome;in utero embryonic development;mitotic G2 DNA damage checkpoint;gastrulation;positive regulation of cell population proliferation;embryonic organ development;post-mRNA release spliceosomal complex	3D-structure;Acetylation;Alternative splicing;Coiled coil;Isopeptide bond;Nucleus;Polymorphism;Reference proteome;Spliceosome;Ubl conjugation;mRNA processing;mRNA splicing	R-HSA-8953854;R-HSA-72203;R-HSA-72163;R-HSA-72172	Metabolism of RNA;Processing of Capped Intron-Containing Pre-mRNA;mRNA Splicing - Major Pathway;mRNA Splicing
COQ8A	positive	FAM117B	ENSG00000138439	COQ8A	1	COQ8A	1	0.00770068674868685					GO:0005515	protein binding	Alternative splicing;Phosphoprotein;Reference proteome		
COQ8A	positive	INSR	ENSG00000171105	COQ8A	1	COQ8A	1	0.00770068674868685	WBGene00000898			Hyperinsulinism due to INSR deficiency;Insulin resistance syndrome type A;Leprechaunism;RABSON-MENDENHALL SYNDROME;DIABETES MELLITUS INSULIN-RESISTANT WITH ACANTHOSIS NIGRICANS;DONOHUE SYNDROME;HYPERINSULINEMIC HYPOGLYCEMIA FAMILIAL 5;PINEAL HYPERPLASIA INSULIN-RESISTANT DIABETES MELLITUS AND SOMATIC ABNORMALITIES	GO:0008284;GO:0046326;GO:0051897;GO:0030335;GO:0001934;GO:0032148;GO:0032869;GO:0042593;GO:0016020;GO:0016021;GO:0000166;GO:0004672;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0004713;GO:0004714;GO:0007169;GO:0005886;GO:0046777;GO:0005515;GO:0005975;GO:0005764;GO:0005768;GO:0005887;GO:0043235;GO:0070062;GO:0010008;GO:0005770;GO:0043548;GO:0043560;GO:0048856;GO:0030424;GO:0001540;GO:0000187;GO:0019904;GO:0008286;GO:0014068;GO:0043410;GO:0032147;GO:0003007;GO:0045429;GO:0051290;GO:0044877;GO:0007612;GO:0018108;GO:0005901;GO:0006355;GO:0045840;GO:0007186;GO:0005525;GO:0097242;GO:0006898;GO:0005159;GO:0045725;GO:0045821;GO:0060267;GO:1990535;GO:0097062;GO:0038024;GO:0009897;GO:0005635;GO:0031981;GO:0005009;GO:0031994;GO:0031995;GO:0043559;GO:0051425;GO:0007613;GO:0019087;GO:0043243;GO:0045995;GO:0048639;GO:0005899;GO:0032590;GO:0032809;GO:0008544;GO:0008584;GO:0009887;GO:0030238;GO:0030325;GO:0031017;GO:0038083;GO:0045893;GO:0051446;GO:0071363;GO:2000194	integral component of membrane;ATP binding;protein binding;membrane;protein phosphorylation;protein kinase activity;transmembrane receptor protein tyrosine kinase signaling pathway;transmembrane receptor protein tyrosine kinase activity;protein tyrosine kinase activity;phosphatidylinositol 3-kinase binding;insulin receptor substrate binding;protein autophosphorylation;positive regulation of cell population proliferation;positive regulation of glucose import;positive regulation of protein kinase B signaling;positive regulation of cell migration;positive regulation of protein phosphorylation;activation of protein kinase B activity;cellular response to insulin stimulus;glucose homeostasis;nucleotide binding;kinase activity;transferase activity;phosphorylation;endosome;plasma membrane;carbohydrate metabolic process;lysosome;integral component of plasma membrane;multicellular organism development;positive regulation of kinase activity;receptor complex;extracellular exosome;endosome membrane;late endosome;anatomical structure development;axon;amyloid-beta binding;activation of MAPK activity;protein domain specific binding;insulin receptor signaling pathway;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of MAPK cascade;activation of protein kinase activity;heart morphogenesis;positive regulation of nitric oxide biosynthetic process;protein-containing complex binding;learning;peptidyl-tyrosine phosphorylation;caveola;regulation of transcription, DNA-templated;positive regulation of mitotic nuclear division;G protein-coupled receptor signaling pathway;GTP binding;amyloid-beta clearance;receptor-mediated endocytosis;insulin-like growth factor receptor binding;positive regulation of glycogen biosynthetic process;positive regulation of glycolytic process;positive regulation of respiratory burst;neuron projection maintenance;dendritic spine maintenance;cargo receptor activity;external side of plasma membrane;nuclear envelope;nuclear lumen;insulin-activated receptor activity;insulin-like growth factor I binding;insulin-like growth factor II binding;insulin binding;PTB domain binding;positive regulation of receptor internalization;memory;transformation of host cell by virus;positive regulation of protein-containing complex disassembly;regulation of embryonic development;positive regulation of developmental growth;insulin receptor complex;dendrite membrane;neuronal cell body membrane;epidermis development;male gonad development;animal organ morphogenesis;male sex determination;adrenal gland development;exocrine pancreas development;peptidyl-tyrosine autophosphorylation;positive regulation of transcription, DNA-templated;positive regulation of meiotic cell cycle;cellular response to growth factor stimulus;regulation of female gonad development	3D-structure;ATP-binding;Alternative splicing;Carbohydrate metabolism;Cell membrane;Cleavage on pair of basic residues;Diabetes mellitus;Direct protein sequencing;Disease mutation;Disulfide bond;Endosome;Glycoprotein;Kinase;Lysosome;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transferase;Transmembrane;Transmembrane helix;Tyrosine-protein kinase	R-HSA-162582;R-HSA-1257604;R-HSA-9006925;R-HSA-9006934;R-HSA-199418;R-HSA-6811558;R-HSA-74751;R-HSA-74752;R-HSA-77387;R-HSA-74713;R-HSA-74749	Signal Transduction;PIP3 activates AKT signaling;Intracellular signaling by second messengers;Signaling by Receptor Tyrosine Kinases;Negative regulation of the PI3K/AKT network;PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling;Insulin receptor signalling cascade;Signaling by Insulin receptor;Insulin receptor recycling;IRS activation;Signal attenuation
COQ8A	positive	FOXN3	ENSG00000053254	COQ8A	1	COQ8A	1	0.00834628700566265					GO:0005634;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0007049;GO:0097094;GO:0006357;GO:0000981;GO:0000790;GO:0008022;GO:0045892;GO:0007095	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;nucleus;DNA binding;protein binding;cell cycle;craniofacial suture morphogenesis;regulation of transcription by RNA polymerase II;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;protein C-terminus binding;negative regulation of transcription, DNA-templated;mitotic G2 DNA damage checkpoint	3D-structure;Alternative splicing;Cell cycle;DNA-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation		
COQ8A	positive	EIF4B	ENSG00000063046	COQ8A	1	COQ8A	1	0.00834628700566265					GO:0003676;GO:0003723;GO:0003743;GO:0006412;GO:0006413;GO:0005829;GO:0005515;GO:0005844;GO:0006446;GO:0016281;GO:0033592;GO:0097010;GO:0030425;GO:0043025;GO:0098794	nucleic acid binding;RNA strand annealing activity;eukaryotic translation initiation factor 4F complex assembly;RNA binding;translation initiation factor activity;translation;translational initiation;cytosol;protein binding;polysome;regulation of translational initiation;eukaryotic translation initiation factor 4F complex	3D-structure;Acetylation;Alternative splicing;Direct protein sequencing;Initiation factor;Isopeptide bond;Phosphoprotein;Polymorphism;Protein biosynthesis;RNA-binding;Reference proteome;Ubl conjugation	R-HSA-392499;R-HSA-162582;R-HSA-8953854;R-HSA-429914;R-HSA-429947;R-HSA-156827;R-HSA-72613;R-HSA-72649;R-HSA-72662;R-HSA-72702;R-HSA-72706;R-HSA-72737;R-HSA-72766;R-HSA-165159;R-HSA-166208	Metabolism of proteins;Signal Transduction;Metabolism of RNA;Deadenylation-dependent mRNA decay;Deadenylation of mRNA;L13a-mediated translational silencing of Ceruloplasmin expression;Eukaryotic Translation Initiation;Translation initiation complex formation;Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S;Ribosomal scanning and start codon recognition;GTP hydrolysis and joining of the 60S ribosomal subunit;Cap-dependent Translation Initiation;Translation;mTOR signalling;mTORC1-mediated signalling
COQ8A	positive	CRBN	ENSG00000113851	COQ8A	1	COQ8A	1	0.00834628700566265	WBGene00010891	WBGene00010891(0)		Autosomal recessive non-syndromic intellectual disability;MENTAL RETARDATION AUTOSOMAL RECESSIVE TYPE 2A;MENTAL RETARDATION AUTOSOMAL RECESSIVE 2	GO:0046872;GO:0005730;GO:0005634;GO:0005737;GO:0016020;GO:0016567;GO:0005515;GO:0032463;GO:0034766;GO:0090073;GO:0043161;GO:0031464	metal ion binding;nucleus;cytoplasm;membrane;protein ubiquitination;protein binding;proteasome-mediated ubiquitin-dependent protein catabolic process;Cul4A-RING E3 ubiquitin ligase complex;ion channel binding;negative regulation of protein-containing complex assembly;positive regulation of protein-containing complex assembly;negative regulation of ion transmembrane transport;perinuclear region of cytoplasm	3D-structure;Alternative splicing;Cytoplasm;Disease mutation;Membrane;Mental retardation;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Ubl conjugation;Ubl conjugation pathway;Zinc		
COQ8A	positive	PHF3	ENSG00000118482	COQ8A	1	COQ8A	1	0.00834628700566265					GO:0046872;GO:0006351;GO:0007275;GO:0003674;GO:0005575	transcription, DNA-templated;metal ion binding;multicellular organism development;molecular_function;cellular_component	3D-structure;Alternative splicing;Isopeptide bond;Metal-binding;Methylation;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation;Zinc;Zinc-finger		
COQ8A	positive	PEX5	ENSG00000139197	COQ8A	1	COQ8A	1	0.00834628700566265	WBGene00004194	WBGene00004194(0)		Infantile Refsum disease;NEONATAL ADRENOLEUKODYSTROPHY;Rhizomelic chondrodysplasia punctata type 5;Zellweger Syndrome;ADRENOLEUKODYSTROPHY NEONATAL;Infantile Refsum disease;Zellweger Syndrome;PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER);PEROXISOME BIOGENESIS DISORDER 2B;RHIZOMELIC CHONDRODYSPLASIA PUNCTATA TYPE 5	GO:0005794;GO:0005829;GO:0005737;GO:0016020;GO:0015031;GO:0005515;GO:0005777;GO:0005778;GO:0016567;GO:0032991;GO:0006625;GO:0047485;GO:0019899;GO:0016558;GO:0016560;GO:1901094;GO:0045046;GO:0031267;GO:0000268;GO:0005052;GO:0005739;GO:0000038;GO:0001764;GO:0006635;GO:0007005;GO:0007006;GO:0007029;GO:0007031;GO:0021795;GO:0021895;GO:0040018;GO:0044255;GO:0048468;GO:0050905	Golgi apparatus;cytosol;protein binding;cytoplasm;membrane;protein transport;peroxisome;peroxisomal membrane;protein ubiquitination;protein-containing complex;protein targeting to peroxisome;protein N-terminus binding;enzyme binding;negative regulation of protein-containing complex assembly;protein import into peroxisome matrix;protein import into peroxisome matrix, docking;peroxisome targeting sequence binding;protein sequestering activity;protein import into peroxisome membrane;small GTPase binding;peroxisome matrix targeting signal-1 binding;peroxisome membrane targeting sequence binding;mitochondrion;very long-chain fatty acid metabolic process;neuron migration;fatty acid beta-oxidation;mitochondrion organization;mitochondrial membrane organization;endoplasmic reticulum organization;peroxisome organization;cerebral cortex cell migration;cerebral cortex neuron differentiation;positive regulation of multicellular organism growth;cellular lipid metabolic process;cell development;neuromuscular process	3D-structure;Alternative splicing;Cytoplasm;Disease mutation;Membrane;Peroxisome;Peroxisome biogenesis disorder;Phosphoprotein;Protein transport;Reference proteome;Repeat;Rhizomelic chondrodysplasia punctata;TPR repeat;Thioester bond;Transport;Ubl conjugation;Zellweger syndrome		
COQ8A	positive	ULK1	ENSG00000177169	COQ8A	1	COQ8A	1	0.00834628700566265	WBGene00006786;WBGene00020324	WBGene00006786(0)			GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0007165;GO:0005829;GO:0005515;GO:0006914;GO:0042802;GO:0005776;GO:0016020;GO:0034045;GO:0005789;GO:0010508;GO:0075044;GO:0010506;GO:0000045;GO:0000407;GO:0008104;GO:0046777;GO:0005741;GO:0044877;GO:0031175;GO:0016241;GO:0042594;GO:0016236;GO:1990316;GO:0032045;GO:0017137;GO:0051020;GO:0007409;GO:0018105;GO:0018107;GO:0031102;GO:0031333;GO:0031669;GO:0048675;GO:2000786;GO:0030424;GO:0055037;GO:0097629;GO:0097632;GO:0097635	ATP binding;signal transduction;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;axonogenesis;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytosol;protein binding;autophagy;identical protein binding;autophagosome;membrane;phagophore assembly site membrane;endoplasmic reticulum membrane;positive regulation of autophagy;positive regulation by symbiont of host autophagy;regulation of autophagy;autophagosome assembly;phagophore assembly site;protein localization;protein autophosphorylation;mitochondrial outer membrane;protein-containing complex binding;neuron projection development;peptidyl-serine phosphorylation;regulation of macroautophagy;response to starvation;macroautophagy;Atg1/ULK1 kinase complex;guanyl-nucleotide exchange factor complex;Rab GTPase binding;GTPase binding;peptidyl-threonine phosphorylation;neuron projection regeneration;negative regulation of protein-containing complex assembly;cellular response to nutrient levels;axon extension;positive regulation of autophagosome assembly;axon;recycling endosome;extrinsic component of omegasome membrane;extrinsic component of phagophore assembly site membrane;extrinsic component of autophagosome membrane	3D-structure;ATP-binding;Acetylation;Autophagy;Cytoplasm;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-5653656;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-9612973;R-HSA-8953897;R-HSA-1632852;R-HSA-5205647;R-HSA-8854214;R-HSA-8934903	Vesicle-mediated transport;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Autophagy;Cellular responses to external stimuli;Macroautophagy;Mitophagy;TBC/RABGAPs;Receptor Mediated Mitophagy
COQ8A	positive	MTA1	ENSG00000182979	COQ8A	1	COQ8A	1	0.00834628700566265	WBGene00003025	WBGene00003025(0)	ARNTL;BCAS3;BCL2L1;CDKN2A;EGFR;NOS2;SNAI1;SNAI2;SUMO2		GO:0005634;GO:0005737;GO:0043231;GO:0008270;GO:0046872;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:1903508;GO:0043565;GO:0005856;GO:0005515;GO:0048511;GO:0006302;GO:0005874;GO:0003682;GO:0032922;GO:0003713;GO:0000122;GO:0003714;GO:0042826;GO:0007165;GO:0043161;GO:0000980;GO:0000978;GO:0005635;GO:0001103;GO:0043153;GO:0016575;GO:0040029;GO:0045475;GO:0010212;GO:0016581;GO:1902499	DNA binding;zinc ion binding;regulation of transcription, DNA-templated;sequence-specific DNA binding;chromatin binding;nucleus;cytoplasm;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;cytosol;cytoskeleton;positive regulation of nucleic acid-templated transcription;protein binding;rhythmic process;double-strand break repair;microtubule;circadian regulation of gene expression;transcription coactivator activity;negative regulation of transcription by RNA polymerase II;transcription corepressor activity;histone deacetylase binding;signal transduction;proteasome-mediated ubiquitin-dependent protein catabolic process;RNA polymerase II cis-regulatory region sequence-specific DNA binding;nuclear envelope;RNA polymerase II repressing transcription factor binding;entrainment of circadian clock by photoperiod;histone deacetylation;regulation of gene expression, epigenetic;locomotor rhythm;response to ionizing radiation;NuRD complex;positive regulation of protein autoubiquitination	3D-structure;Acetylation;Activator;Alternative splicing;Biological rhythms;Cytoplasm;Cytoskeleton;DNA-binding;Isopeptide bond;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-74160;R-HSA-162582;R-HSA-1257604;R-HSA-6807070;R-HSA-9006925;R-HSA-2990846;R-HSA-3108232;R-HSA-8943724;R-HSA-212165;R-HSA-3214815;R-HSA-3247509;R-HSA-4839726;R-HSA-5250913;R-HSA-73762;R-HSA-73854;R-HSA-73864;R-HSA-427389;R-HSA-3232118	Metabolism of proteins;Post-translational protein modification;Gene expression (Transcription);Signal Transduction;PIP3 activates AKT signaling;PTEN Regulation;Intracellular signaling by second messengers;SUMOylation;SUMO E3 ligases SUMOylate target proteins;Regulation of PTEN gene transcription;Epigenetic regulation of gene expression;HDACs deacetylate histones;Chromatin modifying enzymes;Chromatin organization;Positive epigenetic regulation of rRNA expression;RNA Polymerase I Transcription Initiation;RNA Polymerase I Promoter Clearance;RNA Polymerase I Transcription;ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression;SUMOylation of transcription factors
COQ8A	positive	TRAPPC6A	ENSG00000007255	COQ8A	1	COQ8A	1	0.0090389332115296	WBGene00010699	WBGene00010699(1)			GO:0005783;GO:0005794;GO:0005515;GO:0043087;GO:0048193;GO:0016192;GO:0006888;GO:0000139;GO:0005801;GO:0005829;GO:0005802;GO:0048208;GO:0043473;GO:1903232	regulation of GTPase activity;Golgi vesicle transport;endoplasmic reticulum;Golgi apparatus;protein binding;vesicle-mediated transport;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi membrane;cis-Golgi network;cytosol;trans-Golgi network;COPII vesicle coating;TRAPP complex;pigmentation;melanosome assembly	3D-structure;Alternative splicing;ER-Golgi transport;Endoplasmic reticulum;Golgi apparatus;Phosphoprotein;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-199991;R-HSA-8876198;R-HSA-9007101;R-HSA-446203;R-HSA-199977;R-HSA-948021;R-HSA-204005	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Membrane Trafficking;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Asparagine N-linked glycosylation;ER to Golgi Anterograde Transport;Transport to the Golgi and subsequent modification;COPII-mediated vesicle transport
COQ8A	positive	AKAP1	ENSG00000121057	COQ8A	1	COQ8A	1	0.0090389332115296	WBGene00016977	WBGene00016977(0)			GO:0003723;GO:0016020;GO:0016021;GO:0005739;GO:0034237;GO:0010738;GO:0003676;GO:0005515;GO:0005741;GO:0005829;GO:0007596	RNA binding;mitochondrion;protein kinase A regulatory subunit binding;regulation of protein kinase A signaling;membrane;integral component of membrane;nucleic acid binding;protein binding;mitochondrial outer membrane;cytosol;blood coagulation	Alternative splicing;Membrane;Mitochondrion;Mitochondrion outer membrane;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Transit peptide;Transmembrane	R-HSA-109582;R-HSA-382551;R-HSA-983231;R-HSA-8949215	Hemostasis;Transport of small molecules;Factors involved in megakaryocyte development and platelet production;Mitochondrial calcium ion transport
COQ8A	positive	RSAD1	ENSG00000136444	COQ8A	1	COQ8A	1	0.00978141208962879					GO:0005737;GO:0046872;GO:0003824;GO:0005739;GO:0055114;GO:0051536;GO:0051539;GO:0006779;GO:0004109	cytoplasm;catalytic activity;porphyrin-containing compound biosynthetic process;4 iron, 4 sulfur cluster binding;iron-sulfur cluster binding;coproporphyrinogen oxidase activity;metal ion binding;mitochondrion;oxidation-reduction process	4Fe-4S;Alternative splicing;Chaperone;Heme;Iron;Iron-sulfur;Metal-binding;Mitochondrion;Polymorphism;Reference proteome;S-adenosyl-L-methionine;Transit peptide		
COQ8A	positive	EIF2D	ENSG00000143486	COQ8A	1	COQ8A	1	0.00978141208962879	WBGene00016113	WBGene00016113(0)			GO:0003743;GO:0001731;GO:0003723;GO:0005737;GO:0006412;GO:0006413;GO:0005829;GO:0016604;GO:0022627;GO:0032790;GO:0006886;GO:0038023;GO:0075522	translation initiation factor activity;formation of translation preinitiation complex;RNA binding;translational initiation;cytoplasm;translation;cytosol;nuclear body;ribosome disassembly;cytosolic small ribosomal subunit;intracellular protein transport;signaling receptor activity;IRES-dependent viral translational initiation	3D-structure;Acetylation;Alternative splicing;Cytoplasm;Initiation factor;Phosphoprotein;Polymorphism;Protein biosynthesis;Reference proteome		
COQ8A	positive	ZNF652	ENSG00000198740	COQ8A	1	COQ8A	1	0.00978141208962879		WBGene00003933(0)			GO:0003676;GO:0005634;GO:0046872;GO:0003677;GO:0005515;GO:0006974	nucleic acid binding;nucleus;metal ion binding;DNA binding;protein binding;cellular response to DNA damage stimulus	DNA-binding;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat;Repressor;Transcription;Transcription regulation;Zinc;Zinc-finger		
COQ8A	positive	ZBED1	ENSG00000214717	COQ8A	1	COQ8A	1	0.00978141208962879	WBGene00008283;WBGene00010704;WBGene00015662;WBGene00015247				GO:0005634;GO:0046872;GO:0046983;GO:0003677;GO:0005515;GO:0016925;GO:0042802;GO:0000981;GO:0000790;GO:0000978;GO:0005654;GO:0001228;GO:0043565;GO:0045944;GO:0019789	DNA binding;protein dimerization activity;nucleus;metal ion binding;nucleoplasm;nuclear membrane;centrosome;protein binding;protein sumoylation;identical protein binding;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;SUMO transferase activity	3D-structure;DNA-binding;Metal-binding;Nucleus;Reference proteome;Zinc;Zinc-finger	R-HSA-392499;R-HSA-597592;R-HSA-2990846;R-HSA-3108232;R-HSA-4551638	Metabolism of proteins;Post-translational protein modification;SUMOylation;SUMO E3 ligases SUMOylate target proteins;SUMOylation of chromatin organization proteins
COQ8A	negative	TPM4	ENSG00000167460	COQ8A	1	COQ8A	1	7.55263963538866e-05	WBGene00002978	WBGene00002978(1)		Autosomal dominant macrothrombocytopenia;Inflammatory myofibroblastic tumor	GO:0005737;GO:0016020;GO:0046872;GO:0003779;GO:0042803;GO:0005856;GO:0005515;GO:0005509;GO:0005925;GO:0051015;GO:0005829;GO:0070062;GO:0005884;GO:0042802;GO:0007015;GO:0046982;GO:0001725;GO:0006936;GO:0008307;GO:0030049;GO:0001649;GO:0005862	cytoplasm;membrane;metal ion binding;actin binding;cytoskeleton;focal adhesion;protein homodimerization activity;protein binding;identical protein binding;calcium ion binding;actin filament binding;cytosol;extracellular exosome;actin filament;actin filament organization;protein heterodimerization activity;stress fiber;muscle contraction;structural constituent of muscle;muscle filament sliding;osteoblast differentiation;muscle thin filament tropomyosin	Acetylation;Actin-binding;Alternative splicing;Calcium;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;Metal-binding;Muscle protein;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-397014;R-HSA-445355;R-HSA-390522	Muscle contraction;Smooth Muscle Contraction;Striated Muscle Contraction
COQ8A	negative	SPHK1	ENSG00000176170	COQ8A	1	COQ8A	1	0.000505217537382641	WBGene00007918	WBGene00020398(0);WBGene00007918(0)			GO:0005737;GO:0005634;GO:0016020;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0043066;GO:0005829;GO:0005886;GO:0003951;GO:0005515;GO:0000287;GO:0030054;GO:0045202;GO:0046834;GO:0005905;GO:0008289;GO:0005768;GO:0003376;GO:0005516;GO:0010800;GO:0031901;GO:0010008;GO:0030335;GO:0031398;GO:0006457;GO:0007165;GO:0051092;GO:1901224;GO:0003677;GO:0030307;GO:0035556;GO:0030148;GO:0045766;GO:0035924;GO:0034612;GO:0019722;GO:0030139;GO:0006473;GO:1900745;GO:0050764;GO:0045931;GO:0038036;GO:0030100;GO:0045987;GO:0150077;GO:0016407;GO:0032740;GO:0098793;GO:0046512;GO:0048146;GO:0051721;GO:0010803;GO:0006670;GO:0008481;GO:0017050;GO:0046521;GO:1900060;GO:1903978;GO:1905364;GO:0008284;GO:0045840;GO:0006954;GO:0001568;GO:0007420;GO:0032651;GO:0070301;GO:0071897;GO:0090520	kinase activity;NAD+ kinase activity;cytoplasm;nucleus;membrane;nucleotide binding;ATP binding;transferase activity;phosphorylation;negative regulation of apoptotic process;cytosol;plasma membrane;endosome;protein binding;cell junction;lipid phosphorylation;magnesium ion binding;lipid binding;clathrin-coated pit;synapse;sphingosine-1-phosphate receptor signaling pathway;calmodulin binding;regulation of endocytosis;positive regulation of peptidyl-threonine phosphorylation;early endosome membrane;endosome membrane;positive regulation of cell migration;positive regulation of protein ubiquitination;protein folding;positive regulation of NF-kappaB transcription factor activity;positive regulation of NIK/NF-kappaB signaling;DNA binding;positive regulation of cell growth;intracellular signal transduction;sphingosine metabolic process;sphingolipid biosynthetic process;positive regulation of angiogenesis;cellular response to vascular endothelial growth factor stimulus;response to tumor necrosis factor;calcium-mediated signaling;presynapse;endocytic vesicle;protein acetylation;positive regulation of p38MAPK cascade;regulation of phagocytosis;positive regulation of mitotic cell cycle;sphingosine-1-phosphate receptor activity;positive regulation of smooth muscle contraction;regulation of neuroinflammatory response;acetyltransferase activity;positive regulation of interleukin-17 production;sphingosine biosynthetic process;positive regulation of fibroblast proliferation;protein phosphatase 2A binding;regulation of tumor necrosis factor-mediated signaling pathway;sphinganine kinase activity;D-erythro-sphingosine kinase activity;sphingoid catabolic process;negative regulation of ceramide biosynthetic process;regulation of microglial cell activation;regulation of endosomal vesicle fusion;blood vessel development;inflammatory response;brain development;positive regulation of cell population proliferation;regulation of interleukin-1 beta production;positive regulation of mitotic nuclear division;cellular response to hydrogen peroxide;DNA biosynthetic process;sphingolipid mediated signaling pathway	3D-structure;ATP-binding;Alternative splicing;Calmodulin-binding;Cell junction;Cell membrane;Coated pit;Cytoplasm;Endosome;Kinase;Membrane;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Synapse;Transferase	R-HSA-392499;R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-162582;R-HSA-390466;R-HSA-391251;R-HSA-9006934;R-HSA-8939211;R-HSA-9006931;R-HSA-9009391;R-HSA-194138;R-HSA-4420097;R-HSA-390471;R-HSA-1660661;R-HSA-5218921	Metabolism of proteins;Metabolism;Sphingolipid metabolism;Metabolism of lipids;Signal Transduction;Chaperonin-mediated protein folding;Protein folding;Signaling by Receptor Tyrosine Kinases;ESR-mediated signaling;Signaling by Nuclear Receptors;Extra-nuclear estrogen signaling;Signaling by VEGF;VEGFA-VEGFR2 Pathway;Association of TriC/CCT with target proteins during biosynthesis;Sphingolipid de novo biosynthesis;VEGFR2 mediated cell proliferation
COQ8A	negative	SERPINB8	ENSG00000166401	COQ8A	1	COQ8A	1	0.000568648036367359	WBGene00005642;WBGene00005647;WBGene00005648;WBGene00005649;WBGene00005643;WBGene00005644			Exfoliative ichthyosis;PEELING SKIN SYNDROME 5	GO:0005737;GO:0005615;GO:0005829;GO:0005515;GO:0004867;GO:0030414;GO:0010466;GO:0070062;GO:0062023;GO:0010951;GO:0090136	extracellular space;cytoplasm;cytosol;protein binding;serine-type endopeptidase inhibitor activity;peptidase inhibitor activity;negative regulation of peptidase activity;extracellular exosome;collagen-containing extracellular matrix;negative regulation of endopeptidase activity;epithelial cell-cell adhesion	Alternative splicing;Cytoplasm;Polymorphism;Protease inhibitor;Reference proteome;Serine protease inhibitor	R-HSA-109582;R-HSA-75205	Hemostasis;Dissolution of Fibrin Clot
COQ8A	negative	SLC7A11	ENSG00000151012	COQ8A	1	COQ8A	1	0.000639371772932829		WBGene00000010(0);WBGene00000005(0);WBGene00015197(0);WBGene00017747(0);WBGene00000002(0);WBGene00000003(0)			GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005515;GO:0009986;GO:0006865;GO:0050900;GO:0005886;GO:0009636;GO:0015179;GO:0015327;GO:0006749;GO:0006979;GO:0007420;GO:0008542;GO:0014070;GO:0021591;GO:0021756;GO:0030534;GO:0033029;GO:0034599;GO:0034775;GO:0035094;GO:0042127;GO:0048021;GO:0048286;GO:0050804;GO:0050807;GO:0051223;GO:0051775;GO:0060173;GO:0070306;GO:0070527;GO:0071702;GO:0090461;GO:0098712;GO:0140206;GO:1900407;GO:1901494;GO:1903204;GO:1903786;GO:1904717;GO:2000211;GO:0005791;GO:0005856;GO:0031526;GO:0043231;GO:0097449	integral component of membrane;membrane;transmembrane transporter activity;transmembrane transport;amino acid transport;protein binding;cell surface;leukocyte migration;plasma membrane;response to toxic substance;L-amino acid transmembrane transporter activity;cystine:glutamate antiporter activity;glutathione metabolic process;response to oxidative stress;brain development;visual learning;response to organic cyclic compound;ventricular system development;striatum development;adult behavior;regulation of neutrophil apoptotic process;cellular response to oxidative stress;glutathione transmembrane transport;response to nicotine;regulation of cell population proliferation;regulation of melanin biosynthetic process;lung alveolus development;modulation of chemical synaptic transmission;regulation of synapse organization;regulation of protein transport;response to redox state;limb development;lens fiber cell differentiation;platelet aggregation;organic substance transport;glutamate homeostasis;L-glutamate import across plasma membrane;dipeptide import across plasma membrane;regulation of cellular response to oxidative stress;regulation of cysteine metabolic process;negative regulation of oxidative stress-induced neuron death;regulation of glutathione biosynthetic process;regulation of AMPA glutamate receptor clustering;regulation of glutamate metabolic process;rough endoplasmic reticulum;cytoskeleton;brush border membrane;intracellular membrane-bounded organelle;apical part of cell;astrocyte projection	Amino-acid transport;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Reference proteome;Transmembrane;Transmembrane helix;Transport	R-HSA-109582;R-HSA-202733;R-HSA-382551;R-HSA-425407;R-HSA-425393;R-HSA-210991;R-HSA-352230	Hemostasis;Cell surface interactions at the vascular wall;Transport of small molecules;SLC-mediated transmembrane transport;Transport of inorganic cations/anions and amino acids/oligopeptides;Basigin interactions;Amino acid transport across the plasma membrane
COQ8A	negative	MELK	ENSG00000165304	COQ8A	1	COQ8A	1	0.000805766936679553	WBGene00021012	WBGene00021012(1)			GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0018108;GO:0005886;GO:0005515;GO:0007049;GO:0004715;GO:0006915;GO:0005509;GO:0008289;GO:0005634;GO:0005737;GO:0035556;GO:0005938;GO:0008283;GO:0043065;GO:0046777;GO:0030097;GO:0000086;GO:0061351;GO:0008631	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;membrane;nucleotide binding;kinase activity;transferase activity;phosphorylation;peptidyl-tyrosine phosphorylation;plasma membrane;protein binding;cell cycle;non-membrane spanning protein tyrosine kinase activity;apoptotic process;lipid binding;calcium ion binding;nucleus;cytoplasm;intracellular signal transduction;cell cortex;positive regulation of apoptotic process;protein autophosphorylation;hemopoiesis;cell population proliferation;G2/M transition of mitotic cell cycle;neural precursor cell proliferation;intrinsic apoptotic signaling pathway in response to oxidative stress	3D-structure;ATP-binding;Alternative splicing;Apoptosis;Calcium;Cell cycle;Cell membrane;Kinase;Lipid-binding;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase		
COQ8A	negative	ARNTL2	ENSG00000029153	COQ8A	1	COQ8A	1	0.000903142805310009		WBGene00000095(0)	SERPINE1		GO:0045944;GO:0005634;GO:0005737;GO:0005730;GO:0046983;GO:0006355;GO:0003677;GO:0003700;GO:0048511;GO:0005667;GO:0045893;GO:0000981;GO:0000790;GO:0070888;GO:0042753;GO:0000978;GO:0006357;GO:0007623;GO:0009649	regulation of transcription, DNA-templated;nucleus;cytoplasm;DNA-binding transcription factor activity;transcription factor complex;protein dimerization activity;positive regulation of transcription by RNA polymerase II;nucleoplasm;nucleolus;DNA binding;rhythmic process;positive regulation of transcription, DNA-templated;DNA-binding transcription factor activity, RNA polymerase II-specific;nuclear chromatin;E-box binding;positive regulation of circadian rhythm;RNA polymerase II cis-regulatory region sequence-specific DNA binding;regulation of transcription by RNA polymerase II;circadian rhythm;entrainment of circadian clock	3D-structure;Activator;Alternative splicing;Biological rhythms;DNA-binding;Isopeptide bond;Nucleus;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation	R-HSA-1368108;R-HSA-400253	BMAL1:CLOCK,NPAS2 activates circadian gene expression;Circadian Clock
COQ8A	negative	TNFRSF12A	ENSG00000006327	COQ8A	1	COQ8A	1	0.00101123019766447					GO:0016020;GO:0016021;GO:0005886;GO:0043065;GO:0007155;GO:0005515;GO:0006915;GO:0007275;GO:0030154;GO:0033209;GO:0001525;GO:2001238;GO:0061041;GO:0006931;GO:0045765;GO:0045773;GO:0097191;GO:0001726;GO:0009986	plasma membrane;protein binding;positive regulation of apoptotic process;membrane;integral component of membrane;cell adhesion;apoptotic process;multicellular organism development;cell differentiation;tumor necrosis factor-mediated signaling pathway;angiogenesis;positive regulation of extrinsic apoptotic signaling pathway;regulation of wound healing;substrate-dependent cell migration, cell attachment to substrate;regulation of angiogenesis;positive regulation of axon extension;extrinsic apoptotic signaling pathway;ruffle;cell surface	3D-structure;Alternative splicing;Angiogenesis;Apoptosis;Cell adhesion;Developmental protein;Differentiation;Disulfide bond;Membrane;Receptor;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-1280215;R-HSA-5668541;R-HSA-5676594	Immune System;Cytokine Signaling in Immune system;TNFR2 non-canonical NF-kB pathway;TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
COQ8A	negative	TAF13	ENSG00000197780	COQ8A	1	COQ8A	1	0.00157289743905398	WBGene00006397	WBGene00006397(1)		Autosomal recessive primary microcephaly;Autosomal-Recessive Intellectual Disability and Microcephaly;MENTAL RETARDATION AUTOSOMAL RECESSIVE 60	GO:0005634;GO:0005730;GO:0006366;GO:0003700;GO:0046982;GO:0005515;GO:0006367;GO:0006357;GO:0003677;GO:0005669;GO:0003712;GO:0005654;GO:0008022;GO:0006352;GO:1901796;GO:0042795	nucleus;nucleoplasm;nucleolus;transcription by RNA polymerase II;DNA-binding transcription factor activity;protein heterodimerization activity;protein binding;transcription initiation from RNA polymerase II promoter;regulation of transcription by RNA polymerase II;DNA binding;transcription factor TFIID complex;transcription coregulator activity;protein C-terminus binding;DNA-templated transcription, initiation;regulation of signal transduction by p53 class mediator;snRNA transcription by RNA polymerase II	3D-structure;Disease mutation;Mental retardation;Nucleus;Reference proteome;Transcription;Transcription regulation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-1643685;R-HSA-162587;R-HSA-162599;R-HSA-162906;R-HSA-5663205;R-HSA-167172;R-HSA-674695;R-HSA-5633007;R-HSA-6807505;R-HSA-167161;R-HSA-167162;R-HSA-6804756;R-HSA-73776;R-HSA-73779;R-HSA-75953;R-HSA-76042	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Disease;HIV Life Cycle;Late Phase of HIV Life Cycle;HIV Infection;Infectious disease;Transcription of the HIV genome;RNA Polymerase II Pre-transcription Events;Regulation of TP53 Activity;RNA polymerase II transcribes snRNA genes;HIV Transcription Initiation;RNA Polymerase II HIV Promoter Escape;Regulation of TP53 Activity through Phosphorylation;RNA Polymerase II Promoter Escape;RNA Polymerase II Transcription Pre-Initiation And Promoter Opening;RNA Polymerase II Transcription Initiation;RNA Polymerase II Transcription Initiation And Promoter Clearance
COQ8A	negative	PDCD5	ENSG00000105185	COQ8A	1	COQ8A	1	0.00194947774970977	WBGene00008398	WBGene00008398(1)			GO:0005634;GO:0005737;GO:0003677;GO:0006915;GO:0005829;GO:0005515;GO:0008201;GO:0070062;GO:0010628;GO:0008285;GO:0071560;GO:0090200;GO:0043280;GO:0010698;GO:0048487;GO:0043065;GO:1903638;GO:1903645	DNA binding;nucleus;cytoplasm;apoptotic process;cytosol;protein binding;heparin binding;extracellular exosome;positive regulation of gene expression;negative regulation of cell population proliferation;cellular response to transforming growth factor beta stimulus;positive regulation of release of cytochrome c from mitochondria;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;acetyltransferase activator activity;beta-tubulin binding;positive regulation of apoptotic process;positive regulation of protein import into mitochondrial outer membrane;negative regulation of chaperone-mediated protein folding	3D-structure;Acetylation;Alternative splicing;Apoptosis;Direct protein sequencing;Phosphoprotein;Reference proteome		
COQ8A	negative	ACOT9	ENSG00000123130	COQ8A	1	COQ8A	1	0.00194947774970977	WBGene00019015;WBGene00020311;WBGene00020306;WBGene00020674	WBGene00019015(1);WBGene00020674(0);WBGene00020311(1)			GO:0016787;GO:0005739;GO:0052689;GO:0005759;GO:0047617;GO:0006637;GO:0003986	hydrolase activity;mitochondrion;carboxylic ester hydrolase activity;mitochondrial matrix;acyl-CoA hydrolase activity;acyl-CoA metabolic process;acetyl-CoA hydrolase activity	Acetylation;Alternative splicing;Hydrolase;Mitochondrion;Polymorphism;Reference proteome;Repeat;Serine esterase;Transit peptide	R-HSA-1430728;R-HSA-556833;R-HSA-8978868;R-HSA-77289	Metabolism;Metabolism of lipids;Fatty acid metabolism;Mitochondrial Fatty Acid Beta-Oxidation
COQ8A	negative	PHLDA2	ENSG00000181649	COQ8A	1	COQ8A	1	0.00194947774970977					GO:0005737;GO:0016020;GO:0006915;GO:0001890;GO:0009887;GO:0010468;GO:0030334;GO:0045995;GO:0060721;GO:0070873;GO:1903547	positive regulation of apoptotic process;phosphatidylinositol phosphate binding;cytoplasm;membrane;apoptotic process;placenta development;animal organ morphogenesis;regulation of gene expression;regulation of cell migration;regulation of embryonic development;regulation of spongiotrophoblast cell proliferation;regulation of glycogen metabolic process;regulation of growth hormone activity	Cytoplasm;Membrane;Phosphoprotein;Reference proteome		
COQ8A	negative	S100A2	ENSG00000196754	COQ8A	1	COQ8A	1	0.00194947774970977					GO:0046872;GO:0005509;GO:0005515;GO:0042802;GO:0046914;GO:0005575;GO:0043542	calcium ion binding;transition metal ion binding;metal ion binding;protein binding;identical protein binding;cellular_component;endothelial cell migration	3D-structure;Calcium;Direct protein sequencing;Metal-binding;Reference proteome;Repeat		
COQ8A	negative	GARS	ENSG00000106105	COQ8A	1	COQ8A	1	0.00216696673924544	WBGene00001744	WBGene00001744(1)		Autosomal dominant Charcot-Marie-Tooth disease type 2D;Distal hereditary motor neuropathy type 5;CHARCOT-MARIE-TOOTH DISEASE AXONAL TYPE 2D;NEURONOPATHY DISTAL HEREDITARY MOTOR TYPE VA	GO:0005737;GO:0006412;GO:0000166;GO:0005524;GO:0016740;GO:0005829;GO:0016787;GO:0042995;GO:0016874;GO:0005515;GO:0005576;GO:0004812;GO:0006418;GO:0042802;GO:0005739;GO:0030424;GO:0070062;GO:0005759;GO:0046983;GO:0004081;GO:0004820;GO:0006426;GO:0015966;GO:0070150;GO:0030141	ATP binding;cytoplasm;aminoacyl-tRNA ligase activity;tRNA aminoacylation for protein translation;nucleotide binding;glycine-tRNA ligase activity;glycyl-tRNA aminoacylation;translation;transferase activity;cytosol;hydrolase activity;mitochondrion;cell projection;ligase activity;protein binding;extracellular region;identical protein binding;axon;extracellular exosome;mitochondrial matrix;protein dimerization activity;bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity;diadenosine tetraphosphate biosynthetic process;mitochondrial glycyl-tRNA aminoacylation;secretory granule	3D-structure;ATP-binding;Acetylation;Aminoacyl-tRNA synthetase;Cell projection;Charcot-Marie-Tooth disease;Cytoplasm;Disease mutation;Hydrolase;Ligase;Mitochondrion;Neurodegeneration;Neuropathy;Nucleotide-binding;Phosphoprotein;Protein biosynthesis;Reference proteome;Secreted;Transferase	R-HSA-392499;R-HSA-72766;R-HSA-379716;R-HSA-379724;R-HSA-379726	Metabolism of proteins;Translation;Cytosolic tRNA aminoacylation;tRNA Aminoacylation;Mitochondrial tRNA aminoacylation
COQ8A	negative	FHL2	ENSG00000115641	COQ8A	1	COQ8A	1	0.00216696673924544	WBGene00006407	WBGene00006407(0)	CDKN1A;CDKN1B	Familial isolated dilated cardiomyopathy	GO:0005634;GO:0005737;GO:0046872;GO:0043066;GO:0005515;GO:0003713;GO:0045893;GO:0005925;GO:0042802;GO:0001649;GO:0006357;GO:0045892;GO:0055014;GO:0055015;GO:0060347;GO:0070885;GO:0030018;GO:0031430;GO:0000122;GO:0005654;GO:0008134;GO:0030521;GO:0019216;GO:0050681;GO:0009725	nucleus;cytoplasm;metal ion binding;negative regulation of apoptotic process;focal adhesion;protein binding;transcription coactivator activity;positive regulation of transcription, DNA-templated;identical protein binding;negative regulation of transcription by RNA polymerase II;transcription coregulator activity;nucleoplasm;Z disc;transcription factor binding;androgen receptor signaling pathway;regulation of lipid metabolic process;androgen receptor binding;response to hormone;negative regulation of calcineurin-NFAT signaling cascade;osteoblast differentiation;regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;atrial cardiac muscle cell development;ventricular cardiac muscle cell development;heart trabecula formation;M band	3D-structure;Alternative splicing;Cytoplasm;Isopeptide bond;LIM domain;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Ubl conjugation;Zinc;Zinc-finger	R-HSA-1430728;R-HSA-556833;R-HSA-1989781;R-HSA-400206	Metabolism;Metabolism of lipids;PPARA activates gene expression;Regulation of lipid metabolism by PPARalpha
COQ8A	negative	SLC3A2	ENSG00000168003	COQ8A	1	COQ8A	1	0.00216696673924544	WBGene00000224;WBGene00000225				GO:0003723;GO:0016020;GO:0016021;GO:0005634;GO:0005829;GO:0003824;GO:0005765;GO:0005886;GO:0005975;GO:0005515;GO:0035725;GO:0042470;GO:0006816;GO:0030054;GO:0009986;GO:0005764;GO:0006865;GO:0050900;GO:0045296;GO:0070062;GO:0016324;GO:0043330;GO:0003725;GO:0015175;GO:0005432;GO:0015827;GO:1902475;GO:1903801;GO:1990184;GO:0045202	carbohydrate metabolic process;catalytic activity;amino acid transport;RNA binding;membrane;integral component of membrane;nucleoplasm;cytosol;plasma membrane;lysosomal membrane;protein binding;sodium ion transmembrane transport;melanosome;calcium ion transport;cell junction;cell surface;lysosome;leukocyte migration;cadherin binding;extracellular exosome;apical plasma membrane;response to exogenous dsRNA;double-stranded RNA binding;neutral amino acid transmembrane transporter activity;calcium:sodium antiporter activity;tryptophan transport;L-alpha-amino acid transmembrane transport;L-leucine import across plasma membrane;amino acid transport complex;neuronal cell body;apical pole of neuron;synapse	3D-structure;Acetylation;Alternative splicing;Amino-acid transport;Cell junction;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Isopeptide bond;Lysosome;Membrane;Phosphoprotein;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Transport;Ubl conjugation	R-HSA-109582;R-HSA-202733;R-HSA-1430728;R-HSA-382551;R-HSA-425407;R-HSA-71291;R-HSA-1643685;R-HSA-5619115;R-HSA-5619102;R-HSA-425393;R-HSA-71240;R-HSA-210991;R-HSA-352230;R-HSA-5660862	Hemostasis;Cell surface interactions at the vascular wall;Metabolism;Transport of small molecules;SLC-mediated transmembrane transport;Metabolism of amino acids and derivatives;Disease;Disorders of transmembrane transporters;SLC transporter disorders;Transport of inorganic cations/anions and amino acids/oligopeptides;Tryptophan catabolism;Basigin interactions;Amino acid transport across the plasma membrane;Defective SLC7A7 causes lysinuric protein intolerance (LPI)
COQ8A	negative	HSPA13	ENSG00000155304	COQ8A	1	COQ8A	1	0.00240622900975374	WBGene00006059	WBGene00006059(1)			GO:0000166;GO:0005524;GO:0005783;GO:0043231;GO:0005515;GO:0005634;GO:0051082;GO:0042026;GO:0005737;GO:0005829;GO:0016887;GO:0005886;GO:0016192;GO:0034605;GO:0070062;GO:0051085;GO:0031072;GO:0042623;GO:0044183;GO:0051787;GO:0006986;GO:0034620	nucleotide binding;ATP binding;endoplasmic reticulum;intracellular membrane-bounded organelle;protein binding;plasma membrane;nucleus;cytosol;unfolded protein binding;protein refolding;cytoplasm;ATPase activity;vesicle-mediated transport;extracellular exosome;chaperone cofactor-dependent protein refolding;heat shock protein binding;ATPase activity, coupled;protein folding chaperone;misfolded protein binding;response to unfolded protein;cellular response to unfolded protein	ATP-binding;Endoplasmic reticulum;Microsome;Nucleotide-binding;Reference proteome;Signal	R-HSA-2262752;R-HSA-8953897;R-HSA-3371453;R-HSA-3371556	Cellular responses to stress;Cellular responses to external stimuli;Regulation of HSF1-mediated heat shock response;Cellular response to heat stress
COQ8A	negative	HACD1	ENSG00000165996	COQ8A	1	COQ8A	1	0.00266915003679569	WBGene00020517	WBGene00020517(1)		Congenital fiber-type disproportion myopathy	GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0016829;GO:0006629;GO:0006631;GO:0006633;GO:0007275;GO:0030148;GO:0035338;GO:0042761;GO:0030176;GO:0018812;GO:0102158;GO:0102343;GO:0102344;GO:0102345;GO:0030497	membrane;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;lyase activity;lipid metabolic process;fatty acid metabolic process;fatty acid biosynthetic process;multicellular organism development;sphingolipid biosynthetic process;long-chain fatty-acyl-CoA biosynthetic process;very long-chain fatty acid biosynthetic process;integral component of endoplasmic reticulum membrane;3-hydroxyacyl-CoA dehydratase activity;very-long-chain 3-hydroxyacyl-CoA dehydratase activity;3-hydroxy-arachidoyl-CoA dehydratase activity;3-hydroxy-behenoyl-CoA dehydratase activity;3-hydroxy-lignoceroyl-CoA dehydratase activity;fatty acid elongation	Alternative splicing;Developmental protein;Endoplasmic reticulum;Fatty acid biosynthesis;Fatty acid metabolism;Glycoprotein;Lipid biosynthesis;Lipid metabolism;Lyase;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-556833;R-HSA-75105;R-HSA-75876;R-HSA-8978868	Metabolism;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Synthesis of very long-chain fatty acyl-CoAs;Fatty acid metabolism
COQ8A	negative	UBA6	ENSG00000033178	COQ8A	1	COQ8A	1	0.0029577462157262	WBGene00006699				GO:0000166;GO:0005524;GO:0016567;GO:0008641;GO:0006464;GO:0016874;GO:0005515;GO:0006511;GO:0004839;GO:0019780;GO:0007612;GO:0007626;GO:0021764;GO:0021766;GO:0060996;GO:0005634;GO:0005737;GO:0006974;GO:0032446;GO:0005829	ubiquitin-like modifier activating enzyme activity;cellular protein modification process;nucleotide binding;ATP binding;protein ubiquitination;ligase activity;protein binding;ubiquitin-dependent protein catabolic process;nucleus;cytoplasm;ubiquitin activating enzyme activity;FAT10 activating enzyme activity;cellular response to DNA damage stimulus;learning;locomotory behavior;amygdala development;hippocampus development;protein modification by small protein conjugation;dendritic spine development;cytosol	ATP-binding;Acetylation;Alternative splicing;Ligase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-8852135;R-HSA-8866652;R-HSA-983168;R-HSA-983169	Adaptive Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Protein ubiquitination;Synthesis of active ubiquitin: roles of E1 and E2 enzymes;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation
COQ8A	negative	ITGA2	ENSG00000164171	COQ8A	1	COQ8A	1	0.00327417063331326		WBGene00003929(0)		Fetal and neonatal alloimmune thrombocytopenia;BLEEDING DISORDER PLATELET-TYPE 9	GO:0016020;GO:0016021;GO:0046872;GO:0007155;GO:0005515;GO:0009986;GO:0007229;GO:0008305;GO:0046718;GO:0005925;GO:0005886;GO:0016032;GO:0001540;GO:0007596;GO:0030198;GO:0044877;GO:0009887;GO:0007160;GO:0001618;GO:0005518;GO:0031589;GO:0098639;GO:0033627;GO:0048333;GO:0034666;GO:0005178;GO:0038064;GO:0043236;GO:0043395;GO:0046982;GO:0001666;GO:0002687;GO:0006929;GO:0006971;GO:0007565;GO:0008283;GO:0010634;GO:0010694;GO:0014070;GO:0014075;GO:0014850;GO:0014911;GO:0030879;GO:0031346;GO:0032967;GO:0033343;GO:0033591;GO:0038065;GO:0042060;GO:0042493;GO:0043388;GO:0043589;GO:0045184;GO:0045727;GO:0045785;GO:0045987;GO:0048041;GO:0048661;GO:0050729;GO:0050927;GO:0050966;GO:0051971;GO:0060100;GO:0070365;GO:0071107;GO:0071260;GO:0071392;GO:0071407;GO:0005634;GO:0009897;GO:0030424;GO:0042995;GO:0043679;GO:0045178;GO:0048471	cell adhesion;integrin complex;membrane;integral component of membrane;metal ion binding;focal adhesion;protein binding;cell surface;integrin-mediated signaling pathway;viral entry into host cell;plasma membrane;viral process;amyloid-beta binding;blood coagulation;extracellular matrix organization;protein-containing complex binding;animal organ morphogenesis;cell-matrix adhesion;virus receptor activity;collagen binding;cell-substrate adhesion;collagen binding involved in cell-matrix adhesion;cell adhesion mediated by integrin;mesodermal cell differentiation;integrin alpha2-beta1 complex;integrin binding;collagen receptor activity;laminin binding;heparan sulfate proteoglycan binding;response to hypoxia;positive regulation of leukocyte migration;substrate-dependent cell migration;hypotonic response;female pregnancy;cell population proliferation;positive regulation of epithelial cell migration;positive regulation of alkaline phosphatase activity;response to organic cyclic compound;response to amine;response to muscle activity;positive regulation of smooth muscle cell migration;mammary gland development;positive regulation of cell projection organization;positive regulation of collagen biosynthetic process;positive regulation of collagen binding;response to L-ascorbic acid;collagen-activated signaling pathway;wound healing;response to drug;positive regulation of DNA binding;skin morphogenesis;establishment of protein localization;positive regulation of translation;positive regulation of cell adhesion;positive regulation of smooth muscle contraction;focal adhesion assembly;positive regulation of smooth muscle cell proliferation;positive regulation of inflammatory response;positive regulation of positive chemotaxis;detection of mechanical stimulus involved in sensory perception of pain;positive regulation of transmission of nerve impulse;positive regulation of phagocytosis, engulfment;hepatocyte differentiation;response to parathyroid hormone;cellular response to mechanical stimulus;cellular response to estradiol stimulus;cellular response to organic cyclic compound;nucleus;external side of plasma membrane;axon;cell projection;axon terminus;basal part of cell;perinuclear region of cytoplasm	3D-structure;Calcium;Cell adhesion;Direct protein sequencing;Disulfide bond;Glycoprotein;Host cell receptor for virus entry;Host-virus interaction;Integrin;Magnesium;Membrane;Metal-binding;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-109582;R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-162582;R-HSA-1474244;R-HSA-216083;R-HSA-3000178;R-HSA-9006934;R-HSA-3000171;R-HSA-447041;R-HSA-3000170;R-HSA-6806834;R-HSA-3000157;R-HSA-8874081;R-HSA-8875878;R-HSA-75892	Hemostasis;Developmental Biology;L1CAM interactions;Axon guidance;Signal Transduction;Extracellular matrix organization;Integrin cell surface interactions;ECM proteoglycans;Signaling by Receptor Tyrosine Kinases;Non-integrin membrane-ECM interactions;CHL1 interactions;Syndecan interactions;Signaling by MET;Laminin interactions;MET activates PTK2 signaling;MET promotes cell motility;Platelet Adhesion to exposed collagen
COQ8A	negative	MYOF	ENSG00000138119	COQ8A	1	COQ8A	1	0.00362071876223846	WBGene00001414;WBGene00020262				GO:0016021;GO:0007520;GO:0005634;GO:0016020;GO:0043231;GO:0005886;GO:0005901;GO:0031410;GO:0030659;GO:0005515;GO:0070062;GO:0031965;GO:0005635;GO:0006936;GO:0005543;GO:0001778;GO:0008015;GO:0006071;GO:0030947;GO:0033292;GO:0034605;GO:0048747	integral component of membrane;myoblast fusion;nucleus;membrane;intracellular membrane-bounded organelle;plasma membrane;cytoplasmic vesicle;cytoplasmic vesicle membrane;caveola;protein binding;plasma membrane organization;membrane fusion;extracellular exosome;phospholipid binding;nuclear membrane;nuclear envelope;muscle contraction;plasma membrane repair;T-tubule organization;blood circulation;glycerol metabolic process;regulation of vascular endothelial growth factor receptor signaling pathway;cellular response to heat;muscle fiber development	3D-structure;Acetylation;Alternative splicing;Calcium;Cell membrane;Cytoplasmic vesicle;Membrane;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Signal-anchor;Transmembrane;Transmembrane helix		
COQ8A	negative	LIMS1	ENSG00000169756	COQ8A	1	COQ8A	1	0.00362071876223846	WBGene00006826;WBGene00004030	WBGene00006826(1);WBGene00004030(1)			GO:0046872;GO:0016020;GO:0008270;GO:0005886;GO:0005515;GO:0048471;GO:0030054;GO:0005925;GO:0005737;GO:0043547;GO:0005829;GO:0019901;GO:0010628;GO:0005911;GO:0098609;GO:0045892;GO:0071560;GO:0045184;GO:1901224;GO:1900026;GO:0010811;GO:0051894;GO:0034329;GO:0033209;GO:0007569;GO:0045216;GO:2001046	membrane;metal ion binding;zinc ion binding;focal adhesion;plasma membrane;protein binding;perinuclear region of cytoplasm;cell junction;cytoplasm;positive regulation of GTPase activity;cytosol;protein kinase binding;positive regulation of gene expression;cell-cell junction;cell-cell adhesion;negative regulation of transcription, DNA-templated;cellular response to transforming growth factor beta stimulus;establishment of protein localization;positive regulation of NIK/NF-kappaB signaling;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of cell-substrate adhesion;positive regulation of focal adhesion assembly;cell junction assembly;tumor necrosis factor-mediated signaling pathway;cell aging;cell-cell junction organization;positive regulation of integrin-mediated signaling pathway	3D-structure;Acetylation;Alternative splicing;Cell junction;Cell membrane;Direct protein sequencing;LIM domain;Membrane;Metal-binding;Reference proteome;Repeat;Zinc	R-HSA-1500931;R-HSA-446728;R-HSA-446353;R-HSA-446388	Cell-Cell communication;Cell junction organization;Cell-extracellular matrix interactions;Regulation of cytoskeletal remodeling and cell spreading by IPP complex components
COQ8A	negative	JAG1	ENSG00000101384	COQ8A	1	COQ8A	1	0.00399983403765847	WBGene00018547;WBGene00000792;WBGene00001609;WBGene00003001	WBGene00010134(0);WBGene00009114(0);WBGene00013498(0)		Alagille syndrome due to 20p12 microdeletion;Alagille syndrome due to a JAG1 point mutation;Tetralogy of Fallot;Alagille Syndrome;Alagille syndrome 1;DEAFNESS CONGENITAL HEART DEFECTS AND POSTERIOR EMBRYOTOXON;Tetralogy of Fallot	GO:0045944;GO:0016020;GO:0016021;GO:0005509;GO:0008083;GO:0007275;GO:0005515;GO:0005576;GO:0005112;GO:0007219;GO:0007154;GO:0005886;GO:0005887;GO:0007399;GO:0005912;GO:0002456;GO:0001525;GO:0016324;GO:0042127;GO:0001709;GO:0030097;GO:0045746;GO:0045747;GO:0072006;GO:0097150;GO:0022408;GO:0072015;GO:0030216;GO:0001953;GO:0030336;GO:0045446;GO:0005198;GO:0003180;GO:0003184;GO:0061314;GO:2000737;GO:0060411;GO:0045445;GO:0005543;GO:0035909;GO:0003215;GO:0062043;GO:0061309;GO:0001974;GO:0002011;GO:0009887;GO:0032495;GO:0042491;GO:0043010;GO:0045596;GO:0045599;GO:0045602;GO:0045639;GO:0045665;GO:0045669;GO:0048839;GO:0061073;GO:0061156;GO:0061444;GO:0072017;GO:0072070;GO:0045177	integral component of membrane;protein binding;membrane;calcium ion binding;cell communication;multicellular organism development;Notch signaling pathway;Notch binding;positive regulation of transcription by RNA polymerase II;growth factor activity;extracellular region;plasma membrane;integral component of plasma membrane;nervous system development;adherens junction;T cell mediated immunity;angiogenesis;apical plasma membrane;regulation of cell population proliferation;cell fate determination;hemopoiesis;negative regulation of Notch signaling pathway;positive regulation of Notch signaling pathway;nephron development;neuronal stem cell population maintenance;negative regulation of cell-cell adhesion;glomerular visceral epithelial cell development;keratinocyte differentiation;negative regulation of cell-matrix adhesion;negative regulation of cell migration;structural molecule activity;aortic valve morphogenesis;pulmonary valve morphogenesis;Notch signaling involved in heart development;endothelial cell differentiation;negative regulation of stem cell differentiation;cardiac septum morphogenesis;myoblast differentiation;phospholipid binding;aorta morphogenesis;cardiac right ventricle morphogenesis;positive regulation of cardiac epithelial to mesenchymal transition;cardiac neural crest cell development involved in outflow tract morphogenesis;blood vessel remodeling;morphogenesis of an epithelial sheet;animal organ morphogenesis;response to muramyl dipeptide;inner ear auditory receptor cell differentiation;camera-type eye development;negative regulation of cell differentiation;negative regulation of fat cell differentiation;negative regulation of endothelial cell differentiation;positive regulation of myeloid cell differentiation;negative regulation of neuron differentiation;positive regulation of osteoblast differentiation;inner ear development;ciliary body morphogenesis;pulmonary artery morphogenesis;endocardial cushion cell development;distal tubule development;loop of Henle development;apical part of cell	3D-structure;Alternative splicing;Calcium;Deafness;Developmental protein;Disease mutation;Disulfide bond;EGF-like domain;Glycoprotein;Membrane;Notch signaling pathway;Polymorphism;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1643685;R-HSA-5663202;R-HSA-157118;R-HSA-1980143;R-HSA-1980145;R-HSA-2122948;R-HSA-2644602;R-HSA-2644603;R-HSA-2644606;R-HSA-2691230;R-HSA-2691232;R-HSA-2894858;R-HSA-2894862;R-HSA-2979096;R-HSA-9012852;R-HSA-9013507;R-HSA-8878159;R-HSA-9013694;R-HSA-2660825;R-HSA-2660826;R-HSA-9013700;R-HSA-8941856	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Disease;Diseases of signal transduction;Signaling by NOTCH;Signaling by NOTCH1;Signaling by NOTCH2;Activated NOTCH1 Transmits Signal to the Nucleus;Signaling by NOTCH1 PEST Domain Mutants in Cancer;Signaling by NOTCH1 in Cancer;Constitutive Signaling by NOTCH1 PEST Domain Mutants;Signaling by NOTCH1 HD Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD Domain Mutants;Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer;Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants;NOTCH2 Activation and Transmission of Signal to the Nucleus;Signaling by NOTCH3;NOTCH3 Activation and Transmission of Signal to the Nucleus;Transcriptional regulation by RUNX3;Signaling by NOTCH4;Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant;NOTCH4 Activation and Transmission of Signal to the Nucleus;RUNX3 regulates NOTCH signaling
COQ8A	negative	EDEM1	ENSG00000134109	COQ8A	1	COQ8A	1	0.00399983403765847	WBGene00008148;WBGene00008646	WBGene00008148(1)			GO:0016020;GO:0016787;GO:0005509;GO:0003824;GO:0008152;GO:0016798;GO:0004571;GO:0016021;GO:0005783;GO:0005789;GO:0016235;GO:0030433;GO:0036510;GO:1904154;GO:0030176;GO:0044322;GO:0005515;GO:0006986;GO:0036498;GO:0051787;GO:0097466;GO:1904382	membrane;hydrolase activity;calcium ion binding;catalytic activity;metabolic process;hydrolase activity, acting on glycosyl bonds;mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;integral component of membrane;endoplasmic reticulum;endoplasmic reticulum membrane;aggresome;ubiquitin-dependent ERAD pathway;trimming of terminal mannose on C branch;positive regulation of retrograde protein transport, ER to cytosol;integral component of endoplasmic reticulum membrane;endoplasmic reticulum quality control compartment;protein binding;response to unfolded protein;IRE1-mediated unfolded protein response;misfolded protein binding;ubiquitin-dependent glycoprotein ERAD pathway;mannose trimming involved in glycoprotein ERAD pathway	Alternative splicing;Endoplasmic reticulum;Glycoprotein;Membrane;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix;Unfolded protein response	R-HSA-392499;R-HSA-597592;R-HSA-446203;R-HSA-532668;R-HSA-901032;R-HSA-901042;R-HSA-381038;R-HSA-381070;R-HSA-381119	Metabolism of proteins;Post-translational protein modification;Asparagine N-linked glycosylation;N-glycan trimming in the ER and Calnexin/Calreticulin cycle;ER Quality Control Compartment (ERQC);Calnexin/calreticulin cycle;XBP1(S) activates chaperone genes;IRE1alpha activates chaperones;Unfolded Protein Response (UPR)
COQ8A	negative	FST	ENSG00000134363	COQ8A	1	COQ8A	1	0.00399983403765847					GO:0043395;GO:0005515;GO:0005576;GO:0005615;GO:0030154;GO:0000122;GO:0007275;GO:0048185;GO:0002244;GO:0030510;GO:0032926;GO:0038102;GO:0051798	protein binding;heparan sulfate proteoglycan binding;skeletal system development;gamete generation;pattern specification process;female gonad development;BMP signaling pathway;hair follicle morphogenesis;odontogenesis of dentin-containing tooth;keratinocyte proliferation;negative regulation of cell differentiation;nucleus;cytoplasm;extracellular region;extracellular space;cell differentiation;multicellular organism development;negative regulation of transcription by RNA polymerase II;activin binding;hematopoietic progenitor cell differentiation;regulation of BMP signaling pathway;negative regulation of activin receptor signaling pathway;activin receptor antagonist activity;positive regulation of hair follicle development	3D-structure;Alternative splicing;Direct protein sequencing;Disulfide bond;Glycoprotein;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-162582;R-HSA-9006936;R-HSA-1502540;R-HSA-2473224	Signal Transduction;Signaling by TGF-beta family members;Signaling by Activin;Antagonism of Activin by Follistatin
COQ8A	negative	SKIL	ENSG00000136603	COQ8A	1	COQ8A	1	0.00399983403765847					GO:0000122;GO:0046332;GO:0030512;GO:0005515;GO:0005634;GO:0000981;GO:0003714;GO:0005667;GO:0000978;GO:0001227;GO:0005654;GO:0032991;GO:0030514;GO:0003682;GO:0001825;GO:0002260;GO:0007050;GO:0007179;GO:0007283;GO:0034097;GO:0045596;GO:0050772;GO:0070306;GO:1902043;GO:1902231;GO:0001669	negative regulation of transcription by RNA polymerase II;negative regulation of transforming growth factor beta receptor signaling pathway;SMAD binding;protein binding;nucleus;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;transcription factor complex;RNA polymerase II cis-regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;nucleoplasm;protein-containing complex;negative regulation of BMP signaling pathway;chromatin binding;blastocyst formation;lymphocyte homeostasis;cell cycle arrest;transforming growth factor beta receptor signaling pathway;spermatogenesis;response to cytokine;negative regulation of cell differentiation;positive regulation of axonogenesis;lens fiber cell differentiation;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage;acrosomal vesicle	3D-structure;Alternative splicing;Coiled coil;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-212436;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-9006936;R-HSA-170834;R-HSA-2173793;R-HSA-2173795	Generic Transcription Pathway;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Signaling by TGF-beta family members;Signaling by TGF-beta Receptor Complex;Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer;Downregulation of SMAD2/3:SMAD4 transcriptional activity
COQ8A	negative	MYO1C	ENSG00000197879	COQ8A	1	COQ8A	1	0.00399983403765847	WBGene00002035;WBGene00002038			Autosomal dominant non-syndromic sensorineural deafness type DFNA	GO:0051028;GO:0005634;GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0005524;GO:0003774;GO:0003779;GO:0016459;GO:0005886;GO:0042995;GO:0016604;GO:0031410;GO:0045121;GO:0005643;GO:0005654;GO:0005730;GO:0038096;GO:0005516;GO:0005515;GO:0005829;GO:0070062;GO:0030335;GO:0090314;GO:0005902;GO:0031941;GO:0016461;GO:0005102;GO:0017160;GO:0006605;GO:0006612;GO:0038089;GO:0045815;GO:1900748;GO:2000810;GO:0001726;GO:0009925;GO:0016328;GO:0060171;GO:0000146;GO:0008022;GO:0030898;GO:0051015;GO:0030050;GO:0030838;GO:0071346;GO:1900078;GO:0005903;GO:0030659;GO:0032420;GO:0032421;GO:0032587;GO:0045335	ATP binding;protein binding;motor activity;myosin complex;cell;mRNA transport;nucleus;cytoplasm;membrane;protein transport;nucleotide binding;plasma membrane;actin binding;cell projection;nuclear body;cytoplasmic vesicle;membrane raft;nuclear pore;nucleoplasm;nucleolus;Fc-gamma receptor signaling pathway involved in phagocytosis;calmodulin binding;actin filament binding;cytosol;extracellular exosome;positive regulation of cell migration;positive regulation of protein targeting to membrane;actin cytoskeleton;microvillus;microfilament motor activity;actin-dependent ATPase activity;actin filament organization;vesicle transport along actin filament;vesicle;filamentous actin;unconventional myosin complex;signaling receptor binding;Ral GTPase binding;protein targeting;protein targeting to membrane;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;positive regulation of gene expression, epigenetic;positive regulation of vascular endothelial growth factor signaling pathway;regulation of bicellular tight junction assembly;ruffle;basal plasma membrane;lateral plasma membrane;stereocilium membrane;protein C-terminus binding;positive regulation of actin filament polymerization;cellular response to interferon-gamma;positive regulation of cellular response to insulin stimulus;brush border;cytoplasmic vesicle membrane;stereocilium;stereocilium bundle;ruffle membrane;phagocytic vesicle	3D-structure;ATP-binding;Acetylation;Actin-binding;Alternative splicing;Calmodulin-binding;Cell membrane;Cell projection;Cytoplasm;Cytoplasmic vesicle;Direct protein sequencing;Membrane;Methylation;Motor protein;Myosin;Nuclear pore complex;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Translocation;Transport;mRNA transport	R-HSA-168249;R-HSA-168256;R-HSA-2029480;R-HSA-2029482;R-HSA-5653656;R-HSA-199991;R-HSA-1445148	Innate Immune System;Immune System;Fcgamma receptor (FCGR) dependent phagocytosis;Regulation of actin dynamics for phagocytic cup formation;Vesicle-mediated transport;Membrane Trafficking;Translocation of SLC2A4 (GLUT4) to the plasma membrane
COQ8A	negative	MARCKS	ENSG00000277443	COQ8A	1	COQ8A	1	0.00399983403765847					GO:0005737;GO:0016020;GO:0003779;GO:0005856;GO:0005925;GO:0005516;GO:0005886;GO:0070062;GO:0015629;GO:0051015;GO:0005080;GO:0042802;GO:0051017;GO:0051260;GO:0051764;GO:0005813;GO:0005938;GO:0032432;GO:0042585	calmodulin binding;cytoplasm;membrane;actin binding;cytoskeleton;focal adhesion;plasma membrane;extracellular exosome;actin cytoskeleton;actin filament binding;protein kinase C binding;identical protein binding;actin filament bundle assembly;actin crosslink formation;centrosome;cell cortex;actin filament bundle;germinal vesicle	Actin-binding;Calmodulin-binding;Cytoplasm;Cytoskeleton;Lipoprotein;Membrane;Myristate;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-1430728;R-HSA-163685;R-HSA-422356;R-HSA-399997	Metabolism;Integration of energy metabolism;Regulation of insulin secretion;Acetylcholine regulates insulin secretion
COQ8A	negative	CHAC1	ENSG00000128965	COQ8A	1	COQ8A	1	0.00441411327190455	WBGene00017724	WBGene00017724(1)			GO:0005737;GO:0016829;GO:0005794;GO:0005829;GO:0005515;GO:0006915;GO:0007219;GO:0007399;GO:0003839;GO:0006751;GO:0061928;GO:0006986;GO:0005802;GO:0005112;GO:0070059;GO:0006750;GO:0022008;GO:0045746;GO:0010955	glutathione catabolic process;gamma-glutamylcyclotransferase activity;cytoplasm;lyase activity;Golgi apparatus;cytosol;protein binding;apoptotic process;Notch signaling pathway;nervous system development;response to unfolded protein;trans-Golgi network;Notch binding;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;glutathione biosynthetic process;neurogenesis;negative regulation of Notch signaling pathway;negative regulation of protein processing;glutathione specific gamma-glutamylcyclotransferase activity	Alternative splicing;Apoptosis;Cytoplasm;Golgi apparatus;Lyase;Neurogenesis;Notch signaling pathway;Reference proteome;Unfolded protein response	R-HSA-1430728;R-HSA-156580;R-HSA-156590;R-HSA-174403;R-HSA-211859	Metabolism;Phase II - Conjugation of compounds;Glutathione conjugation;Glutathione synthesis and recycling;Biological oxidations
COQ8A	negative	FOXC1	ENSG00000054598	COQ8A	1	COQ8A	1	0.00486631186035247			FGF19	Axenfeld anomaly;Axenfeld-Rieger syndrome;Isolated aniridia;PETERS ANOMALY;RIEGER ANOMALY;Axenfeld-Rieger syndrome type 3;IRIDOGONIODYSGENESIS ANOMALY;PETERS ANOMALY;ANTERIOR SEGMENT DYSGENESIS 3;Axenfeld-Rieger syndrome type 3	GO:0045944;GO:0044212;GO:0005634;GO:0005829;GO:0005654;GO:0006355;GO:0003677;GO:0003700;GO:0043565;GO:0005515;GO:0007275;GO:0001822;GO:0003713;GO:0045893;GO:0000981;GO:0030154;GO:0006357;GO:0000122;GO:0000790;GO:0009653;GO:0016477;GO:0008283;GO:0001228;GO:0001525;GO:0008134;GO:0016525;GO:0010718;GO:0000977;GO:0070098;GO:0045930;GO:0008301;GO:0001958;GO:0042475;GO:1990841;GO:0001223;GO:0071364;GO:0043388;GO:0045618;GO:0001657;GO:0005720;GO:1904798;GO:0038084;GO:0021549;GO:1990869;GO:0001501;GO:0001503;GO:0001541;GO:0001568;GO:0001654;GO:0001701;GO:0001756;GO:0001945;GO:0001974;GO:0003007;GO:0007219;GO:0007420;GO:0007507;GO:0008354;GO:0010628;GO:0014031;GO:0014032;GO:0030199;GO:0030203;GO:0032808;GO:0035050;GO:0036438;GO:0043010;GO:0046620;GO:0048010;GO:0048341;GO:0048762;GO:0048844;GO:0055010;GO:0060038;GO:0072010;GO:0097746;GO:1901491;GO:1901534;GO:1902038;GO:1902257	regulation of transcription, DNA-templated;DNA-binding transcription factor activity;sequence-specific DNA binding;positive regulation of transcription by RNA polymerase II;transcription regulatory region DNA binding;nucleus;nucleoplasm;cytosol;DNA binding;protein binding;multicellular organism development;kidney development;transcription coactivator activity;positive regulation of transcription, DNA-templated;DNA-binding transcription factor activity, RNA polymerase II-specific;anatomical structure morphogenesis;cell differentiation;regulation of transcription by RNA polymerase II;negative regulation of transcription by RNA polymerase II;nuclear chromatin;cell migration;DNA-binding transcription activator activity, RNA polymerase II-specific;angiogenesis;transcription factor binding;negative regulation of angiogenesis;positive regulation of epithelial to mesenchymal transition;RNA polymerase II regulatory region sequence-specific DNA binding;chemokine-mediated signaling pathway;negative regulation of mitotic cell cycle;DNA binding, bending;endochondral ossification;cell population proliferation;odontogenesis of dentin-containing tooth;promoter-specific chromatin binding;transcription coactivator binding;cellular response to epidermal growth factor stimulus;positive regulation of DNA binding;positive regulation of keratinocyte differentiation;ureteric bud development;nuclear heterochromatin;positive regulation of core promoter binding;vascular endothelial growth factor signaling pathway;cerebellum development;cellular response to chemokine;skeletal system development;ossification;ovarian follicle development;blood vessel development;eye development;in utero embryonic development;somitogenesis;lymph vessel development;blood vessel remodeling;heart morphogenesis;Notch signaling pathway;brain development;heart development;germ cell migration;positive regulation of gene expression;mesenchymal cell development;neural crest cell development;collagen fibril organization;glycosaminoglycan metabolic process;lacrimal gland development;embryonic heart tube development;maintenance of lens transparency;camera-type eye development;regulation of organ growth;vascular endothelial growth factor receptor signaling pathway;paraxial mesoderm formation;mesenchymal cell differentiation;artery morphogenesis;ventricular cardiac muscle tissue morphogenesis;cardiac muscle cell proliferation;glomerular epithelium development;regulation of blood vessel diameter;negative regulation of lymphangiogenesis;positive regulation of hematopoietic progenitor cell differentiation;positive regulation of hematopoietic stem cell differentiation;negative regulation of apoptotic process involved in outflow tract morphogenesis	Activator;Angiogenesis;DNA-binding;Deafness;Developmental protein;Disease mutation;Nucleus;Peters anomaly;Phosphoprotein;Polymorphism;Reference proteome;Repressor;Transcription;Transcription regulation;Ubl conjugation		
COQ8A	negative	MAP4K4	ENSG00000071054	COQ8A	1	COQ8A	1	0.00486631186035247	WBGene00003247				GO:0004672;GO:0005524;GO:0006468;GO:0001953;GO:0030335;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0005515;GO:0048812;GO:0008017;GO:0023014;GO:0032147;GO:0035556;GO:0046328;GO:0004111;GO:0032014;GO:0043066;GO:0043547;GO:0051549;GO:0051894;GO:1903393;GO:0005925;GO:0010977;GO:0061179;GO:0070571	ATP binding;protein phosphorylation;protein kinase activity;negative regulation of cell-matrix adhesion;positive regulation of cell migration;cytoplasm;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;protein binding;neuron projection morphogenesis;microtubule binding;regulation of mitotic cell cycle;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;intracellular signal transduction;regulation of JNK cascade;creatine kinase activity;positive regulation of ARF protein signal transduction;negative regulation of apoptotic process;positive regulation of GTPase activity;positive regulation of keratinocyte migration;positive regulation of focal adhesion assembly;positive regulation of focal adhesion disassembly;focal adhesion;negative regulation of neuron projection development;negative regulation of insulin secretion involved in cellular response to glucose stimulus;negative regulation of neuron projection regeneration	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cytoplasm;Kinase;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-2262752;R-HSA-8953897;R-HSA-2559580;R-HSA-2559583	Cellular responses to stress;Cellular responses to external stimuli;Oxidative Stress Induced Senescence;Cellular Senescence
COQ8A	negative	GOLT1B	ENSG00000111711	COQ8A	1	COQ8A	1	0.00486631186035247	WBGene00018270	WBGene00020662(0);WBGene00017764(0);WBGene00009237(0);WBGene00007112(0);WBGene00019029(0);WBGene00020393(0);WBGene00013949(0);WBGene00021601(0);WBGene00013101(0);WBGene00189950(0);WBGene00013037(0);WBGene00013035(0);WBGene00044488(0);WBGene00019368(0);WBGene00013044(0);WBGene00020341(0);WBGene00008044(0);WBGene00008038(0);WBGene00008043(0);WBGene00008042(0);WBGene00013950(0);WBGene00022457(0);WBGene00015775(0);WBGene00019269(0)			GO:0016020;GO:0016021;GO:0016192;GO:0015031;GO:0005794;GO:0000139;GO:0005783;GO:0032991;GO:0043123	vesicle-mediated transport;membrane;integral component of membrane;protein transport;Golgi apparatus;Golgi membrane;endoplasmic reticulum;protein-containing complex;positive regulation of I-kappaB kinase/NF-kappaB signaling	Acetylation;Golgi apparatus;Membrane;Protein transport;Reference proteome;Transmembrane;Transmembrane helix;Transport		
COQ8A	negative	GBP1	ENSG00000117228	COQ8A	1	COQ8A	1	0.00486631186035247					GO:0005737;GO:0016020;GO:0000166;GO:0016787;GO:0003779;GO:0003924;GO:0005525;GO:0005794;GO:0005829;GO:0042803;GO:0005886;GO:0005576;GO:0000139;GO:0002376;GO:0019955;GO:0042802;GO:0051607;GO:0071346;GO:0005515;GO:0071347;GO:0071356;GO:0031410;GO:0019899;GO:0060333;GO:0070373;GO:1900025;GO:0015629;GO:1903076;GO:0051260;GO:0051879;GO:0050860;GO:0019003;GO:1900041;GO:0012506;GO:0030507;GO:0050848;GO:0072665;GO:1903077	GTP binding;GTPase activity;cytoplasm;membrane;nucleotide binding;hydrolase activity;actin binding;Golgi apparatus;cytosol;protein homodimerization activity;plasma membrane;extracellular region;Golgi membrane;immune system process;protein binding;identical protein binding;defense response to virus;cellular response to interferon-gamma;cellular response to interleukin-1;cellular response to tumor necrosis factor;cytoplasmic vesicle;enzyme binding;interferon-gamma-mediated signaling pathway;negative regulation of ERK1 and ERK2 cascade;negative regulation of substrate adhesion-dependent cell spreading;actin cytoskeleton;regulation of protein localization to plasma membrane;Hsp90 protein binding;negative regulation of T cell receptor signaling pathway;GDP binding;cytokine binding;negative regulation of interleukin-2 secretion;vesicle membrane;spectrin binding;regulation of calcium-mediated signaling;protein localization to vacuole;negative regulation of protein localization to plasma membrane	3D-structure;Antiviral defense;Cell membrane;Cytoplasm;GTP-binding;Golgi apparatus;Hydrolase;Immunity;Lipoprotein;Membrane;Methylation;Nucleotide-binding;Polymorphism;Prenylation;Reference proteome;Secreted	R-HSA-168256;R-HSA-1280215;R-HSA-913531;R-HSA-877300	Immune System;Cytokine Signaling in Immune system;Interferon Signaling;Interferon gamma signaling
COQ8A	negative	CDKN1A	ENSG00000124762	COQ8A	1	COQ8A	1	0.00486631186035247				Multiple endocrine neoplasia type 1	GO:1904706;GO:0008285;GO:0005634;GO:0048146;GO:0005737;GO:0046872;GO:0016301;GO:0016310;GO:0005654;GO:0005515;GO:0007049;GO:0016604;GO:0007050;GO:0004860;GO:0004861;GO:0007346;GO:0072331;GO:0006977;GO:0005829;GO:0031625;GO:0032991;GO:0006367;GO:0000082;GO:0019221;GO:0005730;GO:0007507;GO:0030308;GO:0071493;GO:0000079;GO:0034198;GO:0006357;GO:2000379;GO:0007265;GO:0090398;GO:0006974;GO:0071479;GO:0050821;GO:0000307;GO:0070557;GO:0019901;GO:0044877;GO:0019912;GO:0030332;GO:0000086;GO:0031668;GO:0042326;GO:0045860;GO:0071850;GO:0090400;GO:0097193;GO:1904030;GO:1904031;GO:1905179;GO:2000134;GO:0006606;GO:0006978;GO:0009411;GO:0009636;GO:0010033;GO:0010165;GO:0010243;GO:0010629;GO:0010942;GO:0014070;GO:0030890;GO:0031100;GO:0034605;GO:0042246;GO:0042493;GO:0042771;GO:0043066;GO:0043068;GO:0045736;GO:0046685;GO:0051384;GO:0051412;GO:0051726;GO:0055093;GO:0060574;GO:0071480;GO:0090399;GO:2000278;GO:0048471	nucleus;cyclin-dependent protein serine/threonine kinase inhibitor activity;cell cycle arrest;regulation of mitotic cell cycle;signal transduction by p53 class mediator;negative regulation of vascular smooth muscle cell proliferation;negative regulation of cell population proliferation;positive regulation of fibroblast proliferation;cytoplasm;metal ion binding;kinase activity;phosphorylation;nucleoplasm;protein binding;cell cycle;nuclear body;protein kinase inhibitor activity;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cytosol;ubiquitin protein ligase binding;protein-containing complex;transcription initiation from RNA polymerase II promoter;G1/S transition of mitotic cell cycle;cytokine-mediated signaling pathway;mitotic G2 DNA damage checkpoint;nucleolus;heart development;negative regulation of protein binding;negative regulation of cell growth;cellular response to UV-B;regulation of cyclin-dependent protein serine/threonine kinase activity;cellular response to amino acid starvation;regulation of transcription by RNA polymerase II;positive regulation of reactive oxygen species metabolic process;Ras protein signal transduction;cellular senescence;cellular response to DNA damage stimulus;cellular response to ionizing radiation;protein stabilization;cyclin-dependent protein kinase holoenzyme complex;PCNA-p21 complex;protein kinase binding;protein-containing complex binding;cyclin-dependent protein kinase activating kinase activity;cyclin binding;protein sequestering activity;G2/M transition of mitotic cell cycle;cellular response to extracellular stimulus;negative regulation of phosphorylation;positive regulation of protein kinase activity;mitotic cell cycle arrest;stress-induced premature senescence;intrinsic apoptotic signaling pathway;regulation of cell cycle G1/S phase transition;negative regulation of cyclin-dependent protein kinase activity;positive regulation of cyclin-dependent protein kinase activity;negative regulation of cardiac muscle tissue regeneration;negative regulation of G1/S transition of mitotic cell cycle;negative regulation of DNA biosynthetic process;protein import into nucleus;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;response to UV;response to toxic substance;response to organic substance;response to X-ray;response to organonitrogen compound;negative regulation of gene expression;positive regulation of cell death;response to organic cyclic compound;positive regulation of B cell proliferation;animal organ regeneration;cellular response to heat;tissue regeneration;response to drug;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;negative regulation of apoptotic process;positive regulation of programmed cell death;negative regulation of cyclin-dependent protein serine/threonine kinase activity;response to arsenic-containing substance;response to glucocorticoid;response to corticosterone;regulation of cell cycle;response to hyperoxia;intestinal epithelial cell maturation;cellular response to gamma radiation;replicative senescence;regulation of DNA biosynthetic process;perinuclear region of cytoplasm	3D-structure;Acetylation;Cell cycle;Cytoplasm;Direct protein sequencing;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Protein kinase inhibitor;Reference proteome;Ubl conjugation;Zinc;Zinc-finger	R-HSA-168256;R-HSA-1266738;R-HSA-212436;R-HSA-3700989;R-HSA-6791312;R-HSA-6804116;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-1643685;R-HSA-1257604;R-HSA-1280215;R-HSA-2262752;R-HSA-449147;R-HSA-453274;R-HSA-5663202;R-HSA-69242;R-HSA-69275;R-HSA-69278;R-HSA-69563;R-HSA-69580;R-HSA-69615;R-HSA-69620;R-HSA-8852276;R-HSA-8878166;R-HSA-8953897;R-HSA-9006925;R-HSA-2219528;R-HSA-5674400;R-HSA-9614085;R-HSA-187577;R-HSA-453279;R-HSA-69202;R-HSA-69206;R-HSA-69656;R-HSA-8878159;R-HSA-2559583;R-HSA-6785807;R-HSA-69231;R-HSA-69236;R-HSA-2559582;R-HSA-9617828;R-HSA-198323;R-HSA-2559586;R-HSA-9616222;R-HSA-8864260;R-HSA-8866911;R-HSA-8941855;R-HSA-69560;R-HSA-69895	Immune System;Developmental Biology;Generic Transcription Pathway;Transcriptional Regulation by TP53;TP53 Regulates Transcription of Cell Cycle Genes;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;Disease;PIP3 activates AKT signaling;Cytokine Signaling in Immune system;Cellular responses to stress;Signaling by Interleukins;Mitotic G2-G2/M phases;Diseases of signal transduction;S Phase;G2/M Transition;Cell Cycle, Mitotic;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;The role of GTSE1 in G2/M progression after G2 checkpoint;Transcriptional regulation by RUNX2;Cellular responses to external stimuli;Intracellular signaling by second messengers;PI3K/AKT Signaling in Cancer;Constitutive Signaling by AKT1 E17K in Cancer;FOXO-mediated transcription;SCF(Skp2)-mediated degradation of p27/p21;Mitotic G1 phase and G1/S transition;Cyclin E associated events during G1/S transition ;G1/S Transition;Cyclin A:Cdk2-associated events at S phase entry;Transcriptional regulation by RUNX3;Cellular Senescence;Interleukin-4 and Interleukin-13 signaling;Cyclin D associated events in G1;G1 Phase;Senescence-Associated Secretory Phenotype (SASP);FOXO-mediated transcription of cell cycle genes;AKT phosphorylates targets in the cytosol;DNA Damage/Telomere Stress Induced Senescence;Transcriptional regulation of granulopoiesis;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;TFAP2 (AP-2) family regulates transcription of cell cycle factors;RUNX3 regulates CDKN1A transcription;Transcriptional activation of p53 responsive genes  ;Transcriptional  activation of  cell cycle inhibitor p21 
COQ8A	negative	SERPINH1	ENSG00000149257	COQ8A	1	COQ8A	1	0.00486631186035247	WBGene00005642;WBGene00005643;WBGene00005644;WBGene00005647;WBGene00005648;WBGene00005649			Osteogenesis imperfecta type 3;OSTEOGENESIS IMPERFECTA TYPE X;PRETERM PREMATURE RUPTURE OF THE MEMBRANES	GO:0003723;GO:0005615;GO:0005783;GO:0004867;GO:0010951;GO:0005581;GO:0005518;GO:0045121;GO:0005788;GO:0062023;GO:0030199;GO:0006986;GO:0005793;GO:0051082;GO:0003433;GO:0032964;GO:0051604;GO:0005737	extracellular space;serine-type endopeptidase inhibitor activity;collagen binding;RNA binding;endoplasmic reticulum;negative regulation of endopeptidase activity;collagen trimer;membrane raft;endoplasmic reticulum lumen;collagen-containing extracellular matrix;response to unfolded protein;endoplasmic reticulum-Golgi intermediate compartment;collagen fibril organization;unfolded protein binding;chondrocyte development involved in endochondral bone morphogenesis;collagen biosynthetic process;protein maturation;cytoplasm	Acetylation;Chaperone;Endoplasmic reticulum;Glycoprotein;Osteogenesis imperfecta;Phosphoprotein;Polymorphism;Reference proteome;Signal;Stress response	R-HSA-1474244;R-HSA-1474290;R-HSA-1650814	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
COQ8A	negative	NABP1	ENSG00000173559	COQ8A	1	COQ8A	1	0.00486631186035247	WBGene00015554			ACUTE PROMYELOCYTIC LEUKEMIA	GO:0005634;GO:0005829;GO:0005654;GO:0003677;GO:0005515;GO:0006281;GO:0006974;GO:0000784;GO:0042795;GO:0000724;GO:0003697;GO:0007093;GO:0010212;GO:0070876;GO:0003723	nucleus;nucleoplasm;cytosol;DNA binding;protein binding;DNA repair;cellular response to DNA damage stimulus;nuclear chromosome, telomeric region;single-stranded DNA binding;snRNA transcription by RNA polymerase II;double-strand break repair via homologous recombination;mitotic cell cycle checkpoint;response to ionizing radiation;SOSS complex;RNA binding	Alternative splicing;DNA damage;DNA repair;DNA-binding;Nucleus;Polymorphism;Reference proteome	R-HSA-73857;R-HSA-74160;R-HSA-6807505	RNA Polymerase II Transcription;Gene expression (Transcription);RNA polymerase II transcribes snRNA genes
COQ8A	negative	DSE	ENSG00000111817	COQ8A	1	COQ8A	1	0.00535934872854749				Musculocontractural Ehlers-Danlos syndrome;Ehlers-Danlos syndrome musculocontractural type 2;EHLERS-DANLOS SYNDROME MUSCULOCONTRACTURAL TYPE 2	GO:0016020;GO:0016021;GO:0016853;GO:0005829;GO:0005654;GO:0000139;GO:0030208;GO:0005783;GO:0005794;GO:0015012;GO:0030206;GO:0047757	membrane;integral component of membrane;isomerase activity;nucleoplasm;cytosol;Golgi membrane;dermatan sulfate biosynthetic process;endoplasmic reticulum;Golgi apparatus;heparan sulfate proteoglycan biosynthetic process;chondroitin sulfate biosynthetic process;chondroitin-glucuronate 5-epimerase activity;chondroitin sulfate metabolic process;dermatan sulfate metabolic process	3D-structure;Disease mutation;Ehlers-Danlos syndrome;Glycoprotein;Isomerase;Membrane;Polymorphism;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-71387;R-HSA-1630316;R-HSA-1793185;R-HSA-2022923	Metabolism;Metabolism of carbohydrates;Glycosaminoglycan metabolism;Chondroitin sulfate/dermatan sulfate metabolism;Dermatan sulfate biosynthesis
COQ8A	negative	NETO2	ENSG00000171208	COQ8A	1	COQ8A	1	0.00535934872854749	WBGene00019360;WBGene00010587				GO:0016020;GO:0016021;GO:2000312;GO:0035255;GO:0014069;GO:0045202;GO:0005515	protein binding;regulation of kainate selective glutamate receptor activity;membrane;integral component of membrane;ionotropic glutamate receptor binding;postsynaptic density;synapse	Alternative splicing;Direct protein sequencing;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
COQ8A	negative	HAUS2	ENSG00000137814	COQ8A	1	COQ8A	1	0.00589631096785992					GO:0005737;GO:0051301;GO:0005856;GO:0005515;GO:0007049;GO:0005874;GO:0007098;GO:0031023;GO:0051225;GO:0005876;GO:0070652;GO:0005813;GO:0005815;GO:0005819;GO:0005829;GO:0003674;GO:0000086;GO:0010389;GO:0097711	spindle assembly;HAUS complex;centrosome cycle;microtubule organizing center organization;cytoplasm;cytoskeleton;cell division;protein binding;cell cycle;microtubule;spindle microtubule;centrosome;microtubule organizing center;spindle;cytosol;molecular_function;G2/M transition of mitotic cell cycle;regulation of G2/M transition of mitotic cell cycle;ciliary basal body-plasma membrane docking	Alternative splicing;Cell cycle;Cell division;Coiled coil;Cytoplasm;Cytoskeleton;Microtubule;Mitosis;Polymorphism;Reference proteome	R-HSA-1852241;R-HSA-5617833;R-HSA-1640170;R-HSA-453274;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-380320;R-HSA-68877;R-HSA-2565942;R-HSA-380259;R-HSA-380270;R-HSA-380284;R-HSA-380287;R-HSA-5620912;R-HSA-8854518	Organelle biogenesis and maintenance;Cilium Assembly;Cell Cycle;Mitotic G2-G2/M phases;M Phase;G2/M Transition;Cell Cycle, Mitotic;Recruitment of NuMA to mitotic centrosomes;Mitotic Prometaphase;Regulation of PLK1 Activity at G2/M Transition;Loss of Nlp from mitotic centrosomes;Recruitment of mitotic centrosome proteins and complexes;Loss of proteins required for interphase microtubule organization from the centrosome;Centrosome maturation;Anchoring of the basal body to the plasma membrane;AURKA Activation by TPX2
COQ8A	negative	PTS	ENSG00000150787	COQ8A	1	COQ8A	1	0.00589631096785992	WBGene00015010	WBGene00015010(1)		6-pyruvoyl-tetrahydropterin synthase deficiency;6-Pyruvoyltetrahydropterin Synthase Deficiency;HYPERPHENYLALANINEMIA BH4-DEFICIENT A	GO:0046872;GO:0016829;GO:0005515;GO:0042802;GO:0005739;GO:0005737;GO:0005829;GO:0003874;GO:0006729;GO:0007417;GO:0051186;GO:0006520;GO:0042803	tetrahydrobiopterin biosynthetic process;6-pyruvoyltetrahydropterin synthase activity;metal ion binding;lyase activity;protein binding;identical protein binding;mitochondrion;cytoplasm;cytosol;central nervous system development;cofactor metabolic process;cellular amino acid metabolic process	3D-structure;Disease mutation;Lyase;Metal-binding;Phenylketonuria;Phosphoprotein;Reference proteome;Tetrahydrobiopterin biosynthesis;Zinc	R-HSA-1430728;R-HSA-196854;R-HSA-8978934;R-HSA-1474151	Metabolism;Metabolism of vitamins and cofactors;Metabolism of cofactors;Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
COQ8A	negative	CCNYL1	ENSG00000163249	COQ8A	1	COQ8A	1	0.00589631096785992	WBGene00022697	WBGene00022697(0)			GO:0005515;GO:0019901;GO:0005886;GO:0000079;GO:0016538;GO:0045737	protein kinase binding;regulation of cyclin-dependent protein serine/threonine kinase activity;protein binding;plasma membrane;cytoplasm;cyclin-dependent protein serine/threonine kinase regulator activity;positive regulation of cyclin-dependent protein serine/threonine kinase activity;regulation of protein phosphorylation;spermatogenesis;flagellated sperm motility;regulation of protein kinase activity;membrane	Alternative splicing;Cyclin;Phosphoprotein;Reference proteome		
COQ8A	negative	CENPN	ENSG00000166451	COQ8A	1	COQ8A	1	0.00589631096785992					GO:0005634;GO:0005694;GO:0007059;GO:0051382;GO:0000775;GO:0000776;GO:0000777;GO:0005654;GO:0005829;GO:0034080	chromosome segregation;kinetochore assembly;nucleus;nucleoplasm;chromosome;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;cytosol;CENP-A containing nucleosome assembly	3D-structure;Alternative splicing;Centromere;Chromosome;Kinetochore;Nucleus;Phosphoprotein;Polymorphism;Reference proteome	R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-2467813;R-HSA-2555396;R-HSA-68882;R-HSA-68886;R-HSA-69278;R-HSA-69620;R-HSA-195258;R-HSA-2500257;R-HSA-5663220;R-HSA-68877;R-HSA-606279;R-HSA-73886;R-HSA-774815;R-HSA-141424;R-HSA-141444;R-HSA-69618	Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic Anaphase;M Phase;Cell Cycle, Mitotic;Cell Cycle Checkpoints;RHO GTPase Effectors;Resolution of Sister Chromatid Cohesion;RHO GTPases Activate Formins;Mitotic Prometaphase;Deposition of new CENPA-containing nucleosomes at the centromere;Chromosome Maintenance;Nucleosome assembly;Amplification of signal from the kinetochores;Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal;Mitotic Spindle Checkpoint
COQ8A	negative	TRAF1	ENSG00000056558	COQ8A	1	COQ8A	1	0.0064804581043002	WBGene00022454;WBGene00006612	WBGene00006612(0);WBGene00022454(0)			GO:0008270;GO:0005164;GO:0007165;GO:0042981;GO:0005515;GO:0006915;GO:0042802;GO:0031625;GO:0005829;GO:0005737;GO:0051092;GO:0065003;GO:0031996;GO:0009898;GO:0032991;GO:0035631;GO:0010803;GO:2001236	zinc ion binding;protein binding;signal transduction;regulation of apoptotic process;tumor necrosis factor receptor binding;apoptotic process;identical protein binding;ubiquitin protein ligase binding;cytosol;protein K63-linked ubiquitination;cytoplasm;positive regulation of NF-kappaB transcription factor activity;protein-containing complex assembly;thioesterase binding;tumor necrosis factor-mediated signaling pathway;regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of JNK cascade;cytoplasmic side of plasma membrane;regulation of tumor necrosis factor-mediated signaling pathway;regulation of extrinsic apoptotic signaling pathway	3D-structure;Alternative splicing;Apoptosis;Coiled coil;Isopeptide bond;Phosphoprotein;Polymorphism;Reference proteome;Ubl conjugation	R-HSA-162582;R-HSA-73887;R-HSA-5357905;R-HSA-5357956;R-HSA-75893	Signal Transduction;Death Receptor Signalling;Regulation of TNFR1 signaling;TNFR1-induced NFkappaB signaling pathway;TNF signaling
COQ8A	negative	SMOX	ENSG00000088826	COQ8A	1	COQ8A	1	0.0064804581043002	WBGene00000139;WBGene00016061	WBGene00000137(0);WBGene00011615(0);WBGene00005010(0)			GO:0005634;GO:0005737;GO:0043231;GO:0005654;GO:0016491;GO:0055114;GO:0031965;GO:0005829;GO:0006596;GO:0046592;GO:0052901;GO:0046208;GO:0052894;GO:0052895;GO:0006598	oxidation-reduction process;oxidoreductase activity;nucleus;cytoplasm;intracellular membrane-bounded organelle;nucleoplasm;nuclear membrane;cytosol;polyamine biosynthetic process;polyamine oxidase activity;spermine:oxygen oxidoreductase (spermidine-forming) activity;spermine catabolic process;norspermine:oxygen oxidoreductase activity;N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity;polyamine catabolic process	Alternative splicing;Cytoplasm;FAD;Flavoprotein;Nucleus;Oxidoreductase;Polymorphism;Reference proteome		
COQ8A	negative	OPTN	ENSG00000123240	COQ8A	1	COQ8A	1	0.0064804581043002				Amyotrophic lateral sclerosis;AMYOTROPHIC LATERAL SCLEROSIS 12;GLAUCOMA NORMAL TENSION SUSCEPTIBILITY TO;GLAUCOMA PRIMARY OPEN ANGLE	GO:0005737;GO:0016192;GO:0046872;GO:0006914;GO:0005829;GO:0005794;GO:0005515;GO:0048471;GO:0031410;GO:0070530;GO:0002376;GO:0045087;GO:0005634;GO:0042802;GO:0005768;GO:0005776;GO:0005654;GO:0050829;GO:0005802;GO:0055037;GO:0000086;GO:0008022;GO:0034067;GO:0007165;GO:0000139;GO:0090161;GO:0007030;GO:0010508;GO:0017137;GO:0061734;GO:0055038;GO:0008219;GO:0030674;GO:0031593;GO:0043001;GO:0034620;GO:0001920;GO:1904417;GO:0034613;GO:0043124	Golgi apparatus;vesicle-mediated transport;autophagy;cytoplasmic vesicle;K63-linked polyubiquitin modification-dependent protein binding;cytoplasm;metal ion binding;cytosol;endosome;protein binding;perinuclear region of cytoplasm;immune system process;innate immune response;nucleus;identical protein binding;autophagosome;nucleoplasm;defense response to Gram-negative bacterium;trans-Golgi network;viral process;recycling endosome;G2/M transition of mitotic cell cycle;protein C-terminus binding;protein localization to Golgi apparatus;signal transduction;Golgi membrane;regulation of I-kappaB kinase/NF-kappaB signaling;Golgi ribbon formation;Golgi organization;positive regulation of autophagy;Rab GTPase binding;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;recycling endosome membrane;cell death;protein binding, bridging;polyubiquitin modification-dependent protein binding;Golgi to plasma membrane protein transport;cellular response to unfolded protein;negative regulation of receptor recycling;positive regulation of xenophagy;cellular protein localization;negative regulation of I-kappaB kinase/NF-kappaB signaling	3D-structure;Alternative splicing;Amyotrophic lateral sclerosis;Autophagy;Coiled coil;Cytoplasm;Cytoplasmic vesicle;Disease mutation;Endosome;Glaucoma;Golgi apparatus;Host-virus interaction;Immunity;Innate immunity;Metal-binding;Neurodegeneration;Phosphoprotein;Polymorphism;Reference proteome;Zinc;Zinc-finger	R-HSA-5653656;R-HSA-1640170;R-HSA-199991;R-HSA-9007101;R-HSA-453274;R-HSA-69275;R-HSA-69278;R-HSA-2565942;R-HSA-8854214	Vesicle-mediated transport;Cell Cycle;Membrane Trafficking;Rab regulation of trafficking;Mitotic G2-G2/M phases;G2/M Transition;Cell Cycle, Mitotic;Regulation of PLK1 Activity at G2/M Transition;TBC/RABGAPs
COQ8A	negative	CHEK1	ENSG00000149554	COQ8A	1	COQ8A	1	0.0064804581043002	WBGene00000498;WBGene00019817;WBGene00012792;WBGene00017083;WBGene00019814;WBGene00019815				GO:0043231;GO:0004672;GO:0005524;GO:0006468;GO:0005654;GO:0035402;GO:0000077;GO:0000086;GO:0001833;GO:0006281;GO:0006974;GO:0006997;GO:0007093;GO:0010468;GO:0010767;GO:0035407;GO:0042127;GO:0048096;GO:1902742;GO:2000615;GO:0000785;GO:0005634;GO:0005657;GO:0005737;GO:0000166;GO:0004674;GO:0016301;GO:0016740;GO:0016310;GO:0005615;GO:0005856;GO:0005515;GO:0007049;GO:0006915;GO:0005813;GO:0005815;GO:0035556;GO:0005829;GO:0071260;GO:0010569;GO:1901796;GO:0032991;GO:0019904;GO:0006260;GO:0070317;GO:0090399;GO:0000781;GO:0006975;GO:0018107;GO:0045787;GO:0045839;GO:0046602;GO:0072425;GO:0000794	ATP binding;protein phosphorylation;protein kinase activity;intracellular membrane-bounded organelle;nucleoplasm;histone kinase activity (H3-T11 specific);DNA damage checkpoint;G2/M transition of mitotic cell cycle;inner cell mass cell proliferation;DNA repair;cellular response to DNA damage stimulus;nucleus organization;mitotic cell cycle checkpoint;regulation of gene expression;regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage;histone H3-T11 phosphorylation;regulation of cell population proliferation;chromatin-mediated maintenance of transcription;apoptotic process involved in development;regulation of histone H3-K9 acetylation;chromatin;nucleus;replication fork;protein serine/threonine kinase activity;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;cytoskeleton;extracellular space;protein binding;cell cycle;apoptotic process;centrosome;microtubule organizing center;intracellular signal transduction;cytosol;cellular response to mechanical stimulus;regulation of double-strand break repair via homologous recombination;regulation of signal transduction by p53 class mediator;protein-containing complex;protein domain specific binding;DNA replication;negative regulation of G0 to G1 transition;replicative senescence;chromosome, telomeric region;DNA damage induced protein phosphorylation;peptidyl-threonine phosphorylation;positive regulation of cell cycle;negative regulation of mitotic nuclear division;regulation of mitotic centrosome separation;signal transduction involved in G2 DNA damage checkpoint;condensed nuclear chromosome	3D-structure;ATP-binding;Alternative splicing;Cell cycle;Cytoplasm;Cytoskeleton;DNA damage;DNA repair;Isopeptide bond;Kinase;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Ubl conjugation	R-HSA-212436;R-HSA-3700989;R-HSA-73857;R-HSA-74160;R-HSA-162582;R-HSA-1640170;R-HSA-5685942;R-HSA-5693532;R-HSA-5693538;R-HSA-5693567;R-HSA-73894;R-HSA-69481;R-HSA-69601;R-HSA-69610;R-HSA-69613;R-HSA-69615;R-HSA-69620;R-HSA-6796648;R-HSA-9006934;R-HSA-5633007;R-HSA-6804756;R-HSA-176187;R-HSA-8953750;R-HSA-1433557;R-HSA-5693579;R-HSA-5693607;R-HSA-5693616;R-HSA-69473;R-HSA-75035	Generic Transcription Pathway;Transcriptional Regulation by TP53;RNA Polymerase II Transcription;Gene expression (Transcription);Signal Transduction;Cell Cycle;HDR through Homologous Recombination (HRR);DNA Double-Strand Break Repair;Homology Directed Repair;HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA);DNA Repair;G2/M Checkpoints;Ubiquitin Mediated Degradation of Phosphorylated Cdc25A;p53-Independent DNA Damage Response;p53-Independent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;TP53 Regulates Transcription of DNA Repair Genes;Signaling by Receptor Tyrosine Kinases;Regulation of TP53 Activity;Regulation of TP53 Activity through Phosphorylation;Activation of ATR in response to replication stress;Transcriptional Regulation by E2F6;Signaling by SCF-KIT;Homologous DNA Pairing and Strand Exchange;Processing of DNA double-strand break ends;Presynaptic phase of homologous DNA pairing and strand exchange;G2/M DNA damage checkpoint;Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
COQ8A	negative	HRH1	ENSG00000196639	COQ8A	1	COQ8A	1	0.0064804581043002	WBGene00001517;WBGene00001518;WBGene00011382;WBGene00016037;WBGene00044004				GO:0016020;GO:0016021;GO:0004930;GO:0007186;GO:0005829;GO:0005886;GO:0007165;GO:0004969;GO:0098664;GO:0005887;GO:0045907;GO:0007268;GO:0030425;GO:0006954;GO:0004993;GO:0030594;GO:0007187;GO:0071420;GO:0048016;GO:0032962;GO:0007200;GO:0043114;GO:0048245;GO:0007613;GO:0008542;GO:0048167	G protein-coupled receptor signaling pathway;integral component of membrane;G protein-coupled receptor activity;histamine receptor activity;positive regulation of vasoconstriction;regulation of vascular permeability;eosinophil chemotaxis;membrane;cytosol;plasma membrane;signal transduction;synapse;G protein-coupled serotonin receptor signaling pathway;integral component of plasma membrane;chemical synaptic transmission;dendrite;inflammatory response;G protein-coupled serotonin receptor activity;neurotransmitter receptor activity;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;cellular response to histamine;inositol phosphate-mediated signaling;positive regulation of inositol trisphosphate biosynthetic process;phospholipase C-activating G protein-coupled receptor signaling pathway;memory;visual learning;regulation of synaptic plasticity	3D-structure;Cell membrane;Disulfide bond;G-protein coupled receptor;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Transducer;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-416476;R-HSA-500792;R-HSA-373076;R-HSA-375280;R-HSA-390650	Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (q) signalling events;GPCR ligand binding;Class A/1 (Rhodopsin-like receptors);Amine ligand-binding receptors;Histamine receptors
COQ8A	negative	PFKP	ENSG00000067057	COQ8A	1	COQ8A	1	0.00711522594269909	WBGene00022199;WBGene00008230	WBGene00022199(0)			GO:0006096;GO:0003872;GO:0006002;GO:0061615;GO:0005737;GO:0005634;GO:0016020;GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0003824;GO:0008152;GO:0005829;GO:0045296;GO:0070062;GO:0044877;GO:0030388;GO:0061621;GO:0042802;GO:0048029;GO:0016208;GO:0070095;GO:0006007;GO:0051289;GO:0005945;GO:1990830	6-phosphofructokinase activity;glycolytic process;ATP binding;cytoplasm;fructose 6-phosphate metabolic process;nucleus;membrane;metal ion binding;nucleotide binding;kinase activity;transferase activity;phosphorylation;catalytic activity;metabolic process;cytosol;cadherin binding;extracellular exosome;protein-containing complex binding;fructose 1,6-bisphosphate metabolic process;canonical glycolysis;identical protein binding;monosaccharide binding;AMP binding;fructose-6-phosphate binding;glucose catabolic process;protein homotetramerization;6-phosphofructokinase complex;cellular response to leukemia inhibitory factor;glycolytic process through fructose-6-phosphate	3D-structure;ATP-binding;Acetylation;Allosteric enzyme;Alternative splicing;Cytoplasm;Glycolysis;Glycoprotein;Kinase;Magnesium;Metal-binding;Nucleotide-binding;Phosphoprotein;Reference proteome;Transferase	R-HSA-1430728;R-HSA-70171;R-HSA-70326;R-HSA-71387	Metabolism;Glycolysis;Glucose metabolism;Metabolism of carbohydrates
COQ8A	negative	SYNJ2	ENSG00000078269	COQ8A	1	COQ8A	1	0.00711522594269909	WBGene00006763	WBGene00006763(0);WBGene00012353(0)			GO:0003676;GO:0003723;GO:0005737;GO:0016020;GO:0016787;GO:0005886;GO:0005856;GO:0042995;GO:0005515;GO:0045121;GO:0046856;GO:0034595;GO:0042578;GO:0030424;GO:0005829;GO:0061024;GO:0098793;GO:0006661;GO:0048471;GO:0007420;GO:0046855;GO:0004439;GO:0017124	phosphatidylinositol dephosphorylation;nucleic acid binding;phosphoric ester hydrolase activity;phosphatidylinositol phosphate 5-phosphatase activity;RNA binding;cytoplasm;membrane;hydrolase activity;cytoskeleton;plasma membrane;cell projection;protein binding;cell junction;membrane raft;synapse;cytosol;membrane organization;presynapse;phosphatidylinositol biosynthetic process;perinuclear region of cytoplasm;brain development;inositol phosphate dephosphorylation;phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity;SH3 domain binding	3D-structure;Alternative splicing;Cell junction;Cell membrane;Cell projection;Cytoplasm;Cytoskeleton;Hydrolase;Membrane;Phosphoprotein;Polymorphism;RNA-binding;Reference proteome;Synapse	R-HSA-5653656;R-HSA-1430728;R-HSA-556833;R-HSA-199991;R-HSA-8856828;R-HSA-1483255;R-HSA-1483257;R-HSA-1660499	Vesicle-mediated transport;Metabolism;Metabolism of lipids;Membrane Trafficking;Clathrin-mediated endocytosis;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane
COQ8A	negative	PANX1	ENSG00000110218	COQ8A	1	COQ8A	1	0.00711522594269909					GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0005886;GO:0006811;GO:0006812;GO:0006816;GO:0002020;GO:0003779;GO:0005243;GO:0015267;GO:0044325;GO:0046982;GO:0051015;GO:0097110;GO:0002931;GO:0007267;GO:0033198;GO:0050715;GO:0050716;GO:0050717;GO:0050718;GO:0055085;GO:0005921;GO:0030054;GO:0032991;GO:0005262;GO:0070588;GO:0034214;GO:0005102;GO:0032059;GO:0055077;GO:0022840;GO:0022829	channel activity;cation transport;positive regulation of interleukin-1 secretion;membrane;integral component of membrane;plasma membrane;endoplasmic reticulum;endoplasmic reticulum membrane;ion transport;calcium ion transport;protease binding;actin binding;structural molecule activity;gap junction channel activity;ion channel binding;protein-containing complex binding;actin filament binding;scaffold protein binding;response to ischemia;cell-cell signaling;response to ATP;positive regulation of cytokine secretion;positive regulation of interleukin-1 alpha secretion;positive regulation of interleukin-1 beta secretion;transmembrane transport;gap junction;cell junction;protein-containing complex;calcium channel activity;calcium ion transmembrane transport;signaling receptor binding;bleb;leak channel activity;wide pore channel activity	Alternative splicing;Calcium;Calcium channel;Calcium transport;Cell junction;Cell membrane;Differentiation;Disease mutation;Endoplasmic reticulum;Gap junction;Glycoprotein;Ion channel;Ion transport;Membrane;Oogenesis;Polymorphism;Reference proteome;S-nitrosylation;Transmembrane;Transmembrane helix;Transport	R-HSA-168249;R-HSA-168256;R-HSA-112316;R-HSA-168643;R-HSA-622312;R-HSA-844456;R-HSA-112303;R-HSA-112307	Innate Immune System;Immune System;Neuronal System;Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways;Inflammasomes;The NLRP3 inflammasome;Electric Transmission Across Gap Junctions;Transmission across Electrical Synapses 
COQ8A	negative	CSNK1A1	ENSG00000113712	COQ8A	1	COQ8A	1	0.00711522594269909	WBGene00002202;WBGene00002203	WBGene00002202(1)			GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005829;GO:0051301;GO:0005694;GO:0005856;GO:0042995;GO:0005515;GO:0007049;GO:0016055;GO:0005813;GO:0005815;GO:0000775;GO:0000776;GO:0000777;GO:0036064;GO:0090090;GO:0005929;GO:0018105;GO:0007165;GO:0007166;GO:1904886;GO:0045104;GO:0007030;GO:1904885;GO:0005847;GO:0032436;GO:0045095;GO:0000902;GO:1904424;GO:0030877;GO:1990904	ATP binding;protein phosphorylation;protein kinase activity;nucleus;cytoplasm;nuclear speck;membrane;nucleotide binding;protein serine/threonine kinase activity;kinase activity;transferase activity;phosphorylation;cytosol;cytoskeleton;cell division;chromosome;cell projection;protein binding;cell cycle;Wnt signaling pathway;centrosome;microtubule organizing center;chromosome, centromeric region;kinetochore;condensed chromosome kinetochore;ciliary basal body;negative regulation of canonical Wnt signaling pathway;cilium;peptidyl-serine phosphorylation;signal transduction;cell surface receptor signaling pathway;beta-catenin destruction complex disassembly;intermediate filament cytoskeleton organization;Golgi organization;beta-catenin destruction complex assembly;mRNA cleavage and polyadenylation specificity factor complex;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;keratin filament;cell morphogenesis;regulation of GTP binding;beta-catenin destruction complex;ribonucleoprotein complex	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Cell projection;Centromere;Chromosome;Cytoplasm;Cytoskeleton;Direct protein sequencing;Kinase;Kinetochore;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase;Wnt signaling pathway	R-HSA-162582;R-HSA-1643685;R-HSA-195253;R-HSA-195721;R-HSA-201681;R-HSA-5358351;R-HSA-5610783;R-HSA-5610785;R-HSA-5610787;R-HSA-5632684;R-HSA-5663202;R-HSA-5635838;R-HSA-4641262;R-HSA-196299;R-HSA-4791275;R-HSA-4839735;R-HSA-4839743;R-HSA-4839744;R-HSA-4839748;R-HSA-5339716;R-HSA-5358747;R-HSA-5358749;R-HSA-5358751;R-HSA-5358752;R-HSA-5467337;R-HSA-5467340;R-HSA-5467348	Signal Transduction;Disease;Degradation of beta-catenin by the destruction complex;Signaling by WNT;TCF dependent signaling in response to WNT;Signaling by Hedgehog;Degradation of GLI2 by the proteasome;GLI3 is processed to GLI3R by the proteasome;Hedgehog 'off' state;Hedgehog 'on' state;Diseases of signal transduction;Activation of SMO;Disassembly of the destruction complex and recruitment of AXIN to the membrane;Beta-catenin phosphorylation cascade;Signaling by WNT in cancer;AXIN mutants destabilize the destruction complex, activating WNT signaling;phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex;truncated APC mutants destabilize the destruction complex;AMER1 mutants destabilize the destruction complex;Misspliced GSK3beta mutants stabilize beta-catenin;S33 mutants of beta-catenin aren't phosphorylated;S37 mutants of beta-catenin aren't phosphorylated;S45 mutants of beta-catenin aren't phosphorylated;T41 mutants of beta-catenin aren't phosphorylated;APC truncation mutants have impaired AXIN binding;AXIN missense mutants destabilize the destruction complex;Truncations of AMER1 destabilize the destruction complex
COQ8A	negative	ORMDL2	ENSG00000123353	COQ8A	1	COQ8A	1	0.00711522594269909					GO:0016020;GO:0016021;GO:0005783;GO:0005789;GO:0006672;GO:0090155;GO:0090156;GO:1900060;GO:0035339	integral component of membrane;endoplasmic reticulum membrane;ceramide metabolic process;negative regulation of sphingolipid biosynthetic process;cell;membrane;endoplasmic reticulum;cellular sphingolipid homeostasis;negative regulation of ceramide biosynthetic process;SPOTS complex	Endoplasmic reticulum;Membrane;Reference proteome;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-428157;R-HSA-556833;R-HSA-1660661	Metabolism;Sphingolipid metabolism;Metabolism of lipids;Sphingolipid de novo biosynthesis
COQ8A	negative	SGCB	ENSG00000163069	COQ8A	1	COQ8A	1	0.00711522594269909	WBGene00019277	WBGene00019277(0)		Autosomal recessive limb-girdle muscular dystrophy type 2E;MUSCULAR DYSTROPHY LIMB-GIRDLE AUTOSOMAL RECESSIVE 4	GO:0005737;GO:0016020;GO:0016021;GO:0005886;GO:0005856;GO:0005515;GO:0016012;GO:0042383;GO:0007517;GO:0005887;GO:0016010;GO:0048747;GO:0055013;GO:0097084;GO:0016011	integral component of membrane;muscle organ development;sarcoglycan complex;cytoplasm;membrane;cytoskeleton;plasma membrane;protein binding;sarcolemma;integral component of plasma membrane;dystrophin-associated glycoprotein complex;muscle fiber development;cardiac muscle cell development;vascular smooth muscle cell development;dystroglycan complex	Alternative splicing;Cell membrane;Cytoplasm;Cytoskeleton;Direct protein sequencing;Disease mutation;Disulfide bond;Glycoprotein;Limb-girdle muscular dystrophy;Membrane;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix		
COQ8A	negative	BZW1	ENSG00000082153	COQ8A	1	COQ8A	1	0.00780422992628027					GO:0005737;GO:0003723;GO:0016020;GO:0045296;GO:0005515	protein binding;cytoplasm;RNA binding;membrane;cadherin binding	Acetylation;Activator;Alternative splicing;Direct protein sequencing;Isopeptide bond;Phosphoprotein;Reference proteome;Transcription;Transcription regulation;Ubl conjugation		
COQ8A	negative	NRP1	ENSG00000099250	COQ8A	1	COQ8A	1	0.00780422992628027					GO:0010595;GO:0035924;GO:0048008;GO:0070374;GO:0016020;GO:0016021;GO:0046872;GO:0005615;GO:0005886;GO:0043547;GO:0005515;GO:0005576;GO:0007411;GO:0007275;GO:0030154;GO:0017154;GO:0071526;GO:0009887;GO:0005925;GO:0001525;GO:0005021;GO:0019838;GO:0048010;GO:0007399;GO:0008201;GO:0038084;GO:0035767;GO:0005829;GO:0050731;GO:2000251;GO:0001938;GO:0007165;GO:0007267;GO:0043005;GO:0051491;GO:0031410;GO:0042327;GO:0005096;GO:0015026;GO:0019901;GO:0019955;GO:0038085;GO:0001569;GO:0001764;GO:0002040;GO:0002042;GO:0003148;GO:0006930;GO:0007229;GO:0007413;GO:0007507;GO:0008045;GO:0009611;GO:0014911;GO:0016358;GO:0016477;GO:0021612;GO:0021636;GO:0021637;GO:0021649;GO:0021675;GO:0021785;GO:0021828;GO:0030517;GO:0031290;GO:0031532;GO:0032489;GO:0034446;GO:0035729;GO:0036486;GO:0038189;GO:0038190;GO:0043524;GO:0043542;GO:0045766;GO:0048012;GO:0048485;GO:0048666;GO:0048841;GO:0048842;GO:0048843;GO:0048844;GO:0048846;GO:0050918;GO:0051496;GO:0051894;GO:0060301;GO:0060385;GO:0060627;GO:0060666;GO:0060978;GO:0060982;GO:0061299;GO:0061441;GO:0061549;GO:0061551;GO:0071679;GO:0090050;GO:0090259;GO:0097102;GO:0097374;GO:0097475;GO:0097490;GO:0097491;GO:0099173;GO:0150018;GO:0150020;GO:1900026;GO:1901166;GO:1901998;GO:1902285;GO:1902287;GO:1902336;GO:1902378;GO:1902946;GO:1903375;GO:1904835;GO:1905040;GO:2001237;GO:0002116;GO:0005769;GO:0005883;GO:0009986;GO:0030424;GO:0030426;GO:0043025;GO:0043235;GO:0097443;GO:0098978;GO:0099055	membrane;angiogenesis;vascular endothelial growth factor-activated receptor activity;vascular endothelial growth factor receptor signaling pathway;growth factor binding;semaphorin receptor activity;axon guidance;vascular endothelial growth factor signaling pathway;animal organ morphogenesis;endothelial cell chemotaxis;semaphorin-plexin signaling pathway;integral component of membrane;metal ion binding;multicellular organism development;cell differentiation;nervous system development;positive regulation of endothelial cell migration;cellular response to vascular endothelial growth factor stimulus;platelet-derived growth factor receptor signaling pathway;positive regulation of ERK1 and ERK2 cascade;branching involved in blood vessel morphogenesis;cytoplasm;mitochondrion;focal adhesion;extracellular space;plasma membrane;positive regulation of GTPase activity;protein binding;extracellular region;heparin binding;mitochondrial membrane;cytosol;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of actin cytoskeleton reorganization;positive regulation of endothelial cell proliferation;signal transduction;cell-cell signaling;neuron projection;positive regulation of filopodium assembly;cytoplasmic vesicle;positive regulation of phosphorylation;GTPase activator activity;coreceptor activity;protein kinase binding;cytokine binding;vascular endothelial growth factor binding;neuron migration;sprouting angiogenesis;cell migration involved in sprouting angiogenesis;outflow tract septum morphogenesis;substrate-dependent cell migration, cell extension;integrin-mediated signaling pathway;axonal fasciculation;heart development;motor neuron axon guidance;response to wounding;positive regulation of smooth muscle cell migration;dendrite development;cell migration;facial nerve structural organization;trigeminal nerve morphogenesis;trigeminal nerve structural organization;vestibulocochlear nerve structural organization;nerve development;branchiomotor neuron axon guidance;gonadotrophin-releasing hormone neuronal migration to the hypothalamus;negative regulation of axon extension;retinal ganglion cell axon guidance;actin cytoskeleton reorganization;regulation of Cdc42 protein signal transduction;substrate adhesion-dependent cell spreading;cellular response to hepatocyte growth factor stimulus;ventral trunk neural crest cell migration;neuropilin signaling pathway;VEGF-activated neuropilin signaling pathway;negative regulation of neuron apoptotic process;endothelial cell migration;positive regulation of angiogenesis;hepatocyte growth factor receptor signaling pathway;sympathetic nervous system development;neuron development;regulation of axon extension involved in axon guidance;positive regulation of axon extension involved in axon guidance;negative regulation of axon extension involved in axon guidance;artery morphogenesis;axon extension involved in axon guidance;positive chemotaxis;positive regulation of stress fiber assembly;positive regulation of focal adhesion assembly;positive regulation of cytokine activity;axonogenesis involved in innervation;regulation of vesicle-mediated transport;dichotomous subdivision of terminal units involved in salivary gland branching;angiogenesis involved in coronary vascular morphogenesis;coronary artery morphogenesis;retina vasculature morphogenesis in camera-type eye;renal artery morphogenesis;sympathetic ganglion development;trigeminal ganglion development;commissural neuron axon guidance;positive regulation of cell migration involved in sprouting angiogenesis;regulation of retinal ganglion cell axon guidance;endothelial tip cell fate specification;sensory neuron axon guidance;motor neuron migration;sympathetic neuron projection extension;sympathetic neuron projection guidance;postsynapse organization;basal dendrite development;basal dendrite arborization;positive regulation of substrate adhesion-dependent cell spreading;neural crest cell migration involved in autonomic nervous system development;toxin transport;semaphorin-plexin signaling pathway involved in neuron projection guidance;semaphorin-plexin signaling pathway involved in axon guidance;positive regulation of retinal ganglion cell axon guidance;VEGF-activated neuropilin signaling pathway involved in axon guidance;protein localization to early endosome;facioacoustic ganglion development;dorsal root ganglion morphogenesis;otic placode development;negative regulation of extrinsic apoptotic signaling pathway;semaphorin receptor complex;early endosome;neurofilament;cell surface;axon;growth cone;neuronal cell body;receptor complex;sorting endosome;glutamatergic synapse;integral component of postsynaptic membrane	3D-structure;Alternative splicing;Angiogenesis;Calcium;Cell membrane;Cytoplasm;Developmental protein;Differentiation;Direct protein sequencing;Disulfide bond;Glycoprotein;Heparan sulfate;Heparin-binding;Membrane;Metal-binding;Mitochondrion;Neurogenesis;Phosphoprotein;Polymorphism;Proteoglycan;Receptor;Reference proteome;Repeat;Secreted;Signal;Transmembrane;Transmembrane helix	R-HSA-1266738;R-HSA-373760;R-HSA-422475;R-HSA-162582;R-HSA-376176;R-HSA-9006934;R-HSA-194138;R-HSA-447041;R-HSA-373755;R-HSA-399956;R-HSA-194306;R-HSA-399954;R-HSA-399955;R-HSA-445144	Developmental Biology;L1CAM interactions;Axon guidance;Signal Transduction;Signaling by ROBO receptors;Signaling by Receptor Tyrosine Kinases;Signaling by VEGF;CHL1 interactions;Semaphorin interactions;CRMPs in Sema3A signaling;Neurophilin interactions with VEGF and VEGFR;Sema3A PAK dependent Axon repulsion;SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion;Signal transduction by L1
COQ8A	negative	MASTL	ENSG00000120539	COQ8A	1	COQ8A	1	0.00780422992628027				Autosomal thrombocytopenia with normal platelets	GO:0005634;GO:0005737;GO:0000166;GO:0004672;GO:0004674;GO:0005524;GO:0016301;GO:0016740;GO:0006468;GO:0016310;GO:0005654;GO:0051301;GO:0005856;GO:0006974;GO:0007049;GO:0005813;GO:0005815;GO:0035556;GO:0032154;GO:0018105;GO:0051726;GO:0000278;GO:0051721;GO:0000086;GO:0032515;GO:0007147;GO:1904668	ATP binding;protein phosphorylation;protein serine/threonine kinase activity;protein kinase activity;nucleus;cytoplasm;nucleotide binding;kinase activity;transferase activity;phosphorylation;nucleoplasm;cytoskeleton;cell division;cellular response to DNA damage stimulus;cell cycle;centrosome;microtubule organizing center;intracellular signal transduction;cleavage furrow;regulation of cell cycle;peptidyl-serine phosphorylation;mitotic cell cycle;protein phosphatase 2A binding;G2/M transition of mitotic cell cycle;negative regulation of phosphoprotein phosphatase activity;female meiosis II;positive regulation of ubiquitin protein ligase activity	3D-structure;ATP-binding;Acetylation;Alternative splicing;Cell cycle;Cell division;Cytoplasm;Cytoskeleton;Disease mutation;Kinase;Mitosis;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Serine/threonine-protein kinase;Transferase	R-HSA-1640170;R-HSA-68886;R-HSA-69278;R-HSA-68875;R-HSA-2465910	Cell Cycle;M Phase;Cell Cycle, Mitotic;Mitotic Prophase;MASTL Facilitates Mitotic Progression
COQ8A	negative	RAB1A	ENSG00000138069	COQ8A	1	COQ8A	1	0.00780422992628027	WBGene00004266				GO:0005737;GO:0016020;GO:0015031;GO:0000166;GO:0005783;GO:0003924;GO:0005525;GO:0005794;GO:0005829;GO:0005515;GO:0042470;GO:0006914;GO:0006886;GO:0016192;GO:0005768;GO:0005769;GO:0042742;GO:0006888;GO:0045296;GO:0006897;GO:0070062;GO:0000045;GO:0006890;GO:0032482;GO:0016477;GO:0043687;GO:0000139;GO:0048208;GO:0047496;GO:0007030;GO:0090110;GO:0030658;GO:0072606;GO:1904668;GO:0019068;GO:0030252;GO:1903020;GO:0032402;GO:0034446	cell;cytoplasm;membrane;protein transport;nucleotide binding;endoplasmic reticulum;endosome;GTPase activity;GTP binding;Golgi apparatus;cytosol;protein binding;melanosome;autophagy;vesicle-mediated transport;intracellular protein transport;early endosome;endocytosis;defense response to bacterium;endoplasmic reticulum to Golgi vesicle-mediated transport;cadherin binding;extracellular exosome;autophagosome assembly;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Rab protein signal transduction;endomembrane system;cell migration;post-translational protein modification;Golgi membrane;COPII vesicle coating;vesicle transport along microtubule;Golgi organization;COPII-coated vesicle cargo loading;transport vesicle membrane;interleukin-8 secretion;positive regulation of ubiquitin protein ligase activity;virion assembly;growth hormone secretion;positive regulation of glycoprotein metabolic process;melanosome transport;substrate adhesion-dependent cell spreading	3D-structure;Acetylation;Alternative splicing;Autophagy;Cytoplasm;Direct protein sequencing;ER-Golgi transport;Endoplasmic reticulum;Endosome;GTP-binding;Golgi apparatus;Lipoprotein;Membrane;Nucleotide-binding;Phosphoprotein;Prenylation;Protein transport;Reference proteome;Transport	R-HSA-5653656;R-HSA-392499;R-HSA-597592;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-8876198;R-HSA-9007101;R-HSA-446203;R-HSA-8873719;R-HSA-68886;R-HSA-69278;R-HSA-199977;R-HSA-6807878;R-HSA-948021;R-HSA-68875;R-HSA-204005;R-HSA-162658	Vesicle-mediated transport;Metabolism of proteins;Post-translational protein modification;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;RAB GEFs exchange GTP for GDP on RABs;Rab regulation of trafficking;Asparagine N-linked glycosylation;RAB geranylgeranylation;M Phase;Cell Cycle, Mitotic;ER to Golgi Anterograde Transport;COPI-mediated anterograde transport;Transport to the Golgi and subsequent modification;Mitotic Prophase;COPII-mediated vesicle transport;Golgi Cisternae Pericentriolar Stack Reorganization
COQ8A	negative	SPPL2A	ENSG00000138600	COQ8A	1	COQ8A	1	0.00780422992628027	WBGene00007979				GO:0016020;GO:0016021;GO:0043231;GO:0016787;GO:0005765;GO:0005886;GO:0042803;GO:0005515;GO:0008233;GO:0006508;GO:0004190;GO:0042500;GO:0005764;GO:0031293;GO:0005768;GO:0031902;GO:0050776;GO:0070062;GO:0005770;GO:0030660;GO:0006509;GO:0010803;GO:0033619;GO:0071458;GO:0071556	integral component of membrane;aspartic-type endopeptidase activity;aspartic endopeptidase activity, intramembrane cleaving;regulation of immune response;membrane protein intracellular domain proteolysis;membrane;intracellular membrane-bounded organelle;plasma membrane;hydrolase activity;endosome;lysosomal membrane;protein homodimerization activity;protein binding;peptidase activity;proteolysis;lysosome;late endosome membrane;extracellular exosome;late endosome;Golgi-associated vesicle membrane;membrane protein ectodomain proteolysis;regulation of tumor necrosis factor-mediated signaling pathway;membrane protein proteolysis;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane	Endosome;Glycoprotein;Hydrolase;Lysosome;Membrane;Polymorphism;Protease;Reference proteome;Signal;Transmembrane;Transmembrane helix	R-HSA-162582;R-HSA-73887;R-HSA-5357905;R-HSA-75893	Signal Transduction;Death Receptor Signalling;Regulation of TNFR1 signaling;TNF signaling
COQ8A	negative	RAP1GDS1	ENSG00000138698	COQ8A	1	COQ8A	1	0.00780422992628027					GO:0005096;GO:0043547;GO:0005515;GO:0005783;GO:0005739;GO:0005829;GO:0070062;GO:0032471;GO:0051561;GO:0014829;GO:0031034	protein binding;GTPase activator activity;positive regulation of GTPase activity;endoplasmic reticulum;mitochondrion;cytosol;extracellular exosome;negative regulation of endoplasmic reticulum calcium ion concentration;positive regulation of mitochondrial calcium ion concentration;vascular smooth muscle contraction;myosin filament assembly	3D-structure;Acetylation;Alternative splicing;GTPase activation;Polymorphism;Reference proteome;Repeat		
COQ8A	negative	NUP58	ENSG00000139496	COQ8A	1	COQ8A	1	0.00780422992628027	WBGene00003790				GO:0051028;GO:0005634;GO:0016020;GO:0015031;GO:0017056;GO:0005643;GO:0006913;GO:0005515;GO:0075733;GO:0043657;GO:0008139;GO:0006110;GO:0006406;GO:0006409;GO:0016032;GO:0016925;GO:0019083;GO:0060964;GO:1900034;GO:0005635;GO:0031965;GO:0042306;GO:0051260;GO:0051290;GO:0051291;GO:0070208;GO:0032991	nucleocytoplasmic transport;structural constituent of nuclear pore;nuclear pore;nuclear localization sequence binding;mRNA transport;nucleus;membrane;protein transport;protein binding;intracellular transport of virus;host cell;regulation of glycolytic process;mRNA export from nucleus;tRNA export from nucleus;viral process;protein sumoylation;viral transcription;regulation of gene silencing by miRNA;regulation of cellular response to heat;nuclear envelope;nuclear membrane;identical protein binding;protein-containing complex binding;regulation of protein import into nucleus;protein-containing complex	3D-structure;Alternative splicing;Coiled coil;Glycoprotein;Membrane;Nuclear pore complex;Nucleus;Phosphoprotein;Polymorphism;Protein transport;Reference proteome;Repeat;Translocation;Transport;mRNA transport		
COQ8A	negative	MALT1	ENSG00000172175	COQ8A	1	COQ8A	1	0.00780422992628027	WBGene00017702	WBGene00017702(0)		Combined immunodeficiency due to MALT1 deficiency;MALT lymphoma;Immunodeficiency 12	GO:0032731;GO:0005634;GO:0005737;GO:0043066;GO:0005730;GO:0005829;GO:0016787;GO:0001650;GO:0016567;GO:0005515;GO:0008233;GO:0006508;GO:0004842;GO:0048471;GO:0004197;GO:0051092;GO:0038095;GO:0045087;GO:0042802;GO:0006952;GO:0050852;GO:0002223;GO:0032991;GO:0043123;GO:0007250;GO:0042981;GO:0051259;GO:0043621;GO:0031398;GO:0002726;GO:0032743;GO:0051168;GO:0019209;GO:0043280;GO:0032449;GO:0042113;GO:2000321;GO:0002020;GO:0001923;GO:0002237;GO:0009620;GO:0031663;GO:0042098;GO:0050856;GO:0050870	proteolysis;cysteine-type endopeptidase activity;positive regulation of NF-kappaB transcription factor activity;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of interleukin-1 beta production;nucleus;cytoplasm;negative regulation of apoptotic process;cytosol;fibrillar center;hydrolase activity;protein ubiquitination;protein binding;peptidase activity;ubiquitin-protein transferase activity;perinuclear region of cytoplasm;Fc-epsilon receptor signaling pathway;innate immune response;identical protein binding;defense response;T cell receptor signaling pathway;stimulatory C-type lectin receptor signaling pathway;protein-containing complex;positive regulation of I-kappaB kinase/NF-kappaB signaling;activation of NF-kappaB-inducing kinase activity;regulation of apoptotic process;protein self-association;positive regulation of protein ubiquitination;positive regulation of T cell cytokine production;positive regulation of interleukin-2 production;nuclear export;kinase activator activity;CBM complex;B cell activation;positive regulation of T-helper 17 cell differentiation;protease binding;B-1 B cell differentiation;response to fungus;lipopolysaccharide-mediated signaling pathway;T cell proliferation;regulation of T cell receptor signaling pathway;positive regulation of T cell activation;cellular response to lipopolysaccharide;polkadots	3D-structure;Acetylation;Alternative splicing;Chromosomal rearrangement;Cytoplasm;Disease mutation;Disulfide bond;Hydrolase;Immunoglobulin domain;Nucleus;Phosphoprotein;Polymorphism;Protease;Reference proteome;Repeat;Ubl conjugation pathway	R-HSA-1280218;R-HSA-168249;R-HSA-168256;R-HSA-2454202;R-HSA-2871837;R-HSA-983705;R-HSA-202403;R-HSA-202424;R-HSA-1168372;R-HSA-1169091;R-HSA-5607764;R-HSA-5621481;R-HSA-5660668	Adaptive Immune System;Innate Immune System;Immune System;Fc epsilon receptor (FCERI) signaling;FCERI mediated NF-kB activation;Signaling by the B Cell Receptor (BCR);TCR signaling;Downstream TCR signaling;Downstream signaling events of B Cell Receptor (BCR);Activation of NF-kappaB in B cells;CLEC7A (Dectin-1) signaling;C-type lectin receptors (CLRs);CLEC7A/inflammasome pathway
COQ8A	negative	CFLAR	ENSG00000003402	COQ8A	1	COQ8A	1	0.00855126794977723		WBGene00000819(0);WBGene00000821(0);WBGene00000820(0);WBGene00000417(0)			GO:0005737;GO:0042981;GO:0005515;GO:0008234;GO:0006508;GO:0006915;GO:0004197;GO:0002020;GO:0005123;GO:0016504;GO:0044877;GO:0046982;GO:0001666;GO:0007519;GO:0009617;GO:0010667;GO:0010952;GO:0010976;GO:0014732;GO:0014842;GO:0014866;GO:0032869;GO:0033574;GO:0043066;GO:0043154;GO:0043403;GO:0051092;GO:0060546;GO:0070374;GO:0071364;GO:0071392;GO:0071456;GO:0071549;GO:0071732;GO:0072126;GO:1901740;GO:1903055;GO:1903427;GO:1903845;GO:1903944;GO:1904036;GO:2000347;GO:2001237;GO:0031264;GO:0031265;GO:0045121;GO:0097190;GO:0005829;GO:0016032;GO:0043123;GO:0006919;GO:1902041;GO:1902042;GO:0008047;GO:0097153;GO:0097199;GO:0060544;GO:0097342	protein binding;regulation of apoptotic process;proteolysis;cysteine-type peptidase activity;cysteine-type endopeptidase activity;cytoplasm;apoptotic process;apoptotic signaling pathway;cytosol;viral process;positive regulation of I-kappaB kinase/NF-kappaB signaling;activation of cysteine-type endopeptidase activity involved in apoptotic process;protease binding;regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of apoptotic process;positive regulation of NF-kappaB transcription factor activity;death receptor binding;enzyme activator activity;peptidase activator activity;protein-containing complex binding;cysteine-type endopeptidase activity involved in apoptotic process;cysteine-type endopeptidase activity involved in apoptotic signaling pathway;response to hypoxia;skeletal muscle tissue development;response to bacterium;negative regulation of cardiac muscle cell apoptotic process;positive regulation of neuron projection development;skeletal muscle atrophy;regulation of skeletal muscle satellite cell proliferation;skeletal myofibril assembly;cellular response to insulin stimulus;response to testosterone;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;skeletal muscle tissue regeneration;regulation of necroptotic process;negative regulation of necroptotic process;positive regulation of ERK1 and ERK2 cascade;cellular response to epidermal growth factor stimulus;cellular response to estradiol stimulus;cellular response to hypoxia;cellular response to dexamethasone stimulus;cellular response to nitric oxide;positive regulation of glomerular mesangial cell proliferation;negative regulation of myoblast fusion;positive regulation of extracellular matrix organization;negative regulation of reactive oxygen species biosynthetic process;negative regulation of cellular response to transforming growth factor beta stimulus;negative regulation of hepatocyte apoptotic process;negative regulation of epithelial cell apoptotic process;positive regulation of hepatocyte proliferation;negative regulation of extrinsic apoptotic signaling pathway;death-inducing signaling complex;CD95 death-inducing signaling complex;membrane raft;ripoptosome	3D-structure;Alternative splicing;Apoptosis;Host-virus interaction;Polymorphism;Reference proteome;Repeat	R-HSA-162582;R-HSA-73887;R-HSA-75158	Signal Transduction;Death Receptor Signalling;TRAIL  signaling
COQ8A	negative	PKM	ENSG00000067225	COQ8A	1	COQ8A	1	0.00855126794977723	WBGene00009126;WBGene00014001	WBGene00009126(1);WBGene00014001(1)			GO:0003723;GO:0005634;GO:0005737;GO:0046872;GO:0000166;GO:0005524;GO:0016301;GO:0016740;GO:0016310;GO:0005829;GO:0000287;GO:0003824;GO:0006096;GO:0005739;GO:0005515;GO:0008152;GO:0004743;GO:0030955;GO:0005576;GO:0045296;GO:0070062;GO:0062023;GO:0043312;GO:0034774;GO:1904813;GO:0031982;GO:0012501;GO:1903672;GO:1903561;GO:0061621;GO:0023026;GO:0032869;GO:0042802;GO:0043531;GO:0070324;GO:0001666;GO:0001889;GO:0006006;GO:0006754;GO:0007584;GO:0009629;GO:0010033;GO:0014870;GO:0031100;GO:0032868;GO:0042866;GO:0043403;GO:0051289;GO:0005929;GO:1902912	glycolytic process;magnesium ion binding;catalytic activity;pyruvate kinase activity;potassium ion binding;RNA binding;nucleus;cytoplasm;metal ion binding;nucleotide binding;ATP binding;kinase activity;transferase activity;phosphorylation;cytosol;mitochondrion;protein binding;metabolic process;extracellular region;cadherin binding;extracellular exosome;collagen-containing extracellular matrix;neutrophil degranulation;secretory granule lumen;ficolin-1-rich granule lumen;vesicle;programmed cell death;positive regulation of sprouting angiogenesis;extracellular vesicle;canonical glycolysis;MHC class II protein complex binding;cellular response to insulin stimulus;identical protein binding;ADP binding;thyroid hormone binding;response to hypoxia;liver development;glucose metabolic process;ATP biosynthetic process;response to nutrient;response to gravity;response to organic substance;response to muscle inactivity;animal organ regeneration;response to insulin;pyruvate biosynthetic process;skeletal muscle tissue regeneration;cilium;pyruvate kinase complex	3D-structure;ATP-binding;Acetylation;Allosteric enzyme;Alternative splicing;Cytoplasm;Direct protein sequencing;Glycolysis;Hydroxylation;Isopeptide bond;Kinase;Magnesium;Metal-binding;Methylation;Nucleotide-binding;Nucleus;Phosphoprotein;Polymorphism;Potassium;Pyruvate;Reference proteome;Transferase;Ubl conjugation	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ8A	negative	P4HA2	ENSG00000072682	COQ8A	1	COQ8A	1	0.00855126794977723	WBGene00001077;WBGene00004025;WBGene00012815	WBGene00077688(0);WBGene00004026(0);WBGene00015773(0)		MYOPIA 25 AUTOSOMAL DOMINANT	GO:0043231;GO:0046872;GO:0005783;GO:0005829;GO:0005654;GO:0016491;GO:0055114;GO:0005506;GO:0016705;GO:0031418;GO:0051213;GO:0022900;GO:0016702;GO:0005788;GO:0004656;GO:0009055;GO:0018401;GO:0005515;GO:0019511	protein binding;oxidation-reduction process;oxidoreductase activity;endoplasmic reticulum;oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen;iron ion binding;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen;L-ascorbic acid binding;procollagen-proline 4-dioxygenase activity;intracellular membrane-bounded organelle;metal ion binding;nucleoplasm;cytosol;dioxygenase activity;electron transport chain;endoplasmic reticulum lumen;electron transfer activity;peptidyl-proline hydroxylation to 4-hydroxy-L-proline;peptidyl-proline hydroxylation	3D-structure;Alternative splicing;Dioxygenase;Disease mutation;Endoplasmic reticulum;Glycoprotein;Iron;Metal-binding;Oxidoreductase;Reference proteome;Signal;TPR repeat;Vitamin C	R-HSA-1474244;R-HSA-1474290;R-HSA-1650814	Extracellular matrix organization;Collagen formation;Collagen biosynthesis and modifying enzymes
COQ8A	negative	ITGB8	ENSG00000105855	COQ8A	1	COQ8A	1	0.00855126794977723					GO:0045766;GO:0016020;GO:0016021;GO:0007155;GO:0005886;GO:0007229;GO:0051216;GO:0009986;GO:0008305;GO:0038023;GO:0070062;GO:0010628;GO:0016477;GO:0005178;GO:0033627;GO:0010629;GO:0030198;GO:0001570;GO:1990430;GO:1901388;GO:0034686;GO:0060674;GO:0007160;GO:0005102;GO:0001573	cell adhesion;integrin complex;signaling receptor activity;cell-matrix adhesion;integrin-mediated signaling pathway;positive regulation of angiogenesis;membrane;integral component of membrane;plasma membrane;cartilage development;cell surface;extracellular exosome;positive regulation of gene expression;cell migration;integrin binding;cell adhesion mediated by integrin;focal adhesion;negative regulation of gene expression;extracellular matrix organization;vasculogenesis;extracellular matrix protein binding;regulation of transforming growth factor beta activation;integrin alphav-beta8 complex;placenta blood vessel development;signaling receptor binding;ganglioside metabolic process	3D-structure;Alternative splicing;Cell adhesion;Cell membrane;Disulfide bond;Glycoprotein;Integrin;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1474244;R-HSA-216083;R-HSA-1566948;R-HSA-2129379	Extracellular matrix organization;Integrin cell surface interactions;Elastic fibre formation;Molecules associated with elastic fibres
COQ8A	negative	LPXN	ENSG00000110031	COQ8A	1	COQ8A	1	0.00855126794977723	WBGene00016197	WBGene00016389(0);WBGene00018000(0);WBGene00016197(0)			GO:0005634;GO:0005737;GO:0016607;GO:0016020;GO:0046872;GO:0005829;GO:0007155;GO:0005925;GO:0005886;GO:0042995;GO:0005515;GO:0048471;GO:0030054;GO:1903506;GO:0003712;GO:0002102;GO:0007165;GO:0065003;GO:0007162;GO:0050859;GO:0033628	nucleus;cytoplasm;nuclear speck;membrane;metal ion binding;cytosol;cell adhesion;focal adhesion;plasma membrane;cell projection;protein binding;perinuclear region of cytoplasm;cell junction;regulation of nucleic acid-templated transcription;transcription coregulator activity;podosome;signal transduction;protein-containing complex assembly;negative regulation of cell adhesion;negative regulation of B cell receptor signaling pathway;regulation of cell adhesion mediated by integrin;cytoskeleton	3D-structure;Acetylation;Activator;Alternative splicing;Cell adhesion;Cell junction;Cell membrane;Cell projection;Cytoplasm;LIM domain;Membrane;Metal-binding;Nucleus;Phosphoprotein;Polymorphism;Reference proteome;Repeat;Transcription;Transcription regulation;Zinc		
COQ8A	negative	TMEM165	ENSG00000134851	COQ8A	1	COQ8A	1	0.00855126794977723	WBGene00021847	WBGene00021847(1)		TMEM165-CDG;Congenital disorder of glycosylation type IIk;Congenital disorder of glycosylation type IIk	GO:0016020;GO:0016021;GO:0005794;GO:0043231;GO:0005765;GO:0000139;GO:0005764;GO:0005768;GO:0031902;GO:0031901;GO:0010008;GO:0006487;GO:0032588;GO:0006874;GO:0032472;GO:0035751	membrane;integral component of membrane;cell;Golgi apparatus;intracellular membrane-bounded organelle;endosome;lysosomal membrane;Golgi membrane;lysosome;late endosome membrane;early endosome membrane;endosome membrane;protein N-linked glycosylation;calcium ion transmembrane transport;trans-Golgi network membrane;cellular calcium ion homeostasis;manganese ion transmembrane transporter activity;Golgi calcium ion transport;regulation of lysosomal lumen pH;calcium ion transmembrane transporter activity;metal ion transmembrane transporter activity;Golgi calcium ion homeostasis;manganese ion transmembrane transport	Alternative splicing;Coiled coil;Congenital disorder of glycosylation;Disease mutation;Endosome;Golgi apparatus;Lysosome;Membrane;Reference proteome;Signal;Transmembrane;Transmembrane helix		
COQ8A	negative	CKAP4	ENSG00000136026	COQ8A	1	COQ8A	1	0.00855126794977723		WBGene00004873(0);WBGene00012198(0);WBGene00019087(0)			GO:0003723;GO:0005737;GO:0016607;GO:0016020;GO:0016021;GO:0005829;GO:0005783;GO:0005789;GO:0005886;GO:0005856;GO:0048471;GO:0036464;GO:0070062;GO:0044267;GO:0043687;GO:0043312;GO:0035579;GO:0005788;GO:0035577;GO:0005811;GO:0005791;GO:0042599	RNA binding;cytoplasm;nuclear speck;membrane;integral component of membrane;cytosol;endoplasmic reticulum;endoplasmic reticulum membrane;cytoskeleton;plasma membrane;perinuclear region of cytoplasm;cytoplasmic ribonucleoprotein granule;extracellular exosome;cellular protein metabolic process;post-translational protein modification;neutrophil degranulation;specific granule membrane;endoplasmic reticulum lumen;azurophil granule membrane;lipid droplet;rough endoplasmic reticulum;lamellar body	Acetylation;Cell membrane;Coiled coil;Cytoplasm;Cytoskeleton;Direct protein sequencing;Endoplasmic reticulum;Lipoprotein;Membrane;Palmitate;Phosphoprotein;Polymorphism;Reference proteome;Signal-anchor;Transmembrane;Transmembrane helix	R-HSA-168249;R-HSA-168256;R-HSA-392499;R-HSA-597592;R-HSA-6798695;R-HSA-381426;R-HSA-8957275;R-HSA-5683826	Innate Immune System;Immune System;Metabolism of proteins;Post-translational protein modification;Neutrophil degranulation;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Post-translational protein phosphorylation;Surfactant metabolism
COQ8A	negative	EXOG	ENSG00000157036	COQ8A	1	COQ8A	1	0.00855126794977723	WBGene00000787				GO:0003676;GO:0016020;GO:0046872;GO:0016787;GO:0005743;GO:0005739;GO:0004519;GO:0090502;GO:0004518;GO:0005634;GO:0008150;GO:0032991;GO:0004521;GO:0006309;GO:0000014;GO:0000737;GO:0008409;GO:0016021	metal ion binding;hydrolase activity;nucleic acid binding;membrane;mitochondrion;mitochondrial inner membrane;nuclease activity;endonuclease activity;RNA phosphodiester bond hydrolysis, endonucleolytic;nucleus;biological_process;protein-containing complex;endoribonuclease activity;apoptotic DNA fragmentation;DNA catabolic process, endonucleolytic;5'-3' exonuclease activity;single-stranded DNA endodeoxyribonuclease activity;integral component of membrane	3D-structure;Alternative splicing;Endonuclease;Hydrolase;Membrane;Metal-binding;Mitochondrion;Mitochondrion inner membrane;Nuclease;Polymorphism;Reference proteome;Transit peptide		
COQ8A	negative	S100A11	ENSG00000163191	COQ8A	1	COQ8A	1	0.00855126794977723					GO:0005634;GO:0005737;GO:0046872;GO:0005509;GO:0005615;GO:0042803;GO:0005515;GO:0007165;GO:0005576;GO:0048306;GO:0042127;GO:0070062;GO:0043312;GO:0098641;GO:0098609;GO:0005913;GO:0001726;GO:0034774;GO:0008285;GO:0044548;GO:0008156	calcium ion binding;calcium-dependent protein binding;regulation of cell population proliferation;nucleus;cytoplasm;metal ion binding;extracellular space;protein homodimerization activity;protein binding;signal transduction;extracellular region;extracellular exosome;neutrophil degranulation;cadherin binding involved in cell-cell adhesion;cell-cell adhesion;adherens junction;ruffle;secretory granule lumen;negative regulation of cell population proliferation;S100 protein binding;negative regulation of DNA replication;positive regulation of smooth muscle cell migration	3D-structure;Acetylation;Calcium;Cytoplasm;Direct protein sequencing;Disulfide bond;Metal-binding;Nucleus;Phosphoprotein;Reference proteome;Repeat	R-HSA-168249;R-HSA-168256;R-HSA-6798695	Innate Immune System;Immune System;Neutrophil degranulation
COQ8A	negative	TLCD3A	ENSG00000167695	COQ8A	1	COQ8A	1	0.00855126794977723					GO:0016020;GO:0016021;GO:0005886;GO:0005515;GO:0008150	integral component of membrane;membrane;plasma membrane;protein binding;biological_process	Alternative splicing;Cell membrane;Membrane;Reference proteome;Transmembrane;Transmembrane helix		
COQ8A	negative	TUBB6	ENSG00000176014	COQ8A	1	COQ8A	1	0.00855126794977723	WBGene00003171;WBGene00000248;WBGene00006536;WBGene00006537;WBGene00006538	WBGene00006539(0);WBGene00000248(0);WBGene00006536(0);WBGene00006537(0);WBGene00006532(0)		FACIAL PALSY CONGENITAL WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION	GO:0003924;GO:0005525;GO:0005200;GO:0007010;GO:0005874;GO:0007017;GO:0005634;GO:0005737;GO:0000166;GO:0005856;GO:0005515;GO:0000226;GO:0000278;GO:0070062;GO:0003674	GTP binding;microtubule-based process;microtubule;GTPase activity;structural constituent of cytoskeleton;cytoskeleton organization;nucleus;cytoplasm;nucleotide binding;cytoskeleton;protein binding;microtubule cytoskeleton organization;mitotic cell cycle;extracellular exosome;molecular_function	Cytoplasm;Cytoskeleton;Disease mutation;GTP-binding;Isopeptide bond;Microtubule;Nucleotide-binding;Phosphoprotein;Reference proteome	R-HSA-109582;R-HSA-1280218;R-HSA-168256;R-HSA-5653656;R-HSA-1266738;R-HSA-1852241;R-HSA-5617833;R-HSA-5620924;R-HSA-392499;R-HSA-597592;R-HSA-373760;R-HSA-422475;R-HSA-437239;R-HSA-162582;R-HSA-194315;R-HSA-1640170;R-HSA-199991;R-HSA-6811434;R-HSA-6811442;R-HSA-8856688;R-HSA-446203;R-HSA-2262752;R-HSA-2467813;R-HSA-2555396;R-HSA-453274;R-HSA-5358351;R-HSA-5610787;R-HSA-68882;R-HSA-68886;R-HSA-69275;R-HSA-69278;R-HSA-8852276;R-HSA-8953897;R-HSA-112314;R-HSA-112315;R-HSA-112316;R-HSA-195258;R-HSA-1445148;R-HSA-157858;R-HSA-190828;R-HSA-190840;R-HSA-190861;R-HSA-190872;R-HSA-199977;R-HSA-2132295;R-HSA-2500257;R-HSA-3371497;R-HSA-380320;R-HSA-389958;R-HSA-389960;R-HSA-389977;R-HSA-390466;R-HSA-391251;R-HSA-438064;R-HSA-442755;R-HSA-5626467;R-HSA-5663220;R-HSA-6807878;R-HSA-6811436;R-HSA-68877;R-HSA-8955332;R-HSA-948021;R-HSA-9609736;R-HSA-9619483;R-HSA-983189;R-HSA-983231;R-HSA-389957	Hemostasis;Adaptive Immune System;Immune System;Vesicle-mediated transport;Developmental Biology;Organelle biogenesis and maintenance;Cilium Assembly;Intraflagellar transport;Metabolism of proteins;Post-translational protein modification;L1CAM interactions;Axon guidance;Recycling pathway of L1;Signal Transduction;Signaling by Rho GTPases;Cell Cycle;Membrane Trafficking;COPI-dependent Golgi-to-ER retrograde traffic;Intra-Golgi and retrograde Golgi-to-ER traffic;Golgi-to-ER retrograde transport;Asparagine N-linked glycosylation;Cellular responses to stress;Separation of Sister Chromatids;Mitotic Metaphase and Anaphase;Mitotic G2-G2/M phases;Signaling by Hedgehog;Hedgehog 'off' state;Mitotic Anaphase;M Phase;G2/M Transition;Cell Cycle, Mitotic;The role of GTSE1 in G2/M progression after G2 checkpoint;Cellular responses to external stimuli;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Neuronal System;RHO GTPase Effectors;Translocation of SLC2A4 (GLUT4) to the plasma membrane;Gap junction trafficking and regulation;Gap junction trafficking;Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane;Gap junction assembly;Transport of connexons to the plasma membrane;ER to Golgi Anterograde Transport;MHC class II antigen presentation;Resolution of Sister Chromatid Cohesion;HSP90 chaperone cycle for steroid hormone receptors (SHR);Recruitment of NuMA to mitotic centrosomes;Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding;Formation of tubulin folding intermediates by CCT/TriC;Post-chaperonin tubulin folding pathway;Chaperonin-mediated protein folding;Protein folding;Post NMDA receptor activation events;Activation of NMDA receptors and postsynaptic events;RHO GTPases activate IQGAPs;RHO GTPases Activate Formins;COPI-mediated anterograde transport;COPI-independent Golgi-to-ER retrograde traffic;Mitotic Prometaphase;Carboxyterminal post-translational modifications of tubulin;Transport to the Golgi and subsequent modification;Assembly and cell surface presentation of NMDA receptors;Activation of AMPK downstream of NMDARs;Kinesins;Factors involved in megakaryocyte development and platelet production;Prefoldin mediated transfer of substrate  to CCT/TriC
COQ8A	negative	SPRED2	ENSG00000198369	COQ8A	1	COQ8A	1	0.00855126794977723		WBGene00006770(0)			GO:0005737;GO:0016020;GO:0007275;GO:0005886;GO:0005515;GO:0031410;GO:0009966;GO:0005829;GO:0019901;GO:0010801;GO:0008543;GO:0030658;GO:0030291;GO:0043517;GO:0000188;GO:0090311;GO:0005173	membrane;multicellular organism development;regulation of signal transduction;cytoplasm;plasma membrane;protein binding;cytoplasmic vesicle;cytosol;protein kinase binding;negative regulation of peptidyl-threonine phosphorylation;fibroblast growth factor receptor signaling pathway;transport vesicle membrane;protein serine/threonine kinase inhibitor activity;positive regulation of DNA damage response, signal transduction by p53 class mediator;inactivation of MAPK activity;regulation of protein deacetylation;stem cell factor receptor binding	3D-structure;Alternative splicing;Cell membrane;Cytoplasm;Cytoplasmic vesicle;Membrane;Phosphoprotein;Reference proteome;Ubl conjugation	R-HSA-168256;R-HSA-162582;R-HSA-1643685;R-HSA-1280215;R-HSA-449147;R-HSA-449836;R-HSA-5658442;R-HSA-5663202;R-HSA-5673001;R-HSA-5683057;R-HSA-5684996;R-HSA-9607240;R-HSA-9006934;R-HSA-6802957;R-HSA-190236;R-HSA-5654736;R-HSA-5658623;R-HSA-6802949	Immune System;Signal Transduction;Disease;Cytokine Signaling in Immune system;Signaling by Interleukins;Other interleukin signaling;Regulation of RAS by GAPs;Diseases of signal transduction;RAF/MAP kinase cascade;MAPK family signaling cascades;MAPK1/MAPK3 signaling;FLT3 Signaling;Signaling by Receptor Tyrosine Kinases;Oncogenic MAPK signaling;Signaling by FGFR;Signaling by FGFR1;FGFRL1 modulation of FGFR1 signaling;Signaling by RAS mutants
COQ8A	negative	PI4K2B	ENSG00000038210	COQ8A	1	COQ8A	1	0.00936032256270936	WBGene00022501;WBGene00008346	WBGene00022501(1);WBGene00008346(1)			GO:0016301;GO:0016310;GO:0007030;GO:0005886;GO:0005802;GO:0004430;GO:0007032;GO:0046854;GO:0005768;GO:0005737;GO:0016020;GO:0000166;GO:0005524;GO:0016740;GO:0005829;GO:0006661	1-phosphatidylinositol 4-kinase activity;kinase activity;phosphorylation;plasma membrane;Golgi organization;trans-Golgi network;endosome organization;phosphatidylinositol phosphorylation;endosome;cytoplasm;membrane;nucleotide binding;ATP binding;transferase activity;cytosol;phosphatidylinositol biosynthetic process	3D-structure;ATP-binding;Cytoplasm;Kinase;Membrane;Nucleotide-binding;Phosphoprotein;Polymorphism;Reference proteome;Transferase	R-HSA-1430728;R-HSA-556833;R-HSA-1483255;R-HSA-1483257;R-HSA-1660499;R-HSA-1660514;R-HSA-1660516;R-HSA-1483248	Metabolism;Metabolism of lipids;PI Metabolism;Phospholipid metabolism;Synthesis of PIPs at the plasma membrane;Synthesis of PIPs at the Golgi membrane;Synthesis of PIPs at the early endosome membrane;Synthesis of PIPs at the ER membrane
COQ8A	negative	IL1A	ENSG00000115008	COQ8A	1	COQ8A	1	0.00936032256270936					GO:0005615;GO:0045766;GO:0008285;GO:0005576;GO:0005829;GO:0005515;GO:0006955;GO:0006954;GO:0005125;GO:0005149;GO:0071222;GO:0030593;GO:0010628;GO:0070498;GO:0051781;GO:0001660;GO:0019221;GO:0032755;GO:0005507;GO:0043123;GO:0046330;GO:0006915;GO:2001240;GO:0034605;GO:0045840;GO:0010575;GO:0050715;GO:0002248;GO:0035234;GO:0045086;GO:0045944;GO:0046688;GO:0050714;GO:0097192	extracellular region;cytokine activity;immune response;inflammatory response;extracellular space;interleukin-1 receptor binding;positive regulation of angiogenesis;negative regulation of cell population proliferation;positive regulation of tumor necrosis factor secretion;positive regulation of interleukin-6 secretion;cytosol;protein binding;cellular response to lipopolysaccharide;positive regulation of cell division;positive regulation of gene expression;interleukin-1-mediated signaling pathway;fever generation;cytokine-mediated signaling pathway;copper ion binding;apoptotic process;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;positive regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to heat;positive regulation of mitotic nuclear division;positive regulation of vascular endothelial growth factor production;positive regulation of cytokine secretion;positive regulation of interleukin-2 secretion;connective tissue replacement involved in inflammatory response wound healing;inflammatory response to antigenic stimulus;ectopic germ cell programmed cell death;positive regulation of interleukin-2 biosynthetic process;positive regulation of transcription by RNA polymerase II;response to copper ion;positive regulation of protein secretion;extrinsic apoptotic signaling pathway in absence of ligand	3D-structure;Cytokine;Direct protein sequencing;Glycoprotein;Inflammatory response;Lipoprotein;Mitogen;Myristate;Phosphoprotein;Polymorphism;Pyrogen;Reference proteome;Secreted	R-HSA-168256;R-HSA-1280215;R-HSA-2262752;R-HSA-446652;R-HSA-449147;R-HSA-8953897;R-HSA-9020702;R-HSA-2559583;R-HSA-6783783;R-HSA-6785807;R-HSA-2559582;R-HSA-448706	Immune System;Cytokine Signaling in Immune system;Cellular responses to stress;Interleukin-1 family signaling;Signaling by Interleukins;Cellular responses to external stimuli;Interleukin-1 signaling;Cellular Senescence;Interleukin-10 signaling;Interleukin-4 and Interleukin-13 signaling;Senescence-Associated Secretory Phenotype (SASP);Interleukin-1 processing
COQ8A	negative	OSMR	ENSG00000145623	COQ8A	1	COQ8A	1	0.00936032256270936				Familial primary localized cutaneous amyloidosis;AMYLOIDOSIS PRIMARY LOCALIZED CUTANEOUS 1	GO:0008284;GO:0002675;GO:0016020;GO:0016021;GO:0005515;GO:0004896;GO:0009897;GO:0005886;GO:0043235;GO:0019221;GO:0019838;GO:0019955;GO:0034097;GO:0038165;GO:0016324;GO:0004924;GO:0005900	protein binding;positive regulation of cell population proliferation;positive regulation of acute inflammatory response;membrane;integral component of membrane;external side of plasma membrane;plasma membrane;cytokine receptor activity;receptor complex;cytokine-mediated signaling pathway;growth factor binding;cytokine binding;response to cytokine;oncostatin-M-mediated signaling pathway;apical plasma membrane;oncostatin-M receptor activity;oncostatin-M receptor complex	Alternative splicing;Amyloidosis;Disease mutation;Disulfide bond;Glycoprotein;Membrane;Phosphoprotein;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-168256;R-HSA-1280215;R-HSA-449147;R-HSA-6783589;R-HSA-6788467	Immune System;Cytokine Signaling in Immune system;Signaling by Interleukins;Interleukin-6 family signaling;IL-6-type cytokine receptor ligand interactions
COQ8A	negative	TPBG	ENSG00000146242	COQ8A	1	COQ8A	1	0.00936032256270936	WBGene00007261	WBGene00021353(0)			GO:0016020;GO:0016021;GO:0005886;GO:0009986;GO:0005887;GO:0007155;GO:0051965;GO:0005737;GO:0005783;GO:0005515	protein binding;membrane;integral component of membrane;plasma membrane;cell surface;integral component of plasma membrane;cell adhesion;positive regulation of synapse assembly;cytoplasm;endoplasmic reticulum	3D-structure;Cell membrane;Direct protein sequencing;Disulfide bond;Glycoprotein;Leucine-rich repeat;Membrane;Phosphoprotein;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix		
COQ8A	negative	LRP12	ENSG00000147650	COQ8A	1	COQ8A	1	0.00936032256270936	WBGene00003075;WBGene00004374;WBGene00008609;WBGene00015083;WBGene00019756;WBGene00019811				GO:0005515;GO:0016020;GO:0016021;GO:0007165;GO:0005905;GO:0005887;GO:0006897;GO:0040008;GO:0031175;GO:0005041;GO:0001764	protein binding;membrane;integral component of membrane;signal transduction;clathrin-coated pit;endocytosis;integral component of plasma membrane;regulation of growth;neuron projection development;low-density lipoprotein particle receptor activity;neuron migration	Alternative splicing;Coated pit;Disulfide bond;Endocytosis;Glycoprotein;Membrane;Polymorphism;Receptor;Reference proteome;Repeat;Signal;Transmembrane;Transmembrane helix	R-HSA-1430728;R-HSA-162582;R-HSA-372790;R-HSA-388396;R-HSA-418594;R-HSA-196854;R-HSA-2187338;R-HSA-6806667;R-HSA-975634	Metabolism;Signal Transduction;Signaling by GPCR;GPCR downstream signalling;G alpha (i) signalling events;Metabolism of vitamins and cofactors;Visual phototransduction;Metabolism of fat-soluble vitamins;Retinoid metabolism and transport
COQ8A	negative	SLC2A6	ENSG00000160326	COQ8A	1	COQ8A	1	0.00936032256270936		WBGene00013074(0);WBGene00010811(0);WBGene00008730(0);WBGene00019550(0);WBGene00019549(0);WBGene00043980(0);WBGene00017382(0);WBGene00019548(0);WBGene00019547(0);WBGene00016431(0);WBGene00010684(0);WBGene00012536(0);WBGene00019207(0)			GO:0016020;GO:0016021;GO:0022857;GO:0055085;GO:0005765;GO:1902600;GO:0008643;GO:0005764;GO:0005886;GO:0005887;GO:0008645;GO:0006110;GO:0005351;GO:1904659;GO:0005355;GO:0005353;GO:0033300;GO:0015755;GO:0070837;GO:0005215	integral component of membrane;membrane;transmembrane transporter activity;transmembrane transport;lysosomal membrane;proton transmembrane transport;carbohydrate transport;lysosome;plasma membrane;integral component of plasma membrane;hexose transmembrane transport;regulation of glycolytic process;carbohydrate:proton symporter activity;glucose import;glucose transmembrane transport;glucose transmembrane transporter activity;fructose transmembrane transporter activity;dehydroascorbic acid transmembrane transporter activity;fructose transmembrane transport;dehydroascorbic acid transport	Alternative splicing;Glycoprotein;Lysosome;Membrane;Phosphoprotein;Polymorphism;Reference proteome;Sugar transport;Transmembrane;Transmembrane helix;Transport	R-HSA-189200;R-HSA-382551;R-HSA-425407	Cellular hexose transport;Transport of small molecules;SLC-mediated transmembrane transport
COQ8A	negative	SPATS2L	ENSG00000196141	COQ8A	1	COQ8A	1	0.00936032256270936	WBGene00022114	WBGene00022114(0)			GO:0003723;GO:0005634;GO:0005737;GO:0005730;GO:0005829;GO:0032991;GO:0005515	protein binding;RNA binding;nucleus;cytoplasm;nucleoplasm;nucleolus;cytosol;protein-containing complex	Acetylation;Alternative splicing;Coiled coil;Cytoplasm;Nucleus;Phosphoprotein;Reference proteome		
COQ8A	negative	LAMB3	ENSG00000196878	COQ8A	1	COQ8A	1	0.00936032256270936				Hypoplastic amelogenesis imperfecta;Junctional epidermolysis bullosa generalized intermediate;Junctional epidermolysis bullosa generalized severe;Amelogenesis imperfecta type IA;EPIDERMOLYSIS BULLOSA JUNCTIONAL HERLITZ TYPE;EPIDERMOLYSIS BULLOSA JUNCTIONAL NON-HERLITZ TYPE	GO:0007155;GO:0005576;GO:0009887;GO:0009888;GO:0005515;GO:0005201;GO:0016477;GO:0034446;GO:0070831;GO:0005604;GO:0043256;GO:0062023;GO:0005178;GO:0030198;GO:0005198;GO:0008544;GO:0031581;GO:0035987;GO:0044877;GO:0050873;GO:0005610	cell adhesion;extracellular region;protein binding;animal organ morphogenesis;tissue development;extracellular matrix structural constituent;cell migration;substrate adhesion-dependent cell spreading;basement membrane assembly;basement membrane;laminin complex;collagen-containing extracellular matrix;integrin binding;extracellular matrix organization;structural molecule activity;epidermis development;hemidesmosome assembly;endodermal cell differentiation;protein-containing complex binding;brown fat cell differentiation;laminin-5 complex	Amelogenesis imperfecta;Basement membrane;Cell adhesion;Coiled coil;Direct protein sequencing;Disease mutation;Disulfide bond;Epidermolysis bullosa;Extracellular matrix;Glycoprotein;Laminin EGF-like domain;Polymorphism;Reference proteome;Repeat;Secreted;Signal	R-HSA-162582;R-HSA-1474228;R-HSA-1474244;R-HSA-1474290;R-HSA-2022090;R-HSA-9006934;R-HSA-1500931;R-HSA-3000171;R-HSA-446728;R-HSA-6806834;R-HSA-3000157;R-HSA-8874081;R-HSA-8875878;R-HSA-2214320;R-HSA-446107	Signal Transduction;Degradation of the extracellular matrix;Extracellular matrix organization;Collagen formation;Assembly of collagen fibrils and other multimeric structures;Signaling by Receptor Tyrosine Kinases;Cell-Cell communication;Non-integrin membrane-ECM interactions;Cell junction organization;Signaling by MET;Laminin interactions;MET activates PTK2 signaling;MET promotes cell motility;Anchoring fibril formation;Type I hemidesmosome assembly
COQ8A	negative	TMEM185B	ENSG00000226479	COQ8A	1	COQ8A	1	0.00936032256270936	WBGene00013789	WBGene00013789(0)			GO:0016020;GO:0016021	membrane;integral component of membrane	Membrane;Reference proteome;Transmembrane;Transmembrane helix		
